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Fragile X syndrome (FXS) is the most commonly inherited form of intellectual 
disability as well as a leading genetic cause of autism spectrum disorder. It is typically 
the result of a trinucleotide repeat expansion in the Fmr1 gene which leads to loss of 
the encoded protein, fragile X mental retardation protein (FMRP).  
 
Animal model studies over the past twenty years, mainly focusing on the Fmr1 
knockout (KO) mouse, have uncovered several cellular and behavioural phenotypes 
associated with the loss of FMRP. Seminal work using the Fmr1 KO mouse found that 
metabotropic glutamate receptor mediated long-term depression (mGluR-LTD) in the 
hippocampus is both exaggerated (Huber et al., 2002) and independent of new protein 
synthesis (Nosyreva & Huber, 2006). These findings, together with studies focusing 
on other brain regions including the prefrontal cortex (Zhao et al., 2005) and amygdala 
(Suvrathan et al., 2010), have contributed to the ‘mGluR theory of FXS’ (Bear et al., 
2004) which suggests that group 1 metabotropic receptor function is exaggerated in 
FXS. 
 
The development of genetically modified rats allows the modelling of FXS in an 
animal model with more complex cognitive and social behaviours than has been 
previously available. It also provides an opportunity for comparison of phenotypes 
across mammalian species that result from FMRP deletion. While the study of Fmr1 
rats can significantly contribute to our understanding of FXS, we must first confirm 
the assumption that cellular phenotypes are conserved across mouse and rat models. 
 
In this thesis, we first aimed to test if the key cellular and synaptic phenotypes that 
contribute to the ‘mGluR theory of FXS’ are conserved in both the hippocampus and 
amygdala of Fmr1 KO rats. In agreement with mouse studies, we found mGluR-LTD 
was both enhanced and independent of new protein synthesis in Fmr1 KO rats. 
Similarly, group 1 mGluR long-term potentiation (LTP) was significantly decreased 
at both cortical and thalamic inputs to the lateral amygdala. 
iv 
 
Secondly, we investigated mPFC intrinsic excitability and synaptic plasticity in Fmr1 
KO rats. The mPFC plays a key role in several of the cognitive functions that are 
affected in fragile X patients including attention, cognitive flexibility and anxiety 
(Goto et al., 2010). The regulation of mPFC plasticity and intrinsic excitability has 
also been associated with mGluR signalling. Here we found that intralaminar LTP in 
the mPFC showed an age-dependent deficit in Fmr1 KO rats. The mPFC also provides 
top down control of several cortical and subcortical regions through long-range 
connectivity. One pathway of interest in the study of FXS is mPFC-amygdala 
connectivity which is associated with fear learning and anxiety behaviours (Burgos-
Robles et al., 2009). Using retrograde tracing, we showed layer 5 pyramidal neurons 
that provide long-range connections to the basal amygdala were intrinsically 
hypoexcitable in Fmr1 KO rats. This phenotype could possibly be explained through 
homeostatic changes in the axon initial segment which regulates neuronal excitability. 
 
This work provides the first evidence for conservation of cellular phenotypes 
associated with the loss of FMRP in mice and rats which will be key in the 
interpretation of future studies using Fmr1 KO rats. We also provide evidence of 
deficits in mPFC long-range connectivity to the basal amygdala, a pathway that is 
associated with FXS relevant behaviours. Together this highlights how study of the rat 
model of FXS can complement existing studies of Fmr1 KO mice as well as provide 
new insights into the pathophysiology resulting from the loss of FMRP. Some of this 











Fragile X syndrome is a common form of intellectual disability that can also result in 
Autism spectrum disorder. Due to its prevalence and well understood genetic cause, 
Fragile X has been widely studied in an attempt to determine what changes in brain 
function result in this syndrome. Until recently, this work has mainly been carried 
out using a mouse model of Fragile X syndrome which lacks the same protein as 
affected humans. Work using this model has greatly increased our understanding of 
how brains are affected in Fragile X syndrome as well as highlighted possible 
treatments to try and help people with the disorder. Recent advances in genetic 
manipulation have made it possible to create a rat model of Fragile X syndrome. Rats 
have some significant advantages over mice for the study of human disorders as they 
are larger, more intelligent and respond to drugs in a similar way to humans. 
Therefore the rat model of Fragile X syndrome could become a very useful tool for 
studying the human disorder. However, before using the rat model we must first test 
if some of the key findings discovered using mice are also present in the rats as this 
will inform future studies. 
In this thesis, I find that the main findings from studies of the Fragile X mouse which 
have led to clinical trials in human patients are also present in the new rat model of 
Fragile X syndrome. I also highlight changes in the function of multiple brain areas 
of the Fragile X rat that are involved in behaviours associated with Fragile X 
syndrome such as anxiety, memory and decision making. Overall, this work 
highlights that the rat is a good model for the study of Fragile X syndrome that will 
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1.1 Intellectual disability 
 
Intellectual disability (ID) is the most prevalent form of neurodevelopmental disorder 
(NDD) affecting between 1-3% of the population (Leonard & Wen 2002). It is 
characterized by an intelligence quotient (IQ) score of 70 or below at 18 years of age 
with cases ranging from mild (50-70) to severe (<50) (Ropers & Hamel 2005). ID can 
be caused by environmental influences including prenatal alcohol exposure, infection, 
birth complications or malnutrition but it is also known to have many genetic causes 
(Vissers et al. 2015). Genetic causes are thought to account for around 50% of ID cases 
however a genetic diagnosis is lacking in many cases with approximately 60% having 
no known cause (Rauch et al. 2012). 
 
The clinical heterogeneity of ID is reflected in its genetic heterogeneity with several 
hundreds of ID related genes identified. The X chromosome has been a main focus of 
ID research because of the gender bias that exists in ID populations with significantly 
more males affected than females (Leonard & Wen 2002). X-linked mutations 
resulting in monogenic forms of ID have now been identified in over 100 genes which 
collectively comprise approximately 10% of ID in males (Lubs et al. 2012). 
 
The identification of prevalent monogenic forms of ID has led to the generation of 
genetically engineered animal models to study the disorder. These models recapitulate 
many of the behavioural and physiological phenotypes associated with human 
mutations. This has allowed research into the underlying mechanism associated with 
ID causing mutations which allows us to identify potential therapeutic strategies. 
Given the significant phenotypic overlap of many distinct genetic causes of ID, it is 
possible that they may share common underlying pathophysiology that is amenable to 
common therapeutic intervention (Auerbach et al. 2011; Barnes et al. 2015). 
Therefore, in depth study of ID mutations that are available for animal modelling may 




1.2 Fragile X syndrome 
 
Fragile X syndrome (FXS) is the most commonly inherited form of intellectual 
disability affecting approximately 1: 4,000 males and 1: 8,000 females (de Vries et al. 
1997; Coffee et al. 2009). It was first identified by Martin & Bell in 1943 as a novel 
example of ID segregating in an X-linked fashion (Martin & Bell 1943). FXS is often 
first diagnosed in young children at 3 years of age on the basis of speech delay 
followed by genetic testing (Bailey et al. 2009). The severity of ID ranges from 
moderate to severe in some cases and is often found to worsen with age (Wright-
Talamante et al. 1996; Utari et al. 2010). 
 
FXS individuals present many physical features which become more obvious through 
development. Pre-pubertal males typically show normal growth but have larger head 
circumference. Infants may also present hypotonia, gastroesophageal reflux and 
middle ear infections that require medical attention (Hagerman & Hagerman 2002). 
Post-puberty features include a long face with prominent forehead and jaw as well as 
enlarged ears and macro-orchidism. Additional medical concerns can also include 
strabismus, seizures, joint hyperflexibility and excessive skin softness (Bagni et al. 
2012). 
 
The behaviour of FXS individuals is often associated with attention deficit 
hyperactivity disorder (ADHD), impulsivity, anxiety, repetitive language as well as 
poor eye contact (Cordeiro et al. 2011). These behaviours as well as social and 
language deficits often lead to the diagnosis of autism spectrum disorder (ASD) in 
FXS individuals. Approximately one-third of FXS individuals show concomitant 
diagnosis with ASD (Fombonne 2003). This accounts for ~0.5% of all ASD cases 
making the fragile X mutation the most common single gene cause of autism (Coffee 
et al. 2009). The precise link between FXS and ASD is unclear. Studies have identified 
that mutations in several FMRP interacting proteins such as cytoplasmic FMRP 
interacting protein 1 (CYFIP1) (Van Der Zwaag et al. 2010) and eukaryotic initiation 
factor 4E (eIF4E) (Neves-Pereira et al. 2009) can also result in ASD. Likewise, several 
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mRNA targets of FMRP encode proteins that are associated with ASD such as 
Neuroligin 3, Neurexin 1, SHANK3, PTEN, TSC2 and NF1 (Darnell et al. 2011). This 
overlap between FMRP and ASD linked genes may underlie the development of 
autistic phenotypes in FXS however it is still unknown why this affects only a 
subpopulation of individuals. 
 
1.2.1 Fmr1 gene 
 
Early genetic diagnosis of FXS began under a microscope with identification of the 
‘marker X chromosome’ which showed non-staining gaps near the long end of the X 
chromosome (Lubs 1969). This results in a constriction near the q27 site which is 
prone to breakage resulting in chromosomal lesion, hence the name ‘Fragile X’. Using 
methods emerging from the human genome project both the mutation and gene 
associated with this fragile site were identified (Kremer et al. 1991; Verkerk et al. 
1991). The gene, named fragile X mental retardation 1 (FMR1), contains a 
polymorphic CGG repeat in the 5’ untranslated region of exon 1. It is the unstable 
expansion of this trinucleotide sequence that has been identified as the most common 
cause of FXS. FMR1 has three allelic categories which vary depending on this triplet 
repeat expansion. Unaffected individuals carry alleles contain 5 to 44 repeats, with the 
most common allele comprising 29-30 repeats (Nelson et al. 2013) . Premutation 
alleles containing between 55-200 repeats and are associated with phenotypes that are 
not FXS related. Approximately 25% of female carriers are at risk of developing what 
is known as fragile X associated premature ovarian insufficiency (FXPOI) which 
results in ovarian dysfunction and early menopause (Conway et al. 1998). Premutation 
carriers can also develop fragile X associated tremor ataxia syndrome (FXTAS), a late 
onset neurodegenerative condition, however males are at a significantly greater risk 
(Jacquemont et al. 2004). Finally, full mutations contain in excess of 200 repeats. In 
all cases, full mutations are derived from maternal premutations with the length of the 
maternal premutation directly proportional to the risk of expansion in to the full 
mutation range (Fu et al. 1991). In this range, an epigenetic trigger occurs leading to 
hypermethylation of the gene resulting in transcriptional silencing and loss of the gene 
product, fragile X mental retardation protein (FMRP) (Pieretti et al. 1991). Null 
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mutations can also arise from conventional mutations that disrupt the FMR1 gene 
however these are infrequently reported. Two reports of missense mutations have also 
been identified, I340N and R138Q (Feng et al. 1997), in screens of males suspected of 
FXS without the trinucleotide expansion however it is likely that several more exist. 
 
1.2.2 Modelling FXS 
 
The development of FXS animal models has greatly advanced our understanding of 
how the loss of FMRP gives rise to FXS phenotypes.  The FMR1 gene is highly 
conserved across multiple species (Verkerk et al. 1991). This has led to the generation 
of multiple animal models of FXS however the majority of studies have used the Fmr1 
KO mouse as their model. As in the human genome, the mouse Fmr1 gene is located 
on the X chromosome and shows 97% amino acid sequence identity with human 
FMRP (Ashley et al. 1993). The expression level and location of FMRP is also similar 
in mouse tissue compared with human tissue (Bakker et al. 2000).  
 
As human FXS is caused by the absence of FMRP, the initial strategy to make a mouse 
model of FXS was to disrupt the Fmr1 gene. This was achieved by the Dutch-Belgian 
fragile X Consortium who created and initially characterised the Fmr1 KO mouse 
(Bakker et al. 1994). This is in contrast to human FXS, which is typically caused by 
expansion of the FMR1 gene and hypermethylation of the promoter region. However, 
mouse models generated with long CGG repeats (>200) show no increase in promoter 







1.2.3 Structure and function of FMRP 
 
Since the discovery that the absence of FMRP is the cause of FXS, there has been a 
substantial effort to understand the function of FMRP and the consequences of its loss. 
The human FMR1 gene is composed of 17 exons that undergo alternative splicing 
generating FMRP isoforms that can vary from 67-80kDa (Devys et al. 1993). FMRP 
is mainly cytoplasmic and is expressed throughout the body although most strongly in 
the neurons and testes (Verheij et al. 1993). It contains three domains associated with 
RNA binding; two KH domains and a RGG box (Siomi et al. 1993). Through these 
domains, FMRP is able to associate with polyribosomes via RNA binding (Stefani et 
al. 2004). This ability to associate with polyribosomes is clearly a key property of 
FMRP function as the point mutation I304N, which results in FXS (De Boulle et al. 
1993), exists within the KH2 domain and results in loss of RNA binding (Zang et al. 
2009).  
 
Figure 1.1 Fragile X mutation (A) Image of X chromosome of FXS individual. 
Constriction near the q27 site is prone to breakage resulting in chromosomal 
lesion, giving the name ‘Fragile X’. (B) Polymorphic CGG repeat in the 5’ 
untranslated region of exon 1 defines the transcription status of FMR1 gene. 
<45 repeats allows normal transcription and translation of FMRP. Premutation 
alleles with 55-200 repeats can result in fragile X associated tremor ataxia 
syndrome (FXTAS) and fragile X associated premature ovarian insufficiency 
(FXPOI). Full mutation resulting from >200 CGG repeats leads to 
hypermethylation of the promoter region and transcriptional silencing of the 




Through its interactions with polysomes, FMRP is widely thought to function as a 
negative regulator of translation (Nelson et al. 2013). The most commonly accepted 
mechanism is that FMRP directly associates with translational apparatus, stalling 
ribosomes and thereby preventing polypeptide elongation (Darnell et al. 2011). The 
ability of FMRP to influence protein translation is controlled by its phosphorylation 
state. Dephosphorylation of FMRP at serine 500 by PP2A relieves translation 
suppression and increases local protein synthesis (Narayanan et al. 2007). FMRP is 
then rephosphorylated by ribosomal s6 kinase 1 (S6K1) (Narayanan et al. 2008) 
allowing FMRP to bind to its mRNA target. The precise nature of FMRPs RNA 
selectivity is unknown. Analysis of FMRP interacting mRNAs suggested it is RNA 
structural components such as stem G-quartet loops and kissing complex motifs which 
are important for FMRP binding (Darnell et al. 2001; Darnell et al. 2005). However, 
more recent studies using HITS-CLIP mRNA cross linking techniques has identified 
842 mRNA targets which show no enrichment of any particular structural elements 
(Darnell et al. 2011).  
 
In total, FMRP can associate with approximately 4% of all mRNA in the brain which 
are enriched in both pre- and postsynaptic proteins (Darnell et al. 2011). Postsynaptic 
targets include ~30% of post-synaptic density proteins (PSD) including NMDA 
receptor subunits, PSD-95, SynGAP and calcium/calmodulin-dependent protein 
kinase II (CaMKII). FMRP can also regulate as much as 30% of presynaptic proteins 
including many structural elements, synaptic vesicle proteins and voltage-gated Ca2+ 
Figure 1.2 Structure of FMRP Two KH domains and an RGG box in the C-terminus 
act allow FMRP to interact with mRNA binding targets. I340N mutation in the 
KH2 domain prevents FMRP from binding mRNA and results in FXS phenotypes. 
Phosphorylation at S500 controls FMRPs ability to influence protein translation. 
Figure adapted from Nelson et al., 2013. 
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channels. Therefore FMRP is clearly in a position to greatly influence synaptic 
function and plasticity.  
 
1.3 FMRP role at the synapse 
 
The majority of studies investigating the underlying pathophysiology of FXS have 
focused on the glutamatergic synapse. FMRP is located in dendritic spines, 
dynamically regulated by synaptic activity and a regulator of local protein synthesis 
(Weiler et al. 1997; Antar et al. 2004; Bassell & Warren 2008). These functions 
highlight FMRP as a key regulator of synaptic function and plasticity. The loss of 
FMRP is associated with a diverse set of behavioural phenotypes which suggests an 
underlying dysfunction of several functionally distinct brain regions. Here we will 
discuss the effects identified at glutamatergic synapses in various brain areas that 
appear to contribute to the FXS phenotype 
 
A major hallmark of FXS is reduced cognitive ability. Synaptic plasticity, the ability 
of a synapse to modulate its strength in an activity-dependent manner, is thought to be 
the key molecular mechanism underlying memory and cognition. Therefore, many 
studies have investigated synaptic plasticity mechanism in FXS animal models. The 
association of synaptic plasticity and cognitive processing is often investigated within 
the hippocampus, a structure involved in many aspects of cognition such as learning 
and memory. 
 
1.3.1 Hippocampal mGluR-LTD in Fmr1 KO mice 
 
Group 1 metabotropic glutamate receptors (mGluR) are seven transmembrane 
receptors which are canonically linked to Gq proteins, allowing receptor activation to 
stimulate downstream signalling pathways (Gladding et al. 2009). The group 1 
subclass is comprised of mGluR1 and mGluR5 subtypes which show immunoreactivity 
throughout the brain (Ferraguti & Shigemoto 2006). In postsynaptic regions, group 1 
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mGluRs are localised perisynaptically where there activation is known to influence 
synaptic strength in a brain region-dependent manner (Lujan et al. 1996). 
 
Activation of group 1 metabotropic glutamate receptors with the chemical agonist 
(R,S)-3,5-dihydroxyphenylglycine (DHPG) or paired-pulse low frequency stimulation 
(PP-LFS) results in a decrease in synaptic strength in CA1 hippocampus (Palmer et al. 
1997; Huber 2000).  This synaptic depression in long lasting and is mechanistically 
distinct from the classically described NMDA receptor dependent LTD at the same 
synapses (Palmer et al. 1997; Oliet et al. 1997). This form of plasticity was deemed 
particularly relevant to FXS as mGluR signalling is canonically linked to mRNA 
translation activation in excitatory neurons (Weiler & Greenough 1993). Crucially, the 
long term expression of mGluR-LTD has been shown to be dependent on rapid protein 
synthesis of pre-existing mRNAs within dendrites (Huber 2000; Huber et al. 2001). 
FMRP is also rapidly synthesised in response to mGluR activation on the same time 
scale (Weiler et al. 1997). This suggests that FMRP may play a role in regulating the 
long term expression of mGluR-LTD. 
 
Studies investigating mGluR-LTD in CA1 hippocampus of Fmr1 KO mice have found 
enhanced synaptic depression compared to wild-type controls (Huber et al. 2002; Hou 
et al. 2006). In addition, mGluR-LTD is also enhanced in Fmr1 KO cerebellum which 
shares many of the same expression mechanisms (Koekkoek et al. 2005). Given 
FMRPs role as a translational suppressor, it was suggested that this enhanced 
depression was the result of increased levels of proteins that are required for mGluR-
LTD in Fmr1 KO synapses. As FMRP itself is synthesised in response to mGluR 
activation, it was suggested that FMRP may function as a negative feedback 
mechanism to limit mGluR stimulated translation of so called ‘LTD proteins’ thereby 
modulating synaptic depression. Therefore, in the absence of FMRP, unrepressed 
translation following mGluR-activation would lead to excess ‘LTD protein’ translation 
and exaggerated mGluR-LTD. This was termed the ‘mGluR theory of 
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FXS’ (Bear et al. 2004) which proposed that many of the phenotypes associated with 
FXS are the result of excess protein translation downstream of group 1 mGluRs. 
 
Contrary to this hypothesis, mGluR-stimulated protein synthesis is absent in Fmr1 KO 
mice (Todd et al. 2003; Weiler et al. 2004; Osterweil et al. 2010). This suggests that 
the basal levels of ‘LTD proteins’ in Fmr1 KO dendrites are sufficient for the 
expression of mGluR-LTD. Consistent with its role as a negative regulator of protein 
translation, in vivo and in vitro basal protein synthesis levels are exaggerated in Fmr1 
KO mice (Qin 2005; Dölen et al. 2007). This includes the upregulation of several 
Figure 1.3 mGluR-dependent LTD is enhanced and independent of new protein 
synthesis in Fmr1 KO mice (A) Chemical induction of mGluR-LTD with the group 1 
mGluR agonist DHPG results in enhanced synaptic depression in Fmr1 KO CA1 
hippocampus (B) Synaptic induction of mGluR-LTD with 900 paired pulses at 1Hz 
frequency results in enhanced synaptic depression in Fmr1 KO mice (C and D) Both 
chemical and synaptic mGluR-LTD require new protein synthesis for long-term 
expression in WT mice. mGluR-LTD is independent of new protein synthesis in 





proteins that are vital to proper synaptic function including PSD-95, AMPAR subunits 
and CaMKII (Muddashetty et al. 2007; Osterweil et al. 2010). Therefore it was 
hypothesised mGluR-LTD, which is normally blocked in the presence of protein 
synthesis inhibitors, will persist in Fmr1 KO mice as the necessary proteins are already 
present at the synapse. This was confirmed experimentally as mGluR-LTD is 
insensitive to protein synthesis blockade in the absence of FMRP (Nosyreva & Huber 
2002).  
 
1.3.2 mGluR-regulated protein synthesis in Fmr1 KO mice 
 
The finding that mGluR activation does not result in new protein synthesis in FXS 
(Osterweil et al. 2010), suggests dysfunction of the signalling pathways which link 
mGluR activation to protein synthesis. One potential explanation could be that mGluR 
signalling is uncoupled from protein translational machinery in the absence of FMRP. 
Another explanation, which has gathered more experimental evidence, is that 
enhanced basal protein synthesis levels in the Fmr1 KO mice may cause a ceiling 
effect such that further stimulation of mGluR is ineffective (Qin et al. 2005; Osterweil 
et al. 2010). 
 
mGluR activation is believed to be linked to protein translation machinery via two 
intracellular signalling pathways, the mammalian target of rapamycin (mTOR) 
pathway and the ERK/MAPK pathway. mGluRs stimulate translation intiation through 
the formation of the eukaryotic initiation factor complex 4F (eIF4F) (Banko 2006). 
This complex requires phosphorylation of eIF4E binding protein (4E-BP) via 
activation of the mTOR signalling pathway and phosphorylation of eIF4E by Mnk, a 
component of the ERK/MAPK pathway (Banko et al. 2006). Both pathways also 
activate p70 S6 kinase which activates the ribosomal protein S6, stimulating 
translation of 5’ terminal oligopyrimidine tract (TOP) containing mRNAs which 
typically encode components of translation machinery thereby increasing the 




1.3.3 mTOR signalling in Fmr1 KO mice 
 
Although mGluR5 expression is normal in the absence of FMRP, mGluR5 shows 
reduced association with the scaffolding protein Homer (Giuffrida et al. 2005). 
mGluR-Homer interactions are also necessary for coupling mGluR activity with the 
PI3K-mTOR pathway (Ronesi & Huber 2008). In agreement with this, mGluR 
activation fails to activate components of the mTOR pathway in Fmr1 KO mice 
suggesting mGluR is uncoupled from mTOR signalling and is therefore unable to 
trigger protein translation (Ronesi & Huber 2008). However other groups have found 
that the steady state levels of mTOR and Akt phosphorylation are enhanced in Fmr1 
KO mice (Gross et al. 2010; Sharma et al. 2010). This is thought to be the result of 
increased PIKE levels in Fmr1 KO neurons, whose mRNA normally associates with 
FMRP (Darnell et al. 2011; Gross et al. 2010; Sharma et al. 2010). PIKE binds and 
activates PI3K and Akt in response to mGluR activation leading to increased mTOR 
signalling. These differences may stem from the background strain of the animals used, 
FVB (Sharma et al. 2010) or C57BL/6 (Ronesi & Huber 2008) however this effect has 
not been investigated further. 
 
Several studies have found that the expression of mGluR-LTD is sensitive to 
rapamycin suggesting mTOR signalling is necessary for the synthesis of new proteins 
in response to mGluR activation (Hou & Klann 2004; but see below). Furthermore, 
rapamycin also reduces steady state protein synthesis suggesting mTOR signalling 
also regulates basal mRNA translation (Muddashetty et al. 2007). However in Fmr1 
KO mice, mGluR-LTD is insensitive to rapamycin treatment (Sharma et al. 2010). 
mTOR activation in response to mGluR activation is also absent in Fmr1 KO mice 
which is consistent with the finding that mGluR is uncoupled from the mTOR 
signalling (Ronesi & Huber 2008) or could mean that the phosphorylated state of 
mTOR in Fmr1 KO synapses is increased to a state that it is insensitive to further 
mGluR activation (Sharma et al. 2010). Nevertheless, these results are consistent with 
the view that overactive basal protein synthesis in Fmr1 KO mice results in the 
accumulation of synaptic proteins that are sufficient for the expression of mGluR-
LTD. However, a study which examined mTOR activation under the experimental 
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conditions that revealed altered mGluR-dependent synaptic plasticity in CA1 
hippocampus of Fmr1 KO mice found no differences in steady state mTOR signalling 
in Fmr1 KO mice suggesting this pathway is not responsible for the increased basal 
protein synthesis in the absence of FMRP (Osterweil et al. 2010). In agreement with 
this, rapamycin had no effect on basal protein synthesis rates in either genotype 
(Osterweil et al. 2010). The differences in these studies may stem from differences in 
tissue preparation. Whilst Sharma et al (2010) used acutely dissected tissue in their 
study, Osterweil et al (2010) allowed tissue to incubate for 4 hours to reach a stable 
level of protein synthesis. Therefore, it is unclear if results from Sharma and colleagues 
reflects the early post-mortem state of Fmr1 KO mTOR signalling or if these effects 
stem from differential response of Fmr1 KO tissue to acute tissue preparation. These 
results raise questions about the role of mTOR signalling in mGluR-LTD and mGluR-
driven protein synthesis and how it contributes to FXS pathology. 
  
1.3.4 ERK/MAPK signalling in Fmr1 KO mice 
 
Activation of mGluR also stimulates the ERK1/2 pathways (Gallagher 2004; 
Osterweil et al. 2010).  The dual phosphorylation and activation of ERK1/2 is also 
associated with and necessary for mGluR-LTD expression in WT CA1 hippocampus 
(Gallagher et al. 2004; Banko et al. 2006; Hou et al. 2006). Studies have reported that 
steady state levels of ERK phosphorylation are increased in Fmr1 KO animals 
suggesting enhanced ERK signalling may contribute to the FXS phenotype (Hou et al. 
2006).  Consistent with this, preincubation with U0126 normalises basal protein 
synthesis levels to WT levels in Fmr1 KO mice (Osterweil et al. 2010). However, this 
study did not observe any differences in steady state or mGluR-driven ERK activation 
in Fmr1 KO animals compared to WT controls suggesting that hypersensitivity of 
mGluR5 or ERK signalling do not contribute to enhanced basal protein synthesis. 
Therefore, altered protein synthesis rates in Fmr1 KO mice may be the result of 
hypersensitive response of protein translation machinery in the absence of FMRP 




Figure 1.4 Group 1 mGluR signalling links to protein translation machinery 
Stimulation of mGluR1/5 activates local protein translation through mammalian 
target of rapamycin (mTOR) pathway and extracellular signal-regulated kinase 
(ERK) pathway. Both pathways result in Cap dependent-translation of local 
mRNAs as well as TOP dependent mRNA translation which increases the 
translational capacity of the neuron. 
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1.3.5 mGluR theory of FXS 
 
Taken together, the findings that FMRP is normally synthesised in response to mGluR 
activation, basal protein synthesis is exaggerated in the absence of FMRP, that mGluR-
LTD requires new protein synthesis and that mGluR-LTD is enhanced and 
independent of new protein synthesis in Fmr1 KO mice have contributed to the mGluR 
theory of FXS (Bear et al. 2004). This theory suggests that in the absence of FMRP, 
exaggerated protein synthesis downstream of mGluR-signalling results in enhanced 
mGluR-LTD that no longer requires new protein synthesis in Fmr1 KO mice. This 
theory also suggests that many of the phenotypes associated with FXS may be the 
result of exaggerated responses to mGluR activation. In agreement with this, studies 
targeting group 1 mGluR signalling either genetically or pharmacologically have 
shown significant amelioration of many phenotypes in Fmr1 KO mice. Reducing 
mGluR5 signalling restores both basal protein synthesis levels and mGluR-LTD 
magnitude to WT levels (Dölen et al. 2007; Michalon et al. 2012). This strategy has 
also corrected phenotypes at many levels of analysis including spine density 
phenotypes and ocular dominance plasticity in the visual cortex as well as behaviours 
including exaggerated inhibitory avoidance extinction, increased audiogenic seizure 
susceptibility and hyperactivity in open field tests (Yan et al. 2005; Nakamoto et al. 
2007). Interestingly many of these phenotypes could still be rescued when therapeutics 
were administered at 1 month of age indicating these therapeutics may still be 
beneficial to FXS patients when started late in development (Michalon et al. 2012). 
 
1.3.6 NMDAR-dependent plasticity in Fmr1 KO mice 
 
As well as mGluR-LTD, NMDAR-dependent forms of plasticity have also been 
investigated in the hippocampus of Fmr1 KO mice. Some forms of NMDAR-
dependent LTP are also reliant on new protein synthesis such as late phase LTP (L-
LTP), a persistent form of LTP that last in excess of 4 hours. The induction of L-LTP 
is independent of protein synthesis however its long term maintenance requires it 
(Stanton & Sarvey 1984). Due to FMRPs role in translation regulation, L-LTP was 
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also investigated in Fmr1 KO mice however no difference was observed between 
genotypes (Paradee et al. 1999; Zhang et al. 2009). As FMRP loss affects protein-
synthesis dependent LTD but not LTP, this suggests that FMRP may specifically 
regulate proteins required for LTD expression. Alternatively, FMRP may be 
specifically required for the regulation of dendritic protein synthesis. L-LTP is induced 
by multiple trains of high frequency tetanus that rely on neuron wide transcription and 
translation (Abraham & Williams 2003). In contrast, L-LTP induced using a weaker 
theta burst protocol which is solely dependent on dendritic mRNA translation revealed 
reduced LTP in Fmr1 KO mice (Lauterborn et al. 2007). This indicates that FMRP 
may only regulate local mRNA translation at dendritic sites. Protein-synthesis 
independent forms of NMDA-receptor dependent plasticity have also been 
investigated. Hippocampal NMDAR-dependent LTD is unaffected in Fmr1 KO mice 
Figure 1.5 The mGluR theory of fragile X syndrome Model designed to 
explain experimental observations of mGluR-dependent phenotypes in Fmr1 
KO mice. In WT dendritic spine, group 1 mGluR activation results in the 
synthesis of local protein synthesis including FMRP which acts as a repressor 
of local mRNA translation. In Fmr1 KO dendritic spines, basal levels of ‘LTD 
proteins’ are increased in the absence of FMRP leading to excess AMPAR 
removal in response to mGluR activation. These excess levels are also 
sufficient to mediate synaptic depression meaning new protein synthesis is no 




(Huber et al. 2000) suggesting the enhanced synaptic depression is specific to mGluR-
LTD. Similarly early-phase NMDAR-dependent LTP, which is independent of protein 
synthesis, is comparable to WT levels in Fmr1 KO mice (Godfraind et al. 1996; Li et 
al. 2002; Larson et al. 2005). This suggests that NMDAR function and signalling are 
unaffected in the hippocampus of Fmr1 KO mice.  
 
1.4 Amygdala synaptic plasticity 
 
FXS individuals exhibit a common incidence of gaze avoidance, high anxiety and 
elevated acute stress levels consistent with amygdala dysfunction (Hessl et al. 2004). 
In agreement with this, evidence from human neuroimaging studies has shown that 
sensitisation of the amygdala is part of the aberrant emotional response in FXS 
individuals (Watson et al. 2008). Consistent with observations in humans, studies in 
Fmr1 KO mice have revealed changes in amygdala dependent behaviours including 
anxiety and fear learning (McNaughton et al. 2008; Paradee et al. 1999). 
  
The amygdala forms a key component of the brains fear circuitry. The neurobiology 
of fear circuitry has typically been investigated using fear conditioning paradigms in 
rodents. Evidence from lesion and pharmacological studies points to the amygdala as 
the neural system involved in many aspects of fear learning. As the responses to fear 
conditioning paradigms resemble the behavioural and physiological symptoms of 
human fear, an understanding of the neurobiology of fear memories is thought to have 
clinical relevance to human conditions associated with altered fear responses (LeDoux 
2003).  
 
In classical fear conditioning paradigms, a conditioned stimulus (CS), such as a tone, 
is paired with an aversive unconditioned stimulus (US) leading to their association. At 
a neurobiological level, CS and US carrying inputs converge in the lateral amygdala 
(LA) arising from thalamic and cortical synapses respectively (Romanski & LeDoux 
1993). This convergence results in enhanced processing of CS inputs believed to be 
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the result of LTP at thalamic inputs to the LA (Blair et al. 2001; Bauer et al. 2002). 
Crucially for the study of FXS, whilst mGluR5 signalling results in LTD in CA1 
hippocampus, mGluR5 mediates LTP at thalamic inputs to the LA (Rodrigues et al. 
2002). Based on the mGluR theory of FXS, excessive mGluR signalling may be 
expected to result in exaggerated mGluR-LTP in the LA of Fmr1 KO mice. However 
given the observed deficits in fear learning in Fmr1 KO mice (Paradee et al. 1999) this 
suggests that mGluR-LTP is diminished. This has been confirmed experimentally with 
the finding that mGluR-dependent LTP is lost at thalamic inputs to the LA in the 
absence of FMRP (Zhao 2005; Suvrathan et al. 2010). Contrary to plasticity deficits 
in the hippocampus, acute treatment with mGluR antagonists does not rescue this 
phenotype in Fmr1 KO mice (Suvrathan et al. 2010). However, chronic administration 
does rescue this phenotype (personal communication, Professor Shona Chattarji, 
inSTEM). Whilst this provides further evidence on group 1 mGluR dysfunction in 
FXS, it suggests that synaptic phenotypes vary with brain region. 
 
As well as thalamic inputs, plasticity at cortical inputs to the LA can also mediate CS-
US association during fear conditioning (Tsvetkov et al. 2002). Synaptic strengthening 
of the cortical input to the LA also shows a requirement for group 1 mGluR signalling 
(Cho et al. 2011).  This form of plasticity uses an induction protocol which mirrors the 
timing of convergent thalamic and cortical input activation in vivo which suggests it 
may have behavioural relevance. Plasticity at this pathway remains unexplored in 
animal models of FXS but, given the involvement of group 1 mGluR signalling, could 








1.5 Cortical synaptic plasticity 
 
1.5.1 Synaptic plasticity in Primary sensory cortical areas 
 
The activity-dependent plasticity rules that govern learning and memory as well as 
cognition also play a role in refining developing networks in response to experience. 
This mechanism is of particular importance during developmental critical periods. 
Critical periods are developmental time windows in which the ability of experience to 
influence the connectivity of a developing network is greatly enhanced. After this 
period ends, the ability of activity to influence synapses becomes much reduced as 
they become less plastic. Critical periods have been heavily studied in the cortex in 
particular in sensory cortical areas which typically undergo this period of heightened 
plasticity early in an animal’s development. Disruptions in network activity during 
developmental critical periods can drastically alter the ability of a network to respond 
to sensory input resulting in permanent sensory processing deficits. Perhaps the most 
famous example of this phenomenon comes from the work of Hubel & Wiesel (1970) 
which showed that deprived visual experience during the visual critical period of cats 
results in reduced visual acuity in adulthood. 
 
Sensory processing deficits are a common feature across many ASDs including FXS 
(Fagiolini & Leblanc 2011). Studies in Fmr1 KO mice have revealed changes in 
critical period plasticity in cortical areas underlying several sensory modalities. As 
FMRP is expressed in very early development, in a way that is regulated by neuronal 
activity, it is in a key position to regulate activity dependent plasticity of cortical areas 
during early critical periods (Agulhon et al., 1999; Todd et al. 2003). This has been 
highlighted in the somatosensory cortex (S1) where the critical period for NMDAR-
dependent LTP at thalamocortical afferents on to layer IV spiny stellates usually 
occurs early in the postnatal week (Crair & Malenka 1995). The closure of this critical 
period coincides with the time point of peak FMRP expression in S1 (Till et al. 2012). 
In Fmr1 KO mice, this critical period is delayed continuing into the second postnatal 
week (Harlow et al. 2010). A similar delay in the development of translaminar 
connectivity in S1 of Fmr1 KO mice has also been observed. Ascending connections 
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from layer 4 to layer 2/3 pyramidal neurons typically develop in the second postnatal 
week following the closure of the layer 4 critical period. However in the absence of 
FMRP, this pathway is weakened and shows reduced connection probability at this 
stage of development (Bureau et al. 2008). These phenotypes are temporally restricted 
to these early developmental time points, showing a return to WT levels by the third 
postnatal week suggesting they may be the result of a delay in the maturation of S1 
cortical circuits in Fmr1 KO mice. 
 
Visual experience also drives the expression of Fmr1 mRNA suggesting FMRP may 
play a role in visual cortex development (V1) (Gabel et al. 2004). Evidence of visual 
critical period deficits in Fmr1 KO mice comes from studies of ocular dominance 
plasticity. In WT mice, brief 3 day monocular deprivation at P28 results in depression 
of deprived eye responses in the binocular region of V1, followed by potentiation of 
responses from the non-deprived eye 4 days later (Frenkel & Bear 2004). In contrast, 
Fmr1 KO V1 exists in a ‘hyperplastic state’ showing immediate potentiation of 
responses to the non-deprived eye (Dölen et al. 2007). In vitro electrophysiological 
analysis of Fmr1 KO V1 has revealed loss of LTP in juvenile mice, which may 
contribute to this ocular dominance phenotype (Wilson & Cox 2007). Interestingly, 
these phenotypes in Fmr1 KO mice are normalised to WT levels by either genetic or 
pharmacological reduction of mGluR5 signalling (Dölen et al. 2007; Wilson & Cox 
2007). This suggests that the exaggerated mGluR signalling proposed by work in the 
hippocampus may also contribute to changes in sensory cortex development.  
 
1.5.2 Synaptic plasticity in Integrative cortical areas 
 
As well as primary sensory cortical areas, integrative cortical areas also undergo 
synaptic plasticity throughout development. An example with particular relevance to 
FXS is the prefrontal cortex (PFC). Deficits in attention, inhibitory control and 
cognitive flexibility are all common symptoms reported in FXS individuals that are 
associated with PFC function (Royall et al. 2002). Similarly there have been reports of 
deficits in PFC-related behaviours in Fmr1 KO mice suggesting FMRP plays a key 
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role in PFC function (Krueger et al. 2011; Gantois et al. 2013; Kramvis et al. 2013; 
Sidorov et al. 2014). 
 
Unlike primary sensory areas, PFC synapses remain plastic well into adulthood. In 
early adulthood, studies in Fmr1 KO mice have revealed LTP deficits in multiple PFC 
subregions including the anterior cingulate cortex (ACC), medial PFC (mPFC) and 
piriform cortex (Zhao et al. 2005; Meredith et al. 2007; Wang et al. 2008). An 
interesting observation in PFC plasticity of Fmr1 KO mice is an age-dependent loss 
of LTP in some subregions, with LTP intact in juvenile animals but deficits appearing 
in adulthood (Larson et al. 2005; Martin et al. 2015). Given the increasing ID 
associated with ageing in FXS, this progressive LTP loss has been proposed as a 
potential synaptic mechanism of this cognitive deficit. As with sensory areas, acute 
pharmacological blockade with MPEP, a group 1 mGluR negative allosteric 
modulator, has been shown to restore LTP to WT levels in the ACC and mPFC (Xu et 
al. 2012; Martin et al. 2015) suggesting excessive mGluR signalling can contribute to 
cortical deficits in adult Fmr1 KO animals as well as during development. 
 
1.6 Synaptic connectivity in FXS 
 
1.6.1 Dendritic spines 
 
Dendritic spines are postsynaptic compartments where excitatory synaptic contacts are 
formed. The morphology of dendritic spines influences the compartmentalisation of 
signalling cascades as well as synaptic function (Yuste 2011). Therefore, both the 
density of dendritic spines and their shape can influence circuit function. Alterations 
in spine density and morphology have been commonly reported across many cognitive 
disorders (Kaufmann & Moser 2000). Post-mortem analysis of human FXS tissue has 
revealed an increase in spine density, with the majority in an elongated and filopodial 
state (Rudelli et al. 1985; Hinton et al., 1991; Irwin et al. 2001). Given the difficulties 
of performing adequately controlled studies with human tissue in neurodevelopmental 
disorders e.g. age matching, post-mortem interval, and patient medical history; it is 
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unclear if these differences truly reflect the effects of FMRP loss. However, a series 
of studies have identified similar deficits in Fmr1 KO mice. A transient elevation in 
spine density and spine length has been observed in S1 and mPFC neurons in juvenile 
Fmr1 KO mice (Nimchinsky et al. 2001; Testa-Silva et al. 2012). This phenotype then 
reappears in adulthood with increased spine density and immature morphology 
reported in several cortical cell types (Comery et al. 1997; Dölen et al. 2007).  
However, some more recent studies investigating spine density across development in 
various different cell types have failed to repeat these findings (Meredith et al. 2007; 
Cruz-Martín et al. 2010; Harlow et al. 2010; Wijetunge et al. 2014). These 
inconsistencies may arise from differences in methodology e.g. Golgi vs intracellular 
labelling, as it has been suggested Golgi labelling may preferentially label a subset 
neurons which may show spine abnormalities in FXS (Nimchinsky et al. 2001). These 
results could also stem from differences in analysis as some investigators use n as 
number of analysed dendrites or neurons for statistical analysis therefore the use of 
non-independent replicates could result in falsely significant results. 
 
Original studies in human tissue first identified the increased presence of abnormally, 
long and thin dendritic spines in FXS tissue (Rudelli et al. 1985; Hinton et al. 1991; 
Irwin et al. 2001). These abnormally thin and tortuous spines are reminiscent of 
immature spine precursors suggesting a delay in synapse development or pruning 
(Bagni & Greenough 2005). Subsequent studies in Fmr1 KO mice have revealed 
similar immature spine phenotypes across multiple cell types (Meredith et al. 2007; 
Levenga et al. 2011; Qin et al. 2011). As well as suffering from the limitations in 
analysis already discussed these studies have typically examined spine morphology 
using diffraction limited microscopy techniques that lack the spatial resolution to 
image many parameters of spine morphology such as head width, neck length and neck 
width. A recent study using stimulated emission depletion (STED) microscopy, a 
technique with allows imaging with ~50nm spatial resolution, has revealed that the 
developmental trajectory of spine morphology is largely intact in Fmr1 KO mice 
(Wijetunge et al. 2014). This study only identified nanoscale changes in spine 




Whilst this data raises doubts about the presence of immature spine phenotypes in 
FXS, spine morphology in fixed tissue alone provides a limited view of spine maturity 
and function. Dendritic spines are dynamic structures which undergo structural 
transformations over time at rates which vary with maturity (Bonhoeffer & Yuste 
2002). Real-time imaging of spine dynamics using in vivo two photon microscopy in 
Fmr1 KO somatosensory cortex did not observe any changes in spine motility but did 
find increased spine turnover on L2/3 pyramidal neurons at P10-12, a critical period 
in somatosensory circuit development where functional synaptic defects have also 
been reported (see below; Cruz-Martin et al. 2010). Higher spine turnover has also 
been reported in L5 pyramidal neurons of somatosensory cortex at P20 and P30 in the 
absence of FMRP (Pan et al. 2010). These data suggest that spine instability in early 
circuit development, which may persist in some cell types in Fmr1 KO mice, which 
would likely contribute to altered circuit dynamics in FXS. 
 
Together, these data display the brain region and development specificity of spine 
phenotypes in the absence of FMRP but also highlight the flawed methodology of past 
studies in assessing spine density and morphology. It is difficult to suggest what these 
effects may have on neuronal function but it is clear that even subtle perturbations in 
spine morphology could result in large changes at the circuit level. 
 
1.6.2 Functional connectivity 
 
Abnormal neuronal connectivity is proposed to underlie the cognitive and behavioural 
deficits in many neurodevelopmental disorders. Functional magnetic resonance 
(fMRI) studies in ASDs have revealed increased local connectivity with impaired 
long-range synchronisation (Geschwind & Levitt 2007). Abnormalities in dendritic 
spine number and dynamics as well as multiple synaptic plasticity phenotypes suggests 




Studies investigating layer 5 pyramidal neuron local connectivity in both mPFC and 
S1 have revealed a hyperconnected state in the early development of Fmr1 KO mice 
(Testa-Silva et al. 2012; Patel et al. 2014). This hyperconnectivity could drive 
excessive feedback excitation resulting in circuit hyperexcitability. Interestingly these 
phenotypes, similar to spine deficits in the same cortical areas, are developmentally 
transient with normal functional connectivity returning by postnatal week 5. Given the 
observation that increased spine density reappears in many cortical areas in adult Fmr1 
KO mice (Comery et al. 1997; Dölen et al. 2007) this raises the possibility that adult 
Fmr1 KO circuits may also exist in a hyperconnected state however this has not been 
explored experimentally. 
 
Whilst the postsynaptic role of FMRP has been extensively investigated, FMRP also 
plays a role in regulating presynaptic function which can also affect synaptic 
connectivity. A study using mosaic Fmr1 female mice revealed that WT presynaptic 
neurons form synaptic connections at higher rates than neurons lacking FMRP in 
hippocampal organotypic cultures (Hanson & Madison 2007). This effect was 
independent of postsynaptic identity. As FMRP is expressed in axons and growth 
cones of hippocampal neurons, its loss results in altered axonal growth (Antar et al. 
2006). This effect may result in the reduced connectivity observed in mosaic studies 
as the ability of Fmr1 KO axons to target postsynaptic neurons and form synaptic 
connections is unaffected. 
 
As well as through the loss of physical connectivity, synaptic release probability can 
also have a major effect on presynaptic function. This is commonly assessed using 
measurements of paired pulse ratio (PPR), which inversely correlates with synaptic 
release probability (Zucker & Regehr 2002). No changes in PPR have been reported 
in the majority of studies of Fmr1 KO mice which focus on hippocampal and cortical 
excitatory synapses (Pfeiffer & Huber 2007; Gibson et al. 2008; Deng et al. 2011) 
suggesting FMRP does not affect basal presynaptic release in these structures. In 
contrast, Suvrathan et al (2010) have reported enhanced PPR at thalamic inputs to the 
LA as well as a decreased mEPSC frequency on to LA principal neurons suggesting 
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loss of FMRP results in decreased presynaptic release probability in the LA. This 
presynaptic effect was rescued with acute treatment of MPEP suggesting this reduced 
release probability is the result of excessive group 1 mGluR signalling. As mGluR5 
expression is localised postsynaptically in the LA (Rodrigues et al. 2002) the most 
probable explanation for this effect is through modulation of retrograde signalling such 
as endocannabinoids (eCB). eCBs are released from postsynaptic terminals in response 
to mGluR activation and diffuse across the synaptic cleft where they act upon 
presynaptic terminals causing a reduction in presynaptic release (Alger 2002; 
Chevaleyre et al. 2006). Whilst eCB signalling has been heavily investigated in the 
hippocampus and cortex, little is known about its role in the amygdala. However as 
mGluR5 signalling has been proposed to be constitutively active in Fmr1 KO mice 
(Ronesi & Huber 2008) as well as showing enhanced coupling to eCB mobilisation 
(Zhang & Alger 2010), this could provide a potential mechanism for the therapeutic 
action of mGluR antagonism on presynaptic release in the LA.   
 
1.7 Neuronal excitability in FXS 
 
In addition to ID phenotypes, FXS is also associated with a generalised over-arousal 
to sensory stimuli. This has been noted across multiple modalities. In auditory 
processing, FXS individuals exhibit reduced prepulse inhibition (PPI) showing 
increased responsiveness to auditory cues and reduced attenuation of startle responses 
(Frankland et al. 2004). Sufferers also present tactile defensiveness as well as 
avoidance of innocuous tactile stimuli suggesting hypersensitivity of touch (Baranek 
et al., 2008). Sensitivity to visual stimuli, which manifests as gaze aversion, has also 
been noted in approximately 90% of FXS males (Merenstein et al. 1996). This 
hypersensitivity to normal sensory stimuli results in hyperarousal of FXS individuals 
and also contributes to the ASD symptoms associated with the condition such as social 
withdrawal (Kronk et al. 2010). 
The described sensory hypersensitivity is a common feature of ASD and reflects an 
underlying hypersensitivity of cortical circuits to sensory input. Consistent with this, 
event-related potentials in the auditory cortex in response to auditory stimulation are 
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increased in FXS individuals (Castren et al. 2003). This hypersensitivity also results 
in incidences of seizure in 10-20% of FXS individuals (Berry-Kravis 2002). Similarly, 
Fmr1 KO mice exhibit increased auditory circuit activity as well as a reduced threshold 
for audiogenic seizures (Chen & Toth 2001; Musumeci et al. 2000). This 
hypersensitivity is thought to be the result of circuit hyperexcitability in the absence 
of FMRP. Circuit hyperexcitability can arise through changes at multiple levels of 
analysis i.e. molecular, synaptic, cellular, network (Contractor et al. 2015). Given the 
functional complexity of FMRP and its wide range of mRNA targets, changes in both 
the intrinsic physiology of individual neurons as well as synapse-level alterations have 
been proposed as one of multiple mechanisms leading to circuit hyperexcitability have 
been identified in Fmr1 KO animals.  
 
1.7.1 Translation dependent effects of FMRP loss on excitability 
 
CNS neurons convert synaptic input from both excitatory and inhibitory synapses into 
an output signal generated as an action potential. This input-output relationship can be 
influenced by changes in the intrinsic membrane properties of a neuron. These 
properties are dependent on the combination and properties of ion channels expressed 
throughout the neuron. Through its role in mRNA trafficking and translation, FMRP 
is able to influence neuronal intrinsic excitability through regulation of many proteins 
related to membrane properties, ionic homeostasis and action potential firing.  
 
A variety of K+ channels that modulate intrinsic membrane properties have been 
identified as targets of FMRP (Darnell et al. 2011). Changes in K+ channel result in 
increased input resistance of L4 stellate cells in the somatosensory cortex, resulting in 
neuronal hyperexcitability (Gibson et al. 2008). However this is a transient effect as 
neuronal excitability is normalised by 4 weeks of age. Surprisingly, this is the only 
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report of somatic changes in intrinsic membrane properties in Fmr1 KO mice. Other 
studies investigating pyramidal neurons in CA1 hippocampus as well as entorhinal and 
somatosensory cortex (S1) have observed no changes in intrinsic membrane properties 
in the somatic compartment (Deng et al. 2013; Desai et al. 2006; Zhang et al. 2014). 
 
Whilst pyramidal neurons appear largely unaffected in Fmr1 KO mice from somatic 
recordings, recordings in the dendritic compartment of neurons has revealed 
significant alterations in intrinsic membrane properties. These changes are associated 
with changes in ion channel expression throughout the dendritic tree in the absence of 
FMRP. Dendritic ion channels can affect neuronal excitability in various ways and are 
key in mediating somatic integration, synaptic plasticity as well as neuronal firing 
(Beck & Yaari 2008).  
 
One channel that is prominent in regulating dendritic excitability is the 
hyperpolarisation activated cyclic nucleotide gated channel (HCN). These channels 
mediate the Ih current, a non-inactivating cation conductance that is activated in 
response to membrane hyperpolarisation. HCN channels are also active at rest and 
Figure 1.6 FMRP regulation of neuronal excitability Table representing the 
various ways FMRP is able to modulate neuronal excitability through proteins 
whose expression is altered by FMRP loss. Those in bold have been 
experimentally validated to have an effect on neuronal excitability in Fmr1 KO 
mice. Figure from Contractor et al., 2015. 
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therefore can influence resting membrane potential and input resistance (Shah 2014). 
HCN also plays an important role in the summation of dendritic potentials. It is 
expressed in an increasing gradient towards the distal dendrites and the presence of Ih 
results in marked attenuation of EPSP summation (Berger et al. 2001). FMRP has been 
shown to interact with HCN1 mRNA thereby regulating its expression (Darnell et al. 
2011). In agreement with the theory that FMRP represses mRNA translation, Ih 
currents are increased in CA1 dendrites of Fmr1 KO mice (Brager et al. 2012). This 
increased current is associated with a decreased input resistance making dendrites less 
excitable in the absence of FMRP. In contrast, L5 pyramidal neurons in S1 and medial 
prefrontal cortex (mPFC) show reduced dendritic Ih in Fmr1 KO mice resulting in 
increased excitability. 
 
Another channel that is translationally controlled by FMRP is the K+ channel Kv4.2 
(Darnell et al. 2011). This channel mediates the A-type K+ current and display a 
characteristic expression gradient along the somatodendritic axis, increasing with 
distance from the soma (Hoffman et al. 1997). It is activated by subthreshold potential 
and attenuated propagating signals such as EPSP and bAP thereby acting as a powerful 
regulator of dendritic excitability. There have been conflicting reports regarding the 
expression of Kv4.2 channels in Fmr1 KO CA1 pyramidal neuron dendrites. Work 
from Gross et al. (2011) suggested that, in contrast to FMRPs role as a negative 
regulator of translation, Kv4.2 mRNA and protein expression levels were reduced in 
CA1 dendrites of Fmr1 KO mice. Consistent with this, measurement of A-type current 
in the dendritic compartment confirmed a reduction in current density in CA1 dendrites 
resulting in enhanced Ca2+ currents in response to bAP (Routh et al. 2013). However, 
Lee et al. (2011) demonstrated Kv4.2 was upregulated in the same compartment of 
Fmr1 KO mice. The reason for the conflicting results of these studies is not clear. Both 
used biochemical techniques to assess the expression levels of Kv4.2 protein as well 
as its effect on LTP threshold. An additional study by Routh et al (2013) also found 
increased Kv4.2. currents in proximal dendrites of CA1 pyramidal neurons (<200µm 
from soma). Therefore the difference in results could stem from differential changes 
in Kv4.2 expression in subsections of the dendritic tree in Fmr1 KO neurons. 
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In agreement with studies of Ih, opposing phenotypes of Kv4.2 currents in dendrites 
have been observed between pyramidal neurons in CA1 hippocampus (Routh et al. 
2013) and L5 mPFC where levels were decreased (Kalmbach et al. 2015). These 
results highlight the brain region specific differences in FXS phenotypes and how the 
typically held view that neurons are hyperexcitable cannot be universally applied. It 
also suggests that the observed differences in ion channel expression may not be the 
result of mis-translation due to loss of FMRP but may reflect homeostatic or activity 
dependent changes in intrinsic properties. Given the varied circuit dynamics of the 
hippocampus and cortex, this mechanism could explain how FMRP loss can result in 
opposing effects in different brain regions depending on their local activity and 
synaptic input. 
 
1.7.2 Non-canonical role for FMRP: Protein-protein interactions 
 
Whilst FMRP is mainly thought of as a regulator of protein translation, several actions 
of FMRP are also mediated through direct protein-protein interactions. This role 
includes the direct modulation of some ion channels known to modulate neuronal 
excitability. The first example of this was presented by Brown et al. (2010) when they 
showed that FMRP directly interacts with sodium-activated K+ channel ‘Slack’ in the 
auditory brainstem. This interaction is mediated by amino acids 1-298 in the N-
terminus of FMRP, a region which does not interact with ribosomes. Slack channels 
regulate many features of neuronal excitability such as adaptation during sustained 
firing which is crucial for the fidelity of signal processing (Brown et al. 2010). 
Mutations in Slack channels have been linked to seizure events and result in severe 
cases of ID in humans (Kim & Kaczmarek 2014). This suggests that loss of regulation 
by FMRP may contribute to excitability defects in FXS auditory processing. 
 
FMRP also regulates neuronal excitability through a direct interaction with the BK K+ 
channel. This effect has been shown in both hippocampal and cortical pyramidal 
neurons (Deng et al. 2013; Myrick et al. 2015). BK channels are activated by Ca2+ 
entry following membrane depolarisation helping to repolarise action potentials, 
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produce fast-afterhyperpolarisation (fAHP) and close Ca2+ channels (Lee & Cui 2010). 
FMRP binding increases BK channel activity thereby modulating both 
neurotransmitter release and burst firing characteristics of a neuron. Loss of FMRP 
results in excessive presynaptic Ca2+ influx during repetitive activity causing excess 
glutamate release (Deng et al. 2013). FMRP is able to modulate BK channel activity 
by interacting with its β4 subunit (Deng et al. 2013). This protein-protein interaction 
was highlighted by the FMR1 missense mutation R138Q which was identified in a 
patient presenting FXS phenotypes (Collins et al. 2010). Whilst this mutation is in the 
KH RNA binding domain, it does not interfere with FMRPs mRNA binding capability. 
However this mutation prevents FMRP from interacting with the BK channel and 
rendered FMRP unable to modulate action potential duration (Deng et al. 2013). 
Finally, FMRP has also been shown to directly bind to presynaptic N-type voltage 
gated Ca2+ channels via its carboxy terminus (Ferron et al. 2014). This interaction does 
not affect channel activity but does regulate its surface expression. Loss of FMRP 
results in reduced presynaptic Ca2+ currents in Fmr1 KO neurons which has been 
shown to have a major impact on neurotransmitter release in dorsal root ganglion 
neurons (Ferron et al. 2014). 
 
1.7.3 mGluR and neuronal excitability 
 
mGluR activation is commonly studied in relation to synaptic plasticity in FXS 
however mGluRs can also influence neuronal excitability. Whilst it is clear that 
excessive protein translation downstream of mGluR signalling can cause changes in 
excitability, acute mGluR activation can also modulate neuronal excitability. 
Consistent with this, the group 1 mGluR agonist DHPG can transform normal neuronal 
activity intro prolonged epileptiform bursting in CA3 hippocampus (Chuang et al 
2005). This epileptiform activity is the result of a voltage gated cation conductance, 
termed ImGluR(V), which depolarises excitatory neurons thereby increasing neuronal 
activity (Bianchi et al. 2009). Once induced by agonist stimulation, ImGluR(V) remains 
undiminished for several hours following agonist washout. Whilst this effect can only 
be induced by DHPG activation in WT circuits, in the absence of FMRP synaptically 
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released glutamate provides sufficient mGluR activation to drive CA3 epileptiform 
activity (Chuang et al. 2005; Bianchi et al. 2009). 
 
Evidence suggests that as well as excess translation downstream of mGluR5 activation, 
mGluR5 function may also be altered in Fmr1 KO mice. mGluR5 is reduced in post-
synaptic density (PSD) fractions of Fmr1 KO synapses due to an altered balance of 
mGluR5 association with different isoforms of the post-synaptic scaffolding protein 
Homer (Giuffrida et al. 2005). The N-terminal domain of Homer binds with the 
intracellular C-terminal tail of group 1 mGluRs, influencing the localisation and 
function of mGluRs within the synapse (Shiraishi-Yamaguchi & Furuichi 2007). Long 
isoforms of Homer localise mGluRs to the PSD through interactions with the synaptic 
protein SHANK. Homer 1a, the activity induced short form of Homer, disrupts 
mGluR5 binding with the long Homer isoform. This alters mGluR localisation and 
causes constitutive, agonist independent activation of group 1 mGluRs (Ango et al. 
2001). In Fmr1 KO mice, mGluR5 is found in association with H1a at a higher rate 
than in WT controls rendering mGluR5 constitutively active (Giuffrida et al. 2005). 
This phenotype appears to contribute to several protein synthesis independent 
phenotypes of FXS including neocortical hyperexcitability (Ronesi et al. 2012). As 
H1a bound mGluR5 shows agonist independent activity, this suggests that the 
therapeutic action of mGluR5 antagonists in Fmr1 KO mice may partly be the result of 
inhibition of constitutively active mGluR5. 
 
The ability of mGluR5 signalling to modulate excitatory transmission has been well 
established in pyramidal neurons of the mPFC due to their dysfunction in 
neuropsychiatric disorders such as Schizophrenia (Goto et al. 2010). mGluR5 is highly 
expressed on postsynaptic terminals of layer 5 pyramidal neurons (Muly et al. 2003). 
mGluR agonists are able to drive increased network dependent excitatory spontaneous 
activity in these neurons through a mechanism that is blocked by mGluR5 antagonists 
(Marek & Zhang 2008). Similarly, the orthosteric mGluR5 agonist CHPG increases 
intrinsic bursting of layer 5 pyramidal neurons in the mPFC (Fontanez-Nuin et al. 
2011). Therefore, if mGluR5 exists in a constitutively active state in Fmr1 KO neurons, 
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this could result in significant changes in the intrinsic excitability of layer 5 mPFC 
pyramidal neurons. 
 
As well as integrating inputs from various brain regions, the mPFC provides top-down 
control of various cortical and subcortical regions through long range excitatory 
connections allowing it to influence many different behaviours (Vertes 2004). Layer 5 
pyramidal neurons, which form the primary output layer of the mPFC, exist as a 
heterogeneous population exhibiting differing intrinsic properties, neuromodulation 
and synaptic connectivity depending on their long range targets (Wang et al. 2006; 
Brown & Hestrin 2009; Dembrow et al. 2010). This suggests that subnetworks exist 
within the mPFC that modulate specific mPFC-dependent behaviours. 
 
Through its anatomical connectivity with the amygdala, the mPFC is able to exert 
executive control over emotional processing as well as influence fear behaviours 
(Euston et al. 2012). The mPFC is formed by two distinct subregions, the ventral 
portion consists of the prelimbic region (PL) whilst the ventral portion consists of the 
infralimbic cortex (IL), which show distinct connectivity (Vertes 2004; Gabbott et al. 
2005; Hoover & Vertes 2007). These two regions also appear to play distinct roles in 
fear learning. The inactivation of PL results in impairment of fear acquisition, 
consolidation and expression (Choi et al. 2010; Vidal-Gonzalez et al. 2006; Corcoran 
& Quirk 2007) whilst IL activity is required for extinction memory (Hefner et al. 2008; 
Muigg et al. 2008). Therefore, proper function of these cortical regions and their 
connectivity with the amygdala are clearly important for appropriate fear behaviour. 
This suggests that changes in the neuronal excitability of mPFC subnetworks could 
result in significant changes in various aspects of fear learning. As Fmr1 KO animals 
show deficits in learned fear expression (Paradee et al. 1999), changes in the intrinsic 
properties of PL subnetworks that project to the amygdala may contribute to this 
phenotype. The effects of FMRP loss on this circuit are unexplored in FXS however 
given the exaggerated function of mGluR5 in Fmr1 KO brains and observed 




1.7.4 Inhibitory circuits in FXS 
 
Inhibitory transmission, acting through the neurotransmitter GABA, can also influence 
neuronal excitability by balancing circuit activity. Disruption of excitatory/inhibitory 
circuit balance is thought to be a common feature of ASDs (Gogolla et al. 2009). 
Whilst most studies in FXS have focused on excitatory neurotransmission, several 
components of the GABAergic system are also regulated by FMRP expression. 
Studies in Fmr1 KO mice have shown expression of various GABAA subunit mRNA 
are downregulated across multiple brain regions (El Idrissi et al. 2005; Gantois et al. 
2006; D’Hulst et al. 2006; Curia et al. 2009). Despite these extensive changes in 
GABAAR expression, synaptic GABA currents are largely unaffected in Fmr1 KO 
neurons (Paluszkiewicz et al. 2011; Curia et al. 2009). 
 
One area that shows large deficits in inhibitory circuits in Fmr1 KO brains is the basal 
amygdala (BA), a sub-nuclei of the amygdala. Immunostaining for the synthetic 
enzyme for GABA is reduced in Fmr1 KO mice as well as a decrease in the number 
of inhibitory connections (Olmos-Serrano et al. 2010). This is reflected in a decrease 
in both the amplitude and frequency of action potential dependent and independent 
inhibitory synaptic potentials in both the adult (Olmos-Serrano et al. 2010) and 
developing BA of Fmr1 KO mice (Vislay et al. 2013). As well as deficits in synaptic 
inhibitory transmission, there are also deficits in tonic GABAergic transmission on to 
excitatory neurons in both the BA and striatum (Martin et al. 2014; Olmos-Serrano et 
al. 2010; Centonze et al. 2008). Tonic GABA signalling is mediated by extrasynaptic 
GABAARs and can influence neuronal excitability through shunting inhibition 
(Semyanov et al. 2004). Therefore, diminished tonic GABA conductance in the BA 
results in intrinsic hyperexcitability of Fmr1 KO principal neurons (Olmos-Serrano et 
al. 2010). Thus changes in GABAergic tonic inhibition has been proposed as a 
potential therapeutic candidate for the treatment of FXS (Olmos-Serrano et al. 2010; 




1.8 Generation of a rat model of FXS 
 
Genetically modified mice have proved to be an invaluable tool in the investigation of 
human mutations which result in neurological disorders. However advances in genome 
manipulation tools have now allowed the development of genetically engineered rats 
opening a new avenue of investigation. The use of zinc finger nucleases, a class of 
engineered DNA binding proteins, can facilitate targeted editing of the genome by 
creating a double strand break in DNA allowing the insertion or deletion of desired 
DNA sequences.  
 
Rats possess several advantages over mice as a model for the study of NDDs. They 
exhibit more complex social and cognitive behaviours allowing extended modelling 
of several key aspects of ASDs. Additionally, the larger body and brain size of rats can 
facilitate investigations by allowing more complex surgical experimentation, greater 
tissue sample collection as well as non-invasive imaging such as function magnetic 
resonance imaging (fMRI). fMRI uses changes in blood oxygen level as an indirect 
measure of neuronal activation allowing real-time in vivo imaging of brain activity 
(Harris et al. 2015). Due to its non-invasive nature, fMRI has been commonly used to 
investigate the neural systems underlying sensory, cognitive and emotional processing 
in the human brain and the effect that genetic mutations can have on their activity. As 
such, fMRI represents a valuable clinical tool in the study of human disorders such as 
FXS. Finally, rats metabolic physiology is also closer to humans than that of mice 
making the rat a better model for studying the pharmacokinetics/pharmacodynamics 
characteristics of drugs. Therefore, the use of fMRI in rodent models of FXS will be 
useful for the translation of findings into humans, making rats a potentially valuable 
preclinical model. 
 
Despite their common features, mice and rats separated in evolution 12-24 million 
years ago and show very divergent behaviours (Gibbs et al. 2004). Whilst rats will 
clearly become a useful tool in the future of FXS research, experimental interpretation 
will be prone to the untested assumption that cellular phenotypes identified in Fmr1 
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KO mice are conserved across mammalian species. Therefore, it is vital to establish if 
the core physiological deficits associated with FXS from studies using Fmr1 KO mice 
are also present in rat models.  
 
A key cellular phenotype associated with the loss of FMRP in mice is the theory that 
excessive group 1 mGluR signalling is a core pathophysiology of FXS (Bear et al. 
2004). This phenotype has been displayed in many different brain regions, resulting in 
various deficits in synaptic plasticity and neuronal signalling (Huber et al. 2002; 
Noyreva & Huber 2006; Suvrathan et al. 2010; Wilson & Cox 2007; Martin et al. 
2015). Similarly, genetic or pharmacological reduction mGluR5 signalling has been 
shown to ameliorate many cellular and behavioural phenotypes in Fmr1 KO mice 
highlighting mGluR5 as a potential target for the treatment of FXS (Yan et al. 2005; 
Dölen et al. 2007; Osterweil et al. 2010; Michalon et al. 2012; Michalon et al. 2014). 
A role of mGluRs has also been identified in Drosophila that lack the ortholog of 
FMRP, suggesting this pathophysiology is conserved across species (McBride et al. 
2005). However investigation of these core mGluR-dependent phenotypes in Fmr1 
KO rats would also provide cross-mammalian evidence of the effects of FMRP loss 
for the first time that will be important when attempting to translate findings from 
fundamental basic research into therapeutic treatments. 
 
1.9 Aims of this thesis 
 
The generation of the Fmr1 KO rat model has the potential to become a key tool for 
future research of FXS. However in order to inform future studies, we must first 
establish if the key cellular phenotypes identified over the past 20 years of research 
using the Fmr1 KO mouse are conserved in rats. Equally, this provides a unique 
opportunity to investigate the conservation of these phenotypes across mammalian 
species (Till et al. 2015). Seminal work from Bear and colleagues identified that 
protein synthesis downstream of mGluR signalling is exaggerated in Fmr1 KO mice 
resulting in hippocampal mGluR-LTD that is both enhanced and independent of new 
protein synthesis, culminating in the ‘mGluR theory of FXS’ (Huber et al. 2002; 
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Nosyreva & Huber 2006; Osterweil et al. 2010). Therefore, the initial focus of this 
thesis was to investigate the key cellular deficits in the hippocampus that result from 
FMRP deletion are conserved in rats. Next we investigated mGluR-dependent LTP in 
the LA as well as excitatory and inhibitory circuitry of the subnuclei of the basolateral 
amygdala (BLA). Finally, we investigated age dependent deficits in translaminar LTP 
in the PL mPFC as well as the intrinsic properties of the subnetwork of L5 pyramidal 
neurons that project to the BLA, a pathway that is important for behaviours affected 
in Fmr1 KO animals. 
 
Chapter 3 Investigate synaptic and chemical mGluR-LTD in Fmr1 KO rats to 
test if: 
1. mGluR-LTD is enhanced 
2. mGluR5 antagonism can rescue changes in mGluR-LTD 
3. mGluR-LTD is protein synthesis independent 
4. Protein synthesis levels are exaggerated in the hippocampus 
5. NMDAR-dependent plasticity mechanisms are affected in the hippocampus 
 
Chapter 4 Investigate synaptic plasticity and excitatory/inhibitory synaptic 
transmission in the basolateral amygdala to test if in Fmr1 KO rats: 
1. mGluR-dependent LTP is absent at thalamic inputs to the LA 
2. mGluR-dependent LTP is absent at cortical inputs to the LA 
3. Presynaptic release probability is reduced in the LA 
4. Inhibitory and excitatory neurotransmission are affected in the BA 
 
Chapter 5 Investigate synaptic plasticity in the PL mPFC and long-range 
connectivity with the BLA in Fmr1 KO rats to test if: 
1. Translaminar LTP in the PL mPFC shows age-dependent deficit 
2. Subpopulation of L5 pyramidal neurons in the PL that project to the BLA 
have changes in intrinsic excitability 
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2.1.1 Housing and Breeding 
 
All experimental animals were male and housed in cages under a 12:12hr light dark 
cycle with ad libitum access to food and water and in accordance with UK Home 
Office regulations. 
 
2.1.2 Generation of Fmr1 SD rats 
 
Fmr1 mutant rats were constructed on an outbred Sprague Dawley background by 
SAGE laboratories. They were generated using zinc-finger nuclease technology to 
make a 122bp deletion across intron 7/exon 8 junction resulting in loss of FMR1 gene 
protein product (Hamilton et al., 2009)  
 
2.1.3 Generation of Fmr1 LEH rats 
 
Fmr1 mutant rats were constructed on the Long-Evans hooded background by SAGE 
laboratories. They were generated using zinc-finger nuclease technology to insert an 





2.2.1 DNA extraction 
 
Tissue was collected in the form of ear clips at weaning for animal identification and 
genotyping. DNA was extracted using the Hot Shot method.  Tissue samples were 
placed in 600 µl NaOH (50 mM) and heated to 100ºC for 45 mins. This solution was 
then neutralised with 50µl Tris-HCl (1 M, pH 8.0) and heated at 100°C for a further 
2mins. Samples were centrifuged at 13,000 x g for 20 mins and then stored at 4°C. 
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2.2.2 Fmr1 SD primers 
 
Single reaction: 
Forward: 5’ – TGGCATAGACCTTCAGTAGCC – 3’ 
Reverse: 5’ – TATTTGCTTCTCTGAGGGGG – 3’ 
 
2.2.3 Fmr1 LEH primers 
 
Two separate PCRs were required for Fmr1 LEH genotyping, one for the WT allele 
and one for the KO allele 
Wild-type reaction: 
WT forward: 5’- CGA GGA AGG ACG AGA AGA TG -3’ 
WT reverse: 5’- CCG CTT CCC TGA CTG AAC T -3’ 
Knockout reaction: 
KO forward: 5’- ACG TAA ACG GCC ACA AGT TC -3’ 
KO reverse: 5’- ATG CCG TTC TTC TGC TTG TC -3’ 
 
2.2.4 Polymerase chain reaction 
Each reaction consisted of 6µl Promega GoTaq master mix, 1µl extracted DNA, 1µl 
forward primer, 1µl reverse primer and 3µl ddH20. The thermocycler conditions for 
all listed primer sets are shown in Table 2.1. PCR products were run on a 2% agarose 






















All chemicals were purchased from Sigma-Aldrich (St Louis, MO, US) or Abcam 
biochemicals (Cambridge, UK) 
Extracellular 
 




NaCl 86 124 
NaH2PO4 1.2 1.2 
KCl 2.5 2.5 
NaHCO3 25 25 
D-glucose 25 20 
Sucrose 75  
CaCl2 0.5 2 
MgCl2 7 1 
Table 2.1 Thermocycling conditions used for all listed primer sets 
Table 2.2 External solution composition (in mM) 

































Table 2.3 Cs-gluconate internal solution composition (in mM) 
Solutions were adjusted to pH 7.25 with CsOH, osmolarity 295mOsm.L-1 
Table 2.4 K-gluconate internal solution composition (in mM) 








2.3.2 Tissue slicing 
 
Rats were anaesthetised using isoflurane and decapitated. The brain was quickly 
dissected out and placed in ice-cold (<4°C) modified slicing aCSF solution (Table 2.2). 
Brains were prepared depending on experimental brain region required (Table 2.6) and 
mounted to a vibroslice stage. Slices were cut in ice-cold modified slicing aCSF 
solution using a vibratome (UK: VT1200S, Leica, UK; India: VT1000, Leica, UK) 
and transferred to a holding chamber containing recording aCSF solution (Table 2.2) 
where they were maintained at 35°C for 30 mins. For hippocampus experiments, CA3 
was microdissected from slices before transferring to holding chamber. Slices were 
left to recover for a further 30 mins at room temperature prior to the start of 
experimentation. 
 
Brain region Slice plane Animal age Slice thickness 
Hippocampus Horizontal P21-P35 400µm 
Lateral Amygdala Coronal 4-8 weeks 400µm 














Table 2.6 Slice preparation protocols for different brain regions 
Table 2.5 High chloride internal solution composition (in mM) 
Solutions were adjusted to pH 7.25 with CsOH, osmolarity 295mOsm.L-1 
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2.4 Extracellular recordings 
 
Slices were placed in a submerged recording chamber heated to 31°C and perfused 
with pre-warmed carbogenated recording aCSF solution at a rate of 4-5ml/min. fEPSP 
were recorded via aCSF filled micropipettes (1-3MΩ) prepared from boroscillate glass 
capillaries (Harvard apparatus, UK) using a horizontal puller (P-97 Flaming Brown, 
Sutter Instruments, US). Synaptic responses were evoked every 30 secs using a bipolar 
nichrome (80/20) stimulating wire attached to a constant current stimulus isolator 
(Digitimer, UK) delivering a 200µs pulse unless stated elsewhere. 
 For hippocampus, the recording electrode were placed in the stratum radiatum of CA1 
and the stimulating wire was placed on the Schaffer collateral. 
 For mPFC, recording electrodes were placed in layer 5 of the Prelimbic region and 
the stimulating wire was placed in layer 2/3. Stimulating and recording electrodes were 
staggered to prevent direct antidromic stimulation. 
 
2.4.1 Stimulation paradigms 
 
Before the initiation of any stimulation paradigm, a stable baseline of at least 20 mins 
was acquired. DHPG, APV, Cycloheximide, Anisomycin, Picrotoxin and CDPPB 
were all purchased from Abcam biochemical. CTEP was purchased from Axon 
Medchem. For all experiments, baseline stimulation intensity was selected as 40-60% 
of the minimum amplitude at which a population spike appeared. 
 
Input output - Hippocampus 
Basal synaptic transmission was investigated by increasing current intensity to give 
fibre volley amplitudes ranging from 0.05 – 0.5 mV in 0.05 mV increments. 
Corresponding fEPSP slope measurements were taken for each fibre volley amplitude 




Paired pulse facilitation - Hippocampus 
Paired pulse facilitation was generated by delivering a pair of successive stimulations 
with a varying inter-stimulus interval (25 – 1000ms). Paired pulse ratios were 
calculated by dividing the slope of the second fEPSP by the slope of the first fEPSP. 
 
Chemically induced LTD - Hippocampus 
DHPG-LTD was induced by perfusing slices with the group 1 mGluR agonist DHPG 
(50µM or 100µM) for 5 mins. Slices were then perfused with aCSF for a further 60 
mins. For experiments testing DHPG-LTD in the presence of Picrotoxin, Anisomycin, 
Cycloheximide or CTEP, slices were pre-incubated for a minimum of 20 mins prior to 
DHPG wash-on. 
 
Synaptically induced LTD - Hippocampus 
PP-LFS LTD was induced using 900 paired pulses with an inter-stimulus interval of 
50ms at a frequency of 1Hz (0.4ms pulse duration). APV 50µM was present 
throughout the recording to prevent activation of NMDAR which can lead to another 
form of synaptic depression. 
NMDA-LTD was induced using 900 single pulses at a frequency of 1Hz. 
 
Synaptically induced LTP - Hippocampus and mPFC 
In the hippocampus, LTP was induced using a 1s 100Hz high frequency train. For 
these experiments the CA3 area was not microdissected from the hippocampal slice. 
In the mPFC, LTP was induced using 5 trains of 300Hz (0.5s, 0.05ms pulse duration) 





2.4.2 Data Analysis 
 
Signal waveforms were amplified 1000x, low-pass filtered at 1.3kHz (npi electronics) 
and digitized at 20kHz (National Instruments). Data was collected and analysed using 
WinLTP (University of Bristol) before being exported to Microsoft Excel. fEPSP 
slopes were normalised to baseline values. Normalised data were averaged across 
experimental groups and reported as mean ± SE. Significant differences between 
groups were determined using Student’s t-test (p < 0.05) or repeated measures 
ANOVA (p < 0.05) in Graphpad Prism software. Statistical tests were performed using 
n as animals unless stated. 
 
2.5 Intracellular recording 
 
For whole-cell recordings, slices were transferred to a recording chamber of an upright 
microscope (UK: S-SCOPE-II, Scientifica, UK; India: Olympus BX51WI, Olympus, 
Japan). Slices were perfused with carbogenated recording aCSF solution at a rate of 4-
5ml/min. Temperature was set depending on the experimental paradigm (24 – 30°C) 
but was maintained using an HPT-2 inline heater (ALA Scientific, NY, US). Cells 
were visualised with IR-DIC video microscopy using a camera (UK: Watec cameras, 
NY, US; India: HD-210U, Dage, IN, US). Patch pipettes (2.5-3.5MΩ) were prepared 
from boroscillate glass capillaries (Harvard apparatus, UK) using a horizontal puller 
(UK: P-97 Flaming Brown, Sutter Instruments, US; India: P-97 Flaming Brown, Sutter 
Instruments, US) and filled with the experimentally appropriate internal solution. 
When an appropriate neuron was visually identified (CA1 pyramidal neuron, lateral 
amygdala principle neuron or prelimbic mPFC layer 5 pyramidal neuron with 
retrobead labelling (see SURGERY) whole-cell recording was established. Following 
the application of positive pressure, the recording electrode was advanced towards the 
cell using a motor micromanipulator (UK: Patchstar, Scientifica, UK; India: MPC-
200, Sutter Instruments, US). Pipette resistance was monitored using the Clampfit 
membrane test function (-5 mV test step, 10Hz). When an increase in pipette resistance 
and a visible dimple in the target cell was observed, positive pressure was released and 
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negative pressure applied until a giga-ohm seal was achieved (>1GΩ). Pipette 
capacitance was compensated before whole-cell configuration was achieved through 
the application of short, sharp bursts of negative pressure. Following membrane 
rupture, access resistance was monitored throughout experiments. Cells were accepted 
with resting membrane potential lower than -60mV and access resistance <25MΩ. If 
access resistance or holding current changed by >25% during a recording it was 
terminated. 
 
2.5.1 Recording paradigms 
 
Passive membrane properties - Hippocampus and mPFC 
Resting membrane potential (VM) was recorded by switching the amplifier to I=0 
configuration and recording for 60s. Cells were then maintained at a set membrane 
potential of -70mV. Membrane time constant (TM) was calculated by fitting a single 
exponential to 10-90% of the membrane charging curve following -25pA injection. 
Input resistance (Rin) was calculated as the slope of the linear fit of the current-voltage 
plot generated from a family of current injections (500ms, -100pA to 100pA, ∆25pA) 
and the steady-state voltage response. Capacitance (CM) was calculated using CM = TM 
/ Rin. 
Ih current is mediated by HCN channels and results in a pronounced ‘Sag’ current 
when the cell is hyperpolarised. The peak hyperpolarised potential and the steady-state 
voltage response were measured from a -250pA step. Sag ratio was then calculated 
using (peak – steady-state / (peak * 100)).  
 
Active membrane properties – Hippocampus and mPFC 
Neuron firing characteristics were investigated using a family of current steps (500ms, 
0-400pA, ∆25pA). Number of action potentials per 500ms was plotted against injected 




The properties of the first action potential at a current intensity that resulted in 3-4 
action potentials was used to calculate waveform properties. AP peak was defined as 
the maximal spike response and was measured from threshold to peak. AP width was 
measured as the width at half the maximal spike response. AP phase plots were 
generated using the first derivative of the AP signal against membrane voltage. AP 
threshold was classified as the membrane voltage where dvdt exceeded 10ms.mV-1. 
Four different after spike potentials were analysed. Fast AHP (fAHP) was measured 
as the most negative potential following an AP waveform. Medium AHP (mAHP) was 
measured as the maximum negative potential following a train of 5 AP evoked at 
frequencies ranging from 20-100Hz using a 2ms, 2nA current pulse. Slow AHP 
(sAHP) was measured as the negative potential 1s after the last AP of a train of 15 AP 
at 50Hz using a 2ms, 2nA current pulse. After-spike depolarising potential (ADP) was 
measured as the maximum depolarised potential following an AP elicited using a 2ms, 
2nA current pulse. 
 
Whole-cell K+ currents - mPFC 
To isolate whole-cell K+ currents, 1µM TTX and 2mM MnCl2 were added to the 
recording aCSF solution with 0 Ca2+ and 0 Na2HPO4 to block Na+, Ca2+ and Ca2+ -
activated K+ currents. K-gluconate internal solution was used for all experiments. 
Total IK currents (IK-WC) were recorded with a 4 sec -100mV pre-pulse, to deinactivate 
any inactivated voltage gated K+ channels, followed by a test step to +50mV. Non-
inactivating K+ currents (IK-Sustained) were isolated using a 30 sec pre-pulse to +20mV, 
to ensure inactivation of components of the current with slow inactivation kinetics, 
followed by a test step to +50mV. Slowly inactivating K+ current (IK-SLOW) was 
isolated by digital subtraction of IK-Sustained from IK-WC. ‘A-type’ K+ current (IK-FAST) 
was isolated using the subtraction method. A 4 sec -100mV pre-pulse was followed by 
a test pulse to +50mV to elicit IK-WC. In the second part of this protocol, following the 
-100mV pre-pulse, membrane potential was stepped to +20mV for 200ms and then to 
+50mV. This brief 200ms step is designed to inactivate IK-FAST which has very fast 
inactivation kinetics, on the order of tens of ms. Therefore, the step to +50mV will 
only be composed of IK-SLOW and IK-Sustained which can be digitally subtracted from IK-
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WC to give a pure IK-FAST current. Recovery of IK-FAST was tested in the same way using 
two test pulses separated by an interval of 10-100ms (∆10ms). 
 
Synaptic events – Hippocampus, mPFC and lateral amygdala 
Cells were allowed 5mins to stabilise following membrane rupture before postsynaptic 
currents were acquired. Spontaneous currents were recorded using normal recording 
aCSF and AP independent currents (mEPSC/mIPSC) were recorded in normal 
recording aCSF containing 300nM TTX. Excitatory postsynaptic currents (EPSC) 
were measured at -70mV using Cs-gluconate internal solution (Table 2.3) with 75µM 
picrotoxin present in the external solution to block inhibitory currents. Inhibitory 
postsynaptic currents (IPSC) were measure at -70mV using High chloride internal 
solution (Table 2.5) with 20µM CNQX present in the external solution to block 
excitatory currents. Postsynaptic currents were recorded at 10kHz and bessel filtered 
at 2kHz. 
 
Synaptic currents - mPFC 
Synaptic currents were evoked by a bipolar cluster electrode (FHC, ME, US) placed 
in layer 2/3 of prelimbic mPFC. For AMPA/NMDA ratios, excitatory currents were 
measured at membrane potentials of -70mV and +40mV in the presence of 75µM 
picrotoxin to block GABAergic transmission. AMPA currents were measured as the 
peak current at -70mV. NMDA currents were measured 50ms after the peak current at 
+40mV. At this time any AMPAR mediated current should have decayed leaving a 
pure NMDA component. For GABA/AMPA ratios, IV plots were performed to 
calculate excitatory and inhibitory reversal potentials. Excitatory currents were 
pharmacologically isolated using 75µM picrotoxin and tested at membrane potentials 
-80 – 50mV. Inhibitory currents were pharmacologically isolated using 20µM CNQX 
and 50µM APV and tested at membrane potentials -100 - -30mV. Using this method, 
AMPA currents were recorded at -60mV and GABA currents were recorded at 




Paired pulse facilitation – mPFC and lateral amygdala 
Paired pulse facilitation was generated by delivering a pair of successive stimulations 
with a varying interstimulus interval (25-100ms). Paired pulse ratios were calculated 
by dividing the peak amplitude of the second EPSC by the peak amplitude of the first 
EPSC. An average of 5 sweeps was used for each interstimulus interval. 
 
Synaptically induced LTP - mPFC 
In lateral amygdala, high frequency stimulation consisted of two trains of 100 pulse at 
30Hz or 100Hz, separated by 20s. Experiments were performed in 75µM picrotoxin. 
Test pulses were delivered to thalamic inputs at 0.05Hz using a bipolar cluster 
electrode (FHC, ME, US). LTP was quantified by normalising EPSP 10-90% slope to 
baseline levels. 
 
2.5.2 Data analysis 
 
Signal waveforms were acquired using a Multiclamp 700B amplifier and Clampex 
software (Molecular Devices, CA, US). Signals were filtered at 10kHz using the built-
in bessel filter of the amplifier and digitized at 20kHz (Digidata 1440, Molecular 
Devices, CA,US). Data were analysed offline using Clampfit software (Molecular 
Devices, CA, US). Synaptic event data were analysed using the template function in 
Clampfit software.  
 
2.6 Stereotaxic injections 
 
2.6.1 Anaesthesia and preparation 
 
Before surgery, 10-14 week old rats were placed in a plexiglass chamber and 
anaesthetised using a mixture of air and isoflurane (5%, 0.4l/min). When breathing 
rate slowed to approximately 1Hz, rats were transferred to a stereotaxic frame (David 
Kopf, CA, US) where anaesthesia was continued through a mask (1.5 – 3%, 0.4l/min). 
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Anaesthesia level was constantly monitored throughout the experiment through 
observation of breathing rate and loss of toe pinch reflex. Ear bars were placed into 
the skull indentation on the interaural line to fix the head in place. The fur on the head 
was removed using an electric razor and the scalp swabbed with iodine solution. 
Petroleum jelly added to the eyes to prevent drying. All surgical tools were washed 
with Dettol and 70% ethanol before sterilisation using a bead steriliser. Injection 
pipettes were produced from boroscillate glass capillaries (Harvard apparatus, UK) 
using a horizontal puller (P-1000 Flaming Brown, Sutter Instruments, US). 
 
2.6.2 Stereotaxic surgery 
 
A small incision was made along the medial axis of the scalp and the skull exposed by 
clamping the skin with forceps. The skull was cleaned to expose the lambda and 
bregma with any ruptured blood vessels cauterised. The skull and surrounding skin 
was kept hydrated using saline solution throughout the experiment. Bregma and 
lambda co-ordinates were established and the nose bar adjusted to ensure they were in 
the same horizontal plane. Sterotaxic co-ordinates from Paxinos & Watson (2006) for 
the injection site were identified relative to the Bregma and the skull thinned using a 
microdrill. A small gauge needle was used to perforate the skull and carefully removed 
it. Any blood flow was cleaned and stemmed before preceeding with injection. 
Retrobeads IX (Lumafluor) diluted 1:4 with saline were infused bilaterally in the 
basolateral amygdala (AP -3.3mm, ML ±5.0mm, DV -8.1mm). Retrobeads were 
infused at a rate of 100nl/min using a Picospritzer III (Parker Hannifin, NH, US). After 
the infusion of 1 – 1.5ul, injection was stopped and the pipette left in place for a further 
10mins before removing it from the brain. Skull was sealed using bone wax and the 
scalp sutured (Mersilk 5-0, Ethicon) and treated with povidone-iodine solution. 
Animals were transferred to a cage and allowed to recover before oral administration 
of paracetamol suspension (1ml, 50mg/ml). This was repeated for four days post-





2.7 Metabolic labelling 
 
2.7.1 Tissue preparation 
 
Brains were collected from WT and Fmr1 KO rats (P25-32) as previously described 
and whole hippocampi dissected out. Transverse hippocampal slices (500µm) were 
prepared using a Stoeling tissue slice and stored in netwells (Corning, Sigma-Aldrich) 
submerged in oxygenated aCSF at 30ºC. Following a minimum 4 hour incubation, 
slices were transferred to a second recovery chamber of oxygenated aCSF at 30 ºC 
containing actinomycin D (25µM; Tocris) for 30mins to inhibit protein transcription. 
Slices were then incubated in aCSF containing ~0.37 MBq/ml of 35S-Met/Cys protein 
labelling mix (Perkin Elmer) +/- DHPG 100µM for 5mins before transferring to 
oxygenated aCSF containing ~0.37 MBq/ml of 35S-Met/Cys protein labelling mix for 
a further 40mins. Slices were snap frozen on dry ice and then stored at -80ºC until 
further processing. aCSF control samples were taken for further analysis. 
 
2.7.2 Tissue processing 
 
Slices were thawed and homogenised in 150µl homogenising buffer containing (in 
mM)10 HEPES pH 7.4, 2 EDTA, 2 EGTA, 1% Triton X-100, protease and 
phosphatase inhibitors (Sigma-Aldrich).  Proteins were precipitated using 12.5% 
Trichloroacetic acid (Sigma-Aldrich), vortexed and put on ice for 10mins before 
spinning at 13,000x for 5mins at 4ºC. Supernatant was discarded and replaced with 
150µl 1M NaOH and incubated at 37ºC until the pellet dissolved. pH was adjusted 
using 50µl 0.33M HCl. 50µl of sample was added to scintillation vials containing 10ml 
scintillation cocktail (Promega). Sample vials were loaded in a scintillation counter 
reading 35S at 2 minutes per sample. Each sample was run in triplicate. 
 




Protein concentration for each sample was measured using a Bio-Rad DC kit. BSA 
standards were made using a 2mg/ml BSA stock (New England Bio Labs). Serial 
dilutions ranging from 2mg/ml to 0.0625mg/ml were made using ddH2O. 5µl of either 
BSA standard or protein sample were added to a 96 well plate in triplicate. 25µl of 
reagent A was added to each well followed by 200µl of reagent B. Samples were then 
incubated at room temperature for 15mins before being read at an absorbance of 
740nm on a FluoStar Optima plate reader (BMG Labtech). Protein concentrations for 
each sample were calculated based on the measure BSA standard curve. 
 
2.7.4 Analysis of protein samples 
 
Scintillation counts for each sample were divided by its protein concentration to give 
counts per minute/µg protein (CPM/µg). The value for each sample was normalised to 
the CPM of the aCSF control sample and the volume of sample added to the 
scintillation vial (50µl for all samples). The average CPM/µg/µl was calculated for 
each triplicate sample and mean calculated for each animal. The average protein 
synthesis for each animal was expressed as percentage of the WT control. Statistics 
were performed using each animal as n. Significant differences were determined by 
paired Student’s t-test (p>0.05). 
 
2.8 Immunofluorescent labelling 
 
Following acute slicing (see section 2.3.2), slices were allowed to recover for 1 hour 
before being fixed in 4% paraformaldehyde at 4ºC for 1 hour. Slices were then washed 
3 times with 0.1M phosphate buffer (PB) and stored in PB at 4ºC for a minimum of 1 
week until further processing. Immediately prior to processing, slices were washed 3 
times in 0.1M PB for 10-20 minutes each wash. Slices were then washed 3 times in 
phosphate buffered saline (PBS) (0.025M PB + 0.9% NaCl) for 10-20 minutes each 
wash. Slices were then transferred to a 24-well plate containing 0.5ml blocking 
solution containing 10% normal goat serum (NGS), 0.3% Triton-X and 0.05% Sodium 
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azide for 1 hour. Blocking solution was then removed and primary antibody solution 
of 5% NGS, 0.3% Triton-X and 0.05% Sodium azide in PBS containing 1:200 Anti-
AnkG (Rabbit) and 1:100) Anti NeuN (mouse). Slices were then incubated for 72 
hours before washing with PBS, 3 times for 15-20 minutes. Secondary antibody 
solution of PBS containing 3% NGS, 0.1% Triton-X, 0.05% Sodium azide, goat anti-
mouse 633nm antibody 1:500 and goat anti-rabbit 468nm 1:500 was then added to 
slices and incubated at 4ºC overnight. Slices were then washed 3 times with PBS, 
followed by two washes in PB for 10-20mins and one wash for 60-90mins. Slices were 




Images were taken using a Zeiss AxiovertLSM 510 inverted confocal microscope with 
native software. A 63x magnification, numerical aperture 1.5 lens was used to image 
z-stacks with 1µm step sizes. 10 axon initial segments (AIS) were imaged from each 
animal across two slices. AISs were traced using FIJI software (ImageJ). Length was 
manually measured as distance from the distal to proximal end of the AIS. Distance 
from soma was measured as distance from NeuN staining to the proximal end of the 
AIS. 10 measurements were averaged to give an animal average for each measure. 




Significant differences between groups were determined using Student’s t-test (p < 
0.05) or two-way ANOVA (p < 0.05) in Graphpad Prism software. Statistical tests 
were performed using n as animals unless stated. Significance was reported as * 

















Translating the mGluR theory of 
















Fragile X syndrome (FXS) is a common form of intellectual disability and autism 
spectrum disorder (ASD). It is the result of the transcriptional silencing of fragile X 
mental retardation protein (FMRP) (Kremer et al. 1991) which leads to a range of 
cognitive, behavioural and physical symptoms. The generation of the Fmr1 KO mouse 
has been a key tool in the investigation of FXS as it has been shown to reproduce many 
of the phenotypes presented by human patients (Bakker et al. 1994). 
 
Advances in transgenic technologies have allowed the generation of genetic models of 
central nervous system disorders in a range of species including rats (Hamilton et al. 
2014). Whilst mice have been invaluable tools in the study of neurodevelopmental 
disorders, rats possess several advantages such as being more flexible to novel 
situations and having more extensive social interactions. These qualities are 
particularly useful in the study of FXS and ASD where patients exhibit deficits in 
social behaviours as well as anxiety disorders. Rat’s richer behavioural repertoire 
allows testing of more complex cognitive processes which will be key in better 
understanding the aetiology of human intellectual disabilities. Rats also maintain the 
experimental advantages over large mammals by having short gestation periods and 
large litter sizes, typically larger than mice, making them an ideal experimental model. 
 
With the advent of the Fmr1 KO rat, it is crucial to establish whether the key cellular 
deficits identified in other FXS models are conserved in this new model of FXS. 
Studies using the Fmr1 KO mouse have elucidated many cellular processes that appear 
to be aberrant in the absence of FMRP. Changes in group 1 metabotropic dependent 
plasticity (mGluR-LTD) (Huber et al. 2002; Nosyreva & Huber. 2006) as well as 
elevated basal protein synthesis rates in CA1 hippocampus (Osterweil et al. 2010; 
Barnes et al. 2015) have led to the hypothesis that many aspects of FXS are the result 
of exaggerated group 1 mGluR signalling, specifically mGluR5 (Bear et al. 2004). 
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These results have also led to the development of potential therapeutic strategies that 
target mGluR5 and its downstream signalling pathways (Dölen et al. 2007; Osterweil 
et al. 2013) which have shown the reversal of some phenotypes of Fmr1 KO mice.  
 
These preclinical findings have also led to large scale human clinical trials targeting 
mGluR5 signalling as a treatment for FXS. Therefore, the generation of a new rat 
model of FXS provides the opportunity to establish if these phenotypes are conserved 
across mammalian species. This would provide cross-mammalian evidence for the 
‘mGluR theory of FXS’ in species that separated in evolution over 12-24 million years 
ago, validating its targeting as a treatment strategy in human FXS (Gibbs et al. 2004). 
The establishment of these core phenotypes will also provide an important foundation 
for the design and interpretation of future studies that take advantage of the Fmr1 KO 
rats behavioural and technical benefits. 
 
Therefore in this chapter, I aimed to establish if the key electrophysiological findings 
reported in Fmr1 KO mice hippocampus can be recapitulated in the Fmr1 KO rat 
model. I investigated mGluR-LTD using both chemical and synaptic induction. I also 
tested the effect of new generation mGluR5 negative allosteric modulators on mGluR-
LTD in Fmr1 KO rats. Next, I investigated the protein synthesis dependency of 
mGluR-LTD in rat models of FXS. I also investigated if any differences exist in the 
induction of chemical v synaptically induced mGluR-LTD in both genotypes. Finally, 
I examined NMDA-dependent plasticity mechanisms to test if FMRP’s role in 




3.2.1 mGluR-LTD at CA3 – CA1 synapses 
 
Extracellular recordings were made from the stratum radiatum of CA1 pyramidal 
neurons where electrical stimulation of Schaffer collaterals produces a fEPSP. This 
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pathway is commonly used for investigations into synaptic plasticity as the laminated 
structure of inputs and outputs of the hippocampus make it highly amenable to this 
form of experiment. The application of a single pulse to this pathway resulted in a 
fEPSP with a smooth rising phase (Fig 3.1). The slope of this rising phase was used 
for quantification as it has a linear relationship with synaptic conductance whereas the 
peak fEPSP amplitude, which can be contaminated by population spikes and 
polysynaptic activity, has a non-linear relationship with synaptic conductance. By 
plotting fEPSP slope against time, changes in synaptic strength in response to drug 
application or stimulus patterns can be investigated (Fig 3.1 C and D).  
 
3.2.2 mGluR-LTD can be reliably induced both chemically and electrically at 
CA3-CA1 synapses 
 
Several forms of plasticity, with different mechanisms of induction, have been 
reported to be present at hippocampal CA3 – CA1 synapses. mGluR-dependent LTD 
can be induced at these synapses both chemically, using the group I mGluR agonist 
DHPG (DHPG-LTD), or synaptically by application of 900 paired pulses at 1Hz 
frequency (PP-LFS LTD). Here I found that both DHPG-LTD and PP-LFS LTD could 
be reliably induced in juvenile (P21-35) WT animals (Fig 3.1 B and C). DHPG-LTD 
(5 mins, DHPG 100µM) resulted in an acute depression during wash-on which 
recovered to a stable synaptic depression (Fig 3.1 B). Initial attempts to induce PP-
LFS LTD using 200µs pulse width gave very inconsistent levels of synaptic 
depression. Increasing pulse width to 400µs during the induction protocol resulted in 
stable synaptic depression (Fig 3.1 D). Therefore, this protocol was used for any 


































Figure 3.1 mGluR dependent LTD in CA1 hippocampus 
(A) Schematic illustrating experimental set up. Horizontal hippocampal slices 
were taken from P21-P35 WT and Fmr1 KO rats. A stimulating electrode was 
placed in the Schaeffer collateral pathway and fEPSP recorded in the stratum 
radiatum of CA1. An incision was made at the CA3-CA1 to prevent 
contamination by recurrent CA3 activity. (B) Example timecourse of DHPG-LTD 
recording. 5 min DHPG (100µM) wash-on resulted in significant LTD in WT 
hippocampal slices. (C) Example timecourse of PPLFS-LTD recording. 900 paired-
pulse at 1Hz frequency resulted in significant LTD in WT hippocampal slices. 








3.2.3 DHPG-LTD is not influenced by GABAA receptor inhibition 
Early studies into the mechanisms of mGluR-LTD found that its expression was 
facilitated by the presence of GABAA receptor (GABAAR) antagonists. Blocking 
inhibition resulted in an enhancement of DHPG-LTD which was attributed to an 
increase in tissue excitability as a similar result was found in ‘Mg2+-free’ aCSF (Palmer 
et al. 1997). However other studies have been unable to reproduce these results 
suggesting that the effect of GABAAR antagonism on DHPG-LTD may be dependent 
on animal age as well as experimental design (Oliet et al. 1997; Pavlov et al. 2004; 
Rohde et al. 2009). To investigate the effect of disinhibition on DHPG-LTD, slices 
were pre-incubated in the GABAAR antagonist picrotoxin (50µM) for at least 20mins 
prior to LTD induction. The presence of picrotoxin had no effect on the magnitude of 
LTD in WT slices (Fig 3.2 B; Vehicle: 74.72 ± 3.25%, n=6; PTX: 75.58 ± 2.28%, n=6; 
p>0.05). This result indicates that DHPG-LTD is not influenced by GABAAR 
inhibition in our experimental design and was not used in further experiments. 
 
Figure 3.2. DHPG-LTD is not influenced by GABAA receptor inhibition  
(A) Timecourse of DHPG-LTD recording in the presence of vehicle or picrotoxin 
75µM. (B) DHPG-LTD was not significantly different in the presence of picrotoxin 
(Vehicle: 74.72 ± 3.25%, n=6 slices/6 animals; PTX: 75.58 ± 2.28%, n=6 slices/6 

































3.3 Basal synaptic and cellular properties in CA1 of Fmr1 KO LEH rats 
 
3.3.1 Basal excitatory transmission at Schaeffer collateral inputs to CA1 is 
unaffected in Fmr1 KO LEH rats 
 
Previous studies in Fmr1 KO mice have reported no alterations in basal synaptic 
transmission at CA3 – CA1 synapses (Godfraind et al. 1996, Paradee et al. 1999; 
Huber et al. 2002). To ensure that no differences in basal synaptic transmission exist 
in the Fmr1 KO LEH rats that could confound further investigation, I examined both 
the input/output relationship and presynaptic release probability of CA3 – CA1 
synapses. No change in basal synaptic strength were observed in Fmr1 KO LEH rats 
(Fig 3.3 A; F(1,6)=1.20; p=0.32). Paired pulse ratio was not significantly different at 
any of the measured inter-stimulus intervals (Fig 3.3 B; F(1,10)=0.139; p=0.72) 
suggesting that basal release probability is largely unaffected in Fmr1 KO LEH rats. 
These results indicate that basal excitatory transmission at CA3 – CA1 synapses is 
intact in the absence of FMRP. 
 
3.3.2 CA1 intrinsic properties are unchanged in Fmr1 KO LEH CA1 pyramidal 
neurons 
 
There have been no reports of changes in whole-cell intrinsic properties in CA1 
pyramidal neurons in Fmr1 KO mice (Pilpel et al. 2009; Brager et al. 2012). In 
agreement with this, no changes were found here in any passive membrane intrinsic 
properties (Fig 3.4 A, B, C; Input resistance: WT: 94.23 ± 6.95MΩ, n=8, KO: 94.76 ± 
4.80MΩ, n=12, p > 0.05; Capacitance: WT: 215.16 ± 15.99pF, n=8, KO: 231.03 ± 
9.67pF, n=12, p > 0.05; Membrane time constant: WT: 19.39 ± 0.98ms, n=8, KO: 
21.63 ± 0.65ms, n=12, p > 0.05). There was also no change in the active properties of 
CA1 pyramidal neurons (Fig 3.4 D). Fmr1 KO LEH neurons showed no differences 
in the number of action potentials fired in response to current injection (Fig 3.4 D; 
F(1,18)=0.124; p=0.729). The amount of current required to elicit a single action 
potential was also comparable between genotypes (Fig 3.4 E; WT: 154.17 ± 9.65pA, 








Figure 3.3 Basal excitatory synaptic transmission is unaffected at CA3-CA1 
synapses in Fmr1 KO LEH rats (A) Input-output function was measured at CA3-
CA1 synapses by comparison of fibre volley amplitude and fEPSP slope. No 
significant differences were observed between genotypes (F(1,6)=1.20; p=0.32, 
Two-way RM-ANOVA). Example traces from each genotype showing fEPSP at 
various stimulation strengths. Scale 100µV, 20ms. (B) Paired pulse facilitation 
was tested using two concurrent pulses at multiple inter-stimulus intervals (25-
1000ms). Paired pulse facilitation was comparable between WT controls and 
Fmr1 KO LEH rats (F(1,10)=0.139; p=0.72, Two-way RM-ANOVA). Example traces 
from each genotype showing paired pulse facilitation at all tested intervals. 







FMRP does not affect either the passive or active membrane properties in CA1 
pyramidal neurons. 
 
3.4 mGluR-dependent plasticity at CA3-CA1 synapses in Fmr1 KO LEH rats 
 
3.4.1 DHPG-LTD is enhanced in Fmr1 KO LEH rats 
 
mGluR-LTD in CA1 of the hippocampus is both exaggerated and independent of new 
protein synthesis in Fmr1 KO mice (Huber et al. 2002; Nosyreva & Huber 2006). 
These results contributed to the ‘mGluR theory of Fragile X syndrome’ (Bear et al. 
2004) which suggested that aberrant mGluR5 signalling contributed to the 
pathophysiology associated with Fragile X syndrome. Therefore, I investigated 
whether these animals showed the same phenotypes following the induction of 
mGluR-LTD using the group 1 agonist DHPG. As shown previously in Fmr1 KO 
mice, application of DHPG (50µM) resulted in synaptic depression that was 
significantly greater in Fmr1 KO LEH animals than in WT controls (Fig 3.5 A; WT: 
89.60 ± 2.30%, n=10; KO: 82.96 ± 1.80%, n=11; p=0.034). This effect was also seen 
when a higher concentration of DHPG (100µM) was used for DHPG-LTD induction 
(Fig 3.5 B; WT: 74.73 ± 3.97%, n=8; KO: 57.46 ± 4.89%, n=8; p=0.016). These results 
show that DHPG-LTD is enhanced in Fmr1 KO LEH rat’s relative to WT controls. 
For DHPG-LTD induction in WT slices, synaptic depression was found to be more 
reliable when DHPG 100µM rather than DHPG 50µM was used (Fig 3.5 B, DHPG 
100µM: 7 out of 8 slices had LTD >10%; Fig 3.5 A, DHPG 50µM: 3 out of 10 slices 
had LTD >10%). Therefore for all future Fmr1 LEH experiments, DHPG-LTD was 








3.4.2 Presynaptic release is reduced following DHPG-LTD in Fmr1 KO rats 
 
Previous studies have given conflicting reports on whether DHPG-LTD has both a 
presynaptic and postsynaptic locus. The discrepancy in results could be due to 
differences in experimental design, animal age or experimental technique. Studies in 
Fmr1 KO mice have highlighted a presynaptic role of FMRP (Deng et al., 2013) as 
well as a role in regulating retrograde signalling that can influence presynaptic release. 
Therefore, I monitored presynaptic release probability in response to DHPG-LTD in 
Fmr1 KO LEH rats. In this study, DHPG-LTD resulted in no change in paired pulse 
ratio in WT animals (Fig 3.6; WT Baseline: 1.52 ± 0.05; WT 50-60mins: 1.55 ± 0.05; 
n=7; p > 0.05). In contrast, DHPG-LTD resulted in a significant increase in paired 
pulse ratio in KO animals (Fig 3.6; KO Baseline: 1.60 ± 0.04; KO 50-60mins: 1.72 ± 
0.04; n=8; p=0.0009). This result suggests that while there is no apparent presynaptic 
component to DHPG-LTD in WT animals, DHPG-LTD results in a significant 
decrease in presynaptic release probability in Fmr1 KO rats that may contribute to the 
exaggerated synaptic depression. 
 
3.4.3 CTEP corrects enhanced DHPG-LTD in Fmr1 KO LEH rats 
 
Both pharmacological and genetic strategies focusing on mGluR5 signalling have been 
found to be successful in ameliorating some of the phenotypes shown in Fmr1 KO 
mice (Chuang et al. 2005; Yan et al. 2005; Osterweil et al. 2010; Dölen et al. 2007). 
Here I examined if pre-incubation in the mGluR5 negative allosteric modulator CTEP 
(10µM) could restore the level of DHPG-LTD shown by Fmr1 KO LEH rats to WT 
levels. CTEP incubation significantly reduced the magnitude of DHPG-LTD in Fmr1 
KO LEH animals to WT levels (Fig 3.7 D; WT: 84.72 ± 4.61%; n=4; KO: 74.21 ± 
4.75%; p>0.05). CTEP incubation also prevented the reduction in presynaptic release 
probability in Fmr1 KO LEH rats following DHPG-LTD (Fig 3.7 E; WT CTEP 
Baseline: 1.51 ± 0.003; WT CTEP 50-60mins: 1.53 ± 0.01; n=4; p > 0.05; KO CTEP 
Baseline: 1.51 ± 0.05; KO CTEP 50-60mins: 1.54 ± 0.06; n=7; p > 0.05). These data 
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suggest that the enhanced DHPG-LTD shown in these animals is due to exaggerated 
mGluR5 signalling which can be corrected by pharmacological inhibition. 
 
3.4.4 PP-LFS LTD magnitude is unaltered in Fmr1 KO rats 
Previous studies have shown that mGluR-dependent LTD can also be induced 
electrically using different patterns of synaptic stimulation. The most commonly used 
of these stimulation paradigms is PPLFS-LTD where 900 paired pulses (50ms 
interstimulus interval) are delivered at a rate of 1Hz (Kemp & Bashir 1999). Studies 
using Fmr1 KO mice have found PP-LFS LTD is enhanced in slices where FMRP is 
absent (Huber et al. 2002). Therefore, I investigated whether this mGluR-dependent 
WT KO 
Figure 3.6 Presynaptic release is reduced following DHPG-LTD in Fmr1 KO 
LEH rats (A) Paired pulse facilitation was unaffected by DHPG-LTD in WT 
LEH rats (WT Baseline: 1.52 ± 0.05; WT 50-60mins: 1.55 ± 0.05; n=7 
slices/7 animals; p > 0.05) but was significantly increased in Fmr1 KO LEH 
rats (KO Baseline: 1.60 ± 0.04; KO 50-60mins: 1.72 ± 0.04; n=8 slices/8 
animals; p=0.0001. Statistics performed  using Two way RM-ANOVA with 
Bonferroni correction. Example traces showing fEPSP from baseline (black) 
and 60mins post-stimulation (red). First fEPSP in red trace has been scaled 


























































Figure 3.7 CTEP corrects enhanced DHPG-LTD in Fmr1 KO LEH rats (A) 
Timecourse showing DHPG-LTD in WT and Fmr1 KO LEH rats. (B) DHPG-LTD was 
significantly increased in Fmr1 KO LEH rats (WT: 79.53 ± 3.47%; n=4 slices/4 
animals; KO: 60.79 ± 2.15%; n=4 slices/4 animals; p=0.01, Student unpaired t-
test). (C) Timecourse showing DHPG-LTD in WT and Fmr1 KO LEH rats in the 
presence of CTEP 10µM. (D) DHPG-LTD was comparable between genotypes in 
the presence of CTEP 10µM (WT: 84.72 ± 4.61%; n=4 slices/4 animals; KO: 74.21 
± 4.75%; p>0.05, Student unpaired t-test). (E) PPF was not significantly different 
following DHPG-LTD in both WT (WT Baseline: 1.51 ± 0.003; WT 50-60mins: 1.53 
± 0.01; n=4 slices/4 animals; p > 0.05) or Fmr1 KO slices in presence of CTEP (KO 
Baseline: 1.51 ± 0.05; KO 50-60mins: 1.54 ± 0.06; n=4 slices/4 animals; p > 0.05, 








form of LTD is also enhanced in Fmr1 KO LEH rats. Here I found no significant 
difference in the magnitude of PP-LFS LTD between genotypes (Fig 3.8 B; WT: 81.58 
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± 2.37%; n=9; KO: 80.70 ± 1.87%; n=8; p> 0.05). However unlike DHPG stimulation, 
induction of PP-LFS LTD did not affect presynaptic release probability in either 
genotype (Fig 3.8 C; WT Baseline: 1.48 ± 0.05; WT 85-95mins: 1.50 ± 0.06; n=7; p > 
0.05; KO Baseline: 1.52 ± 0.06; KO 85-95mins: 1.56 ± 0.07; n=8; p > 0.05). These 
results suggest that despite both being group 1 mGluR-dependent, DHPG-LTD and 
PP-LFS LTD possess distinct expression mechanisms.  
 
3.5 Protein synthesis dependency of mGluR-LTD in rat models of Fragile X 
syndrome 
 
3.5.1 DHPG-LTD is protein synthesis independent in both WT LEH and Fmr1 
KO LEH rats 
 
The pathophysiology associated with Fragile X syndrome is hypothesised to result, in 
part from of elevated basal protein synthesis downstream from mGluR5-regulated 
signalling pathways (Osterweil et al. 2010). This elevated protein synthesis is believed 
to result in the enhanced and protein-synthesis independent mGluR-LTD that has been 
reported in Fmr1 KO mice (Huber et al. 2002; Nosyreva et al. 2006). Therefore, based 
on the presence of enhanced DHPG-LTD in Fmr1 KO LEH rats, I hypothesised that 
DHPG-LTD would also be independent of new protein synthesis in this animal model 
of Fragile X syndrome. To investigate this I pre-incubated hippocampal slices in 
protein synthesis inhibitor Cycloheximide (100µM) for at least 30mins prior to DHPG-
LTD induction. Contrary to previous results, I found that DHPG-LTD was 
independent of new protein synthesis in both WT animals (Fig 3.9 B; WT: 79.52 ± 
1.32%; n=3; pWTvBaseline > 0.05) and KO animals (Fig 3.9 D; KO: 61.34 ± 2.86%; n=4; 
pWTvBaseline > 0.05). This was consistent when a different protein synthesis inhibitor, 
Anisomycin (20µM), was tested (Fig 3.9 B; WT: 79.55 ± 1.86%; n=4; pWTvBaseline > 
0.05; Fig 3.9 D; KO: 59.77 ± 6.00%; n=4; pWTvBaseline > 0.05). These results are 
consistent with the hypothesis that DHPG-LTD is protein synthesis independent in the 
Fmr1 KO LEH rats however this is confounded by the finding 
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Figure 3.9 Protein synthesis inhibitors had no effect on DHPG-LTD in either 
genotype. (A) Timecourse showing DHPG-LTD in WT LEH animals in the presence 
of cycloheximide (100µM) or anisomycin (20µM). (B) DHPG-LTD caused 
significant synaptic depression in the presence of protein synthesis inhibitors in 
WT LEH  animals (WT CHX: 79.52 ± 1.32%; n=3 slices/3 animals; p=0.004, Student 
paired t-test; WT Aniso: 79.55 ± 1.86%; n=4 slices/4 animals; p=0.002, Student 
paired t-test). (C) Timecourse showing DHPG-LTD in Fmr1 LEH KO animals in the 
presence of cycloheximide (100µM) or anisomycin (20µM). (D) DHPG-LTD caused 
significant synaptic depression in the presence of protein synthesis inhibitors in 
Fmr1 KO LEH animals (KO CHX: 61.34 ± 2.86%; n=4 slice/4 animals; p=0.0009, 
Student paired t-test; KO Aniso: 59.77 ± 6.00%; n=4 slices/4 animals; p=0.007, 









that WT LEH rats also exhibited protein synthesis independent DHPG-LTD. The 
addition of protein synthesis inhibitors also had no effect on the decrease in 
presynaptic release probability in Fmr1 KO LEH rats (Fig 3.10 A and B; 
Cycloheximide WT Baseline: 1.57 ± 0.09; Cycloheximide WT 50-60mins: 1.62 ± 0.1; 
n=3; p > 0.05; Cycloheximide KO Baseline: 1.52 ± 0.54; Cycloheximide KO 50-
60mins: 1.70 ± 0.07; n=4; p=0.01; Anisomycin WT Baseline: 1.53 ± 0.78; Anisomycin 
WT 50-60mins: 1.57 ± 0.08; n=4; p > 0.05;  Anisomycin KO Baseline: 1.49 ± 0.07; 
Anisomycin KO 50-60mins: 1.64 ± 0.08; n=4; p=0.0006). These findings show that 
inhibition of new protein synthesis has no effect on either the magnitude or mechanism 
of DHPG-LTD in either genotype.  
 
3.5.2 Basal protein synthesis is not elevated in Fmr1 KO LEH rats and is not 
affected by DHPG treatment in either genotype 
 
Previous reports in Fmr1 KO mice have found that exaggerated and protein synthesis 
independent DHPG-LTD is associated with an increase in basal protein synthesis 
(Dölen et al. 2007). Therefore, I used metabolic labelling to assess basal protein 
synthesis levels in our Fmr1 KO LEH rats and WT controls. Here I found a subtle but 
not significantly different increase in protein synthesis levels in hippocampal slice 
from Fmr1 KO rats (Fig 3.11; WT: 100.00 ± 0.00%; n=8; KO: 113.63 ± 7.56%; n=8; 
p>0.05). This suggests that exaggerated basal protein synthesis levels do not contribute 
to the exaggerated DHPG-LTD observed in Fmr1 KO rats. 
 
It has previously been shown that the protocol used to induce DHPG-LTD in 
hippocampal slices results in a significant increase in protein synthesis rates in WT 
animals that is not observed in Fmr1 KO mice (Osterweil et al. 2010). This DHPG-
induced protein synthesis is thought to represent the rapid translation of proteins 
responsible for the long-term expression of DHPG-LTD. Therefore, I tested the 
effected of DHPG stimulation on protein synthesis levels in our Fmr1 LEH rats, where 
neither genotype show protein synthesis dependent DHPG-LTD. Application of 
DHPG 100µM during the first 5mins of metabolic labelling did not result in a 
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Figure 3.10 Incubation with protein synthesis inhibitors does not affect PPF 
increase following DHPG-LTD in Fmr1 LEH KO rats (A) Paired pulse facilitation 
was unaffected by DHPG-LTD in presence of Cycloheximide 100µM in WT LEH 
rats (WT Baseline: 1.57 ± 0.09; WT 50-60mins: 1.62 ± 0.1; n=3 slices/3 
animals; p > 0.05) but was significantly increased in Fmr1 KO LEH rats (KO 
Baseline: 1.52 ± 0.54; KO 50-60mins: 1.70 ± 0.07; n=4 slice/4 animals; 
p=0.01). (B) Paired pulse facilitation was unaffected by DHPG-LTD in presence 
of anisomycin 20µM in WT LEH rats (WT Baseline: 1.53 ± 0.78; WT 50-60mins: 
1.57 ± 0.08; n=4 slices/4 animals; p > 0.05) but was significantly increased in 
Fmr1 KO LEH rats (KO Baseline: 1.49 ± 0.07; KO 50-60mins: 1.64 ± 0.08; n=4 








significant increase in protein synthesis rates compared to vehicle control in either 
genotype (Fig 3.11; WT vehicle: 100.00 ± 0.00%; n=8; WT DHPG: 111.83 ± 6.35%; 
n=8; p>0.05; KO vehicle: 113.63 ± 7.56%; n=8; KO DHPG: 114.50 ± 9.86%; n=8; 
p>0.05). This data suggests that the absence of protein synthesis dependent DHPG-
LTD in this colony may be the result of an inability of group 1 mGluR activation to 
trigger downstream protein synthesis in these rats 
 
3.5.3 Harlan WT LEH rats show protein synthesis dependent DHPG-LTD 
 
The protein synthesis dependence of DHPG-LTD in wild-type animals is a well 
reported phenotype across the field in both mouse and rat studies (Huber et al. 2000; 
Barnes et al. 2015, Auerbach et al. 2011, Tian et al. 2015). It has been noted previously 




























Figure 3.11 Basal protein synthesis is not elevated in Fmr1 KO LEH rats and is 
not affected by DHPG treatment in either genotype (A) Basal protein synthesis 
was not significantly enhanced in Fmr1 KO LEH rats (WT: 100.00 ± 0.00%; n=8 
animals; KO: 113.63 ± 7.56%; n=8 animals; p>0.05). DHPG did not significantly 
increase protein synthesis rates in either genotype (WT vehicle: 100.00 ± 
0.00%; n=8 animals; WT DHPG: 111.83 ± 6.35%; n=8 animals; p>0.05; KO 
vehicle: 113.63 ± 7.56%; n=8 animals; KO DHPG: 114.50 ± 9.86%; n=8 animals; 





synthesis dependency of DHPG-LTD (Personal communication, Professor K. Huber, 
University of Texas Southwestern). Therefore, I tested the effect of a protein synthesis 
inhibitor on DHPG-LTD in Blue Spruce Long Evans rats sourced from Harlan 
laboratories. In these animals I found that the magnitude of DHPG-LTD was not 
significantly different from baseline in the presence of the protein synthesis inhibitor 
Cycloheximide (Fig 3.12; aCSF: 75.12 ± 4.80%; n=6; paCSFvBaseline = 0.004; CHX: 
93.08 ± 5.86%; n=6; pCHXvBaseline > 0.05). This result suggests that the lack of protein 
synthesis dependent DHPG-LTD that I see in our Fmr1 LEH colony could be due to 
their genetic background strain. 
 
3.5.4 DHPG-LTD is enhanced and independent of new protein synthesis in 
Sprague Dawley Fmr1 KO rats 
 
During the course of this investigation I was also given access to an Fmr1 KO rat bred 
on the Sprague Dawley (SD) genetic strain, created by Horizon laboratories (Till et al. 
2015). This strain was first used to confirm our finding that DHPG-LTD was enhanced 
in Fmr1 KO rats. Here, hippocampal DHPG-LTD was examined in juvenile (P21-32) 
WT and Fmr1 KO SD rats. Consistent with findings in Fmr1 KO LEH rats, application 
Figure 3.12 DHPG-LTD is protein synthesis dependent in WT LEH rats from a 
different vendor (A) Timecourse showing DHPG-LTD in WT LEH rats from a 
different vendor in the presence of cycloheximide 100µM. (B) DHPG-LTD was 
dependent on new protein synthesis in these WT LEH rats (aCSF: 75.12 ± 
4.80%; n=6 slices/6 animals; p = 0.004, Student paired t-test; CHX: 93.08 ± 


































of DHPG (50µM, 5 mins) resulted in synaptic depression that was significantly greater 
than WT littermate controls (Fig 3.13 A; WT: 78.64 ± 3.70%, n=17; KO: 67.53 ± 
4.11%, n=17; p=0.023). Next, I investigated the protein synthesis dependency of 
mGluR-LTD in both genotypes of the Fmr1 SD rats. Hippocampal slices were pre-
incubated in the protein synthesis inhibitor Cycloheximide (100µM) for a minimum 
of 30 mins prior to DHPG-LTD induction, which then remained present for the 
remainder of the experiment. The inhibition of new protein synthesis prevented the 
maintenance of DHPG-LTD in WT slices (Fig 3.13 D; WT: 98.08 ± 8.35%, n=11; 
pWTvBaseline>0.05). In contrast, DHPG-LTD was independent of new protein synthesis 
in Fmr1 KO rats (Fig 3.13 D; KO: 74.22 ± 7.42%, n=11; pKOvBaseline=0.022). Therefore, 
in agreement with findings in Fmr1 KO mice, DHPG-LTD was both exaggerated and 
independent of new protein synthesis in Fmr1 KO SD rats compared to WT littermate 
controls.  
3.5.5 Basal excitatory transmission at Schaeffer collateral inputs to CA1 is 
unaffected in Sprague Dawley Fmr1 KO rats 
 
As changes in basal synaptic strength or release probability could affect the induction 
or expression of synaptic plasticity (Palmer et al. 1997), I investigated these parameters 
in the Fmr1 SD rat model. Here, the input/output relationship of this synapse was 
investigated by incrementally increasing stimulus intensity and plotting the evoked 
fibre volley amplitude against fEPSP slope. In agreement with other Fragile X models, 
no change in basal synaptic strength were observed at CA3 – CA1 synapses in Fmr1 
KO SD rats (Fig  3.14 A; F(1,14)=0.09; p=0.77). Next, I investigated paired pulse 
ratios by applying two stimulus pulses with a varying inter-stimulus interval (20-
1000ms) which has been interpreted as a measure of pre-synaptic release probability 
(Zucker & Regehr 2002). Paired pulse ratio was not significantly different at any of 
the measured inter-stimulus intervals (Fig 3.14 B; F(1,18)=0.195; p=0.664) suggesting 
that basal release probability is largely unaffected in Fmr1 KO SD rats. From these 





for any plasticity differences between the two Fragile X Syndrome rat models.  
 
3.5.6 PP-LFS LTD is protein-synthesis dependent in WT LEH rats but protein 
synthesis independent in Fmr1 KO LEH rats 
 
Synaptically induced mGluR-LTD has also been shown to be protein synthesis 
dependent in WT animals as well as protein synthesis independent in Fmr1 KO mice 
(Nosyreva & Huber 2006). Here I tested the protein synthesis-dependency of PP-LFS 
LTD in Fmr1 LEH rats. In contrast to DHPG-LTD, PPLFS-LTD was not significantly 
different from baseline when new protein synthesis was inhibited in WT slices (Fig 
3.15 B; WT aCSF: 81.71 ± 2.89%; n=7; CHX: 94.12 ± 3.48%; n=7; pCHXvBaseline > 
0.05). However, PPLFS-LTD cause significant synaptic depression in Fmr1 KO LEH 
rats in the presence of Cycloheximide (Fig 3.15 D; KO aCSF: 77.34 ± 0.68%; n=5; 
KO CHX: 78.66 ± 4.23%; n=5; pCHXvBaseline = 0.007). This data is in direct agreement 
with studies in the Fmr1 KO mice that have shown PP-LFS LTD is independent of 
new protein-synthesis in the absence of FMRP (Nosyreva & Huber 2006). This data 
also provides further evidence that a difference in the mechanism of DHPG-LTD and 
PP-LFS LTD expression may exist. 
 
3.7 NMDA-dependent plasticity mechanisms are unaffected in the absence of 
FMRP 
 
Previous studies in Fmr1 KO mice have found no changes in NMDA-dependent 
plasticity mechanisms in CA1 hippocampus (Godfraind et al. 1996; Paradee et al. 
1999; Huber et al. 2002). Here I investigated two forms of plasticity in Fmr1 LEH rats, 
NMDA-dependent LTD and NMDA-dependent LTP. No significant differences were 
observed in the magnitude of LTD induced by 900 single pulses at a frequency of 1Hz 
(Fig 3.16 A; WT: 81.16 ± 3.11%; n=6; KO: 80.25 ± 4.93%; n=5; p > 0.05). Similarly 
no significant differences were observed in the magnitude of NMDA- 
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Figure 3.14 Basal excitatory synaptic transmission is unaffected at CA3-CA1 
synapses in Fmr1 KO SD rats (A) Input-output function was measured at CA3-
CA1 synapses by comparison of fibre volley amplitude and fEPSP slope. No 
significant differences were observed between genotypes (F(1,14)=0.091; 
p=0.7678, Two way RM-ANOVA). Example traces from each genotype showing 
fEPSP at various stimulation strenths. Scale 100µV, 20ms. (B) Paired pulse 
facilitation was tested using two concurrent pulses at multiple interstimulus 
intervals (25-1000ms). Paired pulse facilitation was comparable between WT 
controls and Fmr1 KO SD rats (F(1,18)=0.1945; p=0.6644, Two way RM-ANOVA). 
Example traces from each genotype showing paired pulse facilitation at all 








dependent LTP between genotypes (Fig 3.16 B; WT: 152.68 ± 15.38%; n=4; KO: 
146.09 ± 10.54%; n=4; p > 0.05). 
 
 3.8 Discussion 
In this chapter, the core physiological hippocampal phenotypes identified in Fmr1 KO 
mice that have contributed to the ‘mGluR theory of FXS’ have been assessed in Fmr1 
KO rats. I have shown that DHPG-LTD is enhanced in two separate rat models of FXS 
relative to control animals and this appears to be corrected by incubation with mGluR5 
negative allosteric modulators. In contrast to previous studies, I did not observe a 
protein synthesis dependent component to DHPG-LTD in LEH WT rats. This appears 
to be restricted to this outbred LEH strain as protein synthesis dependent DHPG-LTD 
was observed in WT animals from a separate LEH colony and also SD rats. In line 
with studies in Fmr1 KO mice, Fmr1 SD KO rats showed protein synthesis 
independent DHPG-LTD. Using Fmr1 LEH rats, no difference in the magnitude of 
PPLFS-LTD was observed between genotypes. However this form of plasticity was 
found to be dependent on new protein synthesis in WT rats but independent of new 
protein synthesis in Fmr1 KO LEH rats. This data suggests that DHPG-LTD and 
PPLFS-LTD have distinct mechanisms of expression. Together, this work highlights 
the conservation of mGluR dependent phenotypes caused by the loss of FMRP 
between mice and rats 
 
3.8.1 Induction of mGluR-LTD in CA1 hippocampus 
 
Long-term depression resulting from the stimulation of group 1 mGluRs has been 
commonly studied at Schaeffer collateral synapses onto CA1 pyramidal neurons. A 
common method is through application of DHPG, an agonist of mGluR1/5, which 
produces a stable synaptic depression lasting in excess of 1hr. Early studies into the 
mechanisms of DHPG-LTD found that its expression was enhanced when tissue 
excitability was increased either by the presence of GABAAR antagonists or using 































Figure 3.16 NMDAR-dependent plasticity mechanisms were unaffected by 
the loss of FMRP. (A) Timecourse showing NMDAR-dependent LTD induced 
with 900 pulses at 1Hz frequency resulted in equal magnitude synaptic 
depression in both genotypes (WT: 81.16 ± 3.11%; n=6 slices/ 6 animals; KO: 
80.25 ± 4.93%; n=5 slices/5 animals; p > 0.05, Student unpaired t-test). (B) 
Timecourse showing NMDAR-dependent LTP induced with 1s, 100Hz train 
resulted in equal magnitude synaptic potentiation in both genotypes (WT: 
152.68 ± 15.38%; n=4 slices/4 animals; KO: 146.09 ± 10.54%; n=4 slices/4 





disinhibition had no effect on DHPG-LTD magnitude. This may be caused by 
differences in experimental design as this previous study used adult, female rats as 
well as using the ‘grease-gap’ recording method where the recording electrode is 
placed in the alveus of CA1 hippocampus. The recordings shown here were performed 
in CA1 stratum radiatum, as were those in another study that showed no effect of 
disinhibition on DHPG-LTD (Rohde et al. 2009). Therefore differences in GABAergic 
innervation or the activity of interneurons in different lamina could explain the 
differences in mechanism observed here as has previously been hypothesised for 
NMDA-LTD on CA1 apical dendrites (Parvez et al. 2010).  
 
3.8.2 Mechanistic differences in chemical v synaptic induction of mGluR-LTD 
 
mGluR-LTD can be induced using both patterned synaptic stimulation as well as 
chemical agonists such as DHPG. Chemical stimulation is most commonly used in the 
study of the mechanism of mGluR-LTD because of the ability to perform 
complimentary molecular and biochemical analysis. Classically, the mechanisms of 
both chemical (DHPG-LTD) and synaptic mGluR-LTD (PPLFS-LTD) are thought to 
be analogous. Several studies have shown the long term expression of both DHPG-
LTD and PPLFS-LTD to be dependent on mGluR5 signalling (Huber et al. 2000; Moult 
et al. 2008; Faas et al. 2002). Both forms have been shown to be dependent on similar 
signalling pathways involving activation of mitogen activated protein kinase (MAPK), 
protein tyrosine phosphatases (PTP) and Jun N-term kinase (Gallagher 2004; Huang 
et al. 2004; Moult et al. 2008; Li et al. 2007). Similarly, studies have shown that both 
forms of mGluR-LTD are dependent on new protein synthesis (Huber et al. 2000; 
Nosyreva and Huber 2006). Both DHPG-LTD and PPLFS-LTD have also been shown 
to occlude one another at some developmental ages which also suggests a shared 
mechanism (Huber et al. 2001).  
 
Whilst these findings suggest that both chemical and synaptic mGluR-LTD share one 
mechanism, the data in this chapter provide evidence of the contrary. Firstly, when 
comparing mGluR-LTD between genotypes in our Fmr1 LEH colony, DHPG-LTD 
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was found to be exaggerated in Fmr1 KO LEH rats whereas the magnitude of PPLFS-
LTD was unaffected. This suggests that the loss of FMRP affects the expression of 
DHPG-LTD through a mechanism that is not involved in PPLFS-LTD. The magnitude 
of mGluR-LTD in CA1 hippocampus has previously been linked with the level of 
basal protein synthesis (Osterweil et al. 2010) however I observed no significant 
difference in this between WT controls and Fmr1 KO LEH rats, although repeat 
experiments are required to confirm this (Fig 3.11). This suggests that elevated basal 
protein synthesis is not the cause of the observed exaggerated DHPG-LTD in Fmr1 
LEH KO rats.  
 
One possible explanation for the exaggerated DHPG-LTD in the absence of FMRP 
could be through an additional presynaptic depression. DHPG wash on resulted in a 
significant increase in paired pulse facilitation (PPF), which is associated with a 
reduction in synaptic release probability, in Fmr1 LEH KO slices. I saw no long term 
effect on PPF following DHPG wash-on in WT controls suggesting DHPG-LTD is 
expressed postsynaptically in WT animals. No change in PPF was observed in either 
genotype following PPLFS-LTD induction (Fig 3.8) suggesting that the reduction in 
release probability following DHPG-LTD in Fmr1 KO LEH slices may contribute to 
the exaggerated synaptic depression. This is further supported by preliminary data 
showing the normalisation of DHPG-LTD magnitude as well as PPF in the absence of 
FMRP following incubation with the mGluR5 negative allosteric modulator CTEP (Fig 
3.7). As group 1 mGluR expression in CA1 hippocampus is typically restricted to the 
postsynaptic terminal, this reduction in presynaptic release could be mediated by a 
retrograde signalling mechanism such as endocannabinoid (eCB) release.  
 
Following postsynaptic depolarisation and mGluR activation, eCBs are release from 
the postsynaptic terminal into the synaptic cleft where they act upon presynaptic 
afferents (Chevaleyre et al. 2006). The eCB receptor subtype cannabinoid 1 receptor 
(CB1R) is expressed in many brain regions including the hippocampus and its 
activation is thought to lead to a reduction in the probability of neurotransmitter release 
(Alger 2002). Whilst CB1R activation is not typically thought to be involved in LTD 
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at excitatory synapses, CB1R antagonism has been shown to reduce the acute short-
term depression following DHPG application suggesting eCB release plays a role in 
mGluR-LTD (Rouach & Nicoll 2003). Group 1 mGluR activation has also been shown 
to be required for eCB-mediated plasticity at inhibitory terminals in CA1 hippocampus 
highlighting an important regulatory role of mGluR signalling in eCB release (Varma 
et al. 2001). In Fmr1 KO mice, mGluR5 signalling has been found to be both 
constitutively active as well as showing enhanced coupling with eCB mobilization 
(Ronesi et al. 2012; Zhang & Alger 2010). This has been shown to lead to alterations 
in eCB-mediated plasticity mechanisms in several brain areas (Zhang & Alger 2010; 
Maccarrone et al. 2010; Jung et al. 2012). Therefore, one could hypothesise that 
enhanced mGluR5 signalling and eCB release at Fmr1 LEH KO synapses could result 
in depression of vesicle release at presynaptic terminals, resulting in enhanced DHPG-
LTD in the absence of FMRP. This could be further investigated by testing the effects 
of CB1R antagonism on DHPG-LTD in Fmr1 LEH KO rats. 
 
Whilst an increase in PPF is indicative of reduction in presynaptic release probability, 
it can also be explained through other mechanisms. The locus of expression of mGluR-
LTD has raised some controversy in the field since it was first identified. Some work 
in adolescent WT animals has suggested a presynaptic effect through observations of 
increased PPF and a reduction in mEPSC frequency, but not amplitude, following 
DHPG application (Oliet et al. 1997; Faas et al. 2002; Fitzjohn et al. 1999) whereas 
others have proposed postsynaptic effect through AMPAR internalisation in a process 
that is dependent on postsynaptic protein synthesis (Snyder et al. 2001; Huber et al. 
2000). These presynaptic changes could also be explained through a postsynaptic 
mechanism if AMPAR internalisation took place preferentially at synapses that have 
a higher probability of glutamate release than average, counter to a mechanism 
previously suggested for postsynaptic LTP (Poncer & Malinow 2001). However this 
mechanism would likely require the activation of both mGluR and AMPAR. Given 
that DHPG-LTD can be induced without concurrent synaptic stimulation (Fitzjohn et 
al. 1999; Huber et al. 2001) this is unlikely to explain the increased PPF observed here. 
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3.8.3 Protein synthesis dependency of mGluR-LTD in Fmr1 rats 
 
Several lines of evidence suggest that the expression of mGluR-LTD is dependent on 
rapid dendritic protein synthesis (Huber et al. 2000; Huber et al. 2001). Contrary to 
this, in this thesis I found that DHPG-LTD was independent of new protein synthesis 
in WT LEH rats (Fig 3.9). It has been suggested that some rodent background strains 
may contain genetic mutations which result in protein synthesis independent plasticity 
(Professor Kimberly Huber, personal communication, University of Texas 
Southwestern). In agreement with this I saw protein synthesis dependent DHPG-LTD 
in two other strains of WT rat under the same recording conditions. The stimulation of 
mGluRs has been shown to increase protein synthesis levels in conditions that induce 
LTD in the hippocampus (Osterweil et al. 2010). This new protein synthesis is thought 
to represent the expression of proteins which lead to AMPAR internalisation and 
depression of synaptic transmission, of which there are several candidates (Zhang et 
al. 2008; Davidkova & Carroll 2007). Metabolic labelling revealed that DHPG did not 
cause a significant increase in protein synthesis rates in WT LEH rats (Fig 3.11). One 
potential explanation for this finding is that protein synthesis levels are already 
saturated in this strain of WT animals. As proposed for Fmr1 KO mice, elevated basal 
protein synthesis downstream of mGluRs could lead to protein synthesis independent 
LTD as the existing protein pool is sufficient to support the expression of synaptic 
depression. Analysis using RNA sequencing to compare the transcriptomes of these 
different rat strains may provide information on the underlying cause of these 
differences in DHPG-LTD mechanism. 
 
In contrast to DHPG-LTD, I found PPLFS-LTD was abolished in the presence of 
protein synthesis inhibitors in WT LEH rats (Fig 3.15) suggesting the expression of 
chemical and synaptic mGluR-LTD are supported by different populations of proteins 
in these animals. PPLFS-LTD may be acting through a different group of receptors 
than DHPG-LTD which is the result of group 1 mGluR activation with a specific 
agonist. In agreement with this, Volk et al. (2006) showed that PPLFS-LTD can persist 
in systems where group 1 mGluRs are both genetically deleted or blocked 
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pharmacologically. This LTD could be mediated by other Gq coupled receptors such 
as M1 muscarinic acetylcholine receptors (mAChRs) which is also dependent on new 
protein synthesis (Volk et al. 2007). Interestingly, disruption of mGluR interactions 
with the protein Homer, which is thought to link mGluR activation with downstream 
protein synthesis, disrupts DHPG-LTD whilst having no effect on PPLFS-LTD 
(Ronesi & Huber 2008). This supports the hypothesis that whilst DHPG-LTD is 
independent of new protein synthesis due to an unknown mutation in this WT strain 
resulting in saturated protein synthesis downstream of mGluR signalling, PPLFS-LTD 
is unaffected as it is being mediated through a different set of synaptic receptors, 
potentially mAChRs, which requires a different subpool of proteins for its expression. 
Future experiments addressing the protein synthesis dependency of carbachol induced-
LTD and its ability to stimulate new protein synthesis in this strain of WT animals 
could also inform this hypothesis. 
 
3.8.4 Translating the ‘mGluR theory’ to a rat model of FXS 
 
The ‘mGluR theory of FXS’ is based on the observation that mGluR-LTD in CA1 
hippocampus is both exaggerated and independent of new protein synthesis in Fmr1 
KO mice (Huber et al. 2002; Nosyreva & Huber 2006). These phenotypes are thought 
to be the result of exaggerated basal protein synthesis caused by aberrant mGluR5 
signalling (Osterweil et al. 2010). These findings have contributed to the hypothesis 
that many aspects of FXS are the result of exaggerated group 1 mGluR signalling (Bear 
et al. 2004).  
 
The generation of rat models of FXS has enabled us to investigate if these hippocampal 
phenotypes are conserved across mammalian species. Using the SD Fmr1 rat 
generated by Horizon laboratories, I found DHPG-LTD was both enhanced and 
independent of new protein synthesis (Fig 3.13). Basal protein synthesis rates were 
also enhanced in Fmr1 SD KO rats relative to WT controls (Till et al. 2015). These 
results are in good agreement with the original findings in Fmr1 KO mice. 
Experiments using a second rat model of FXS on a different genetic background, the 
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Fmr1 LEH rat, have revealed some intriguing findings however this most likely a 
result of WT strain issues. DHPG-LTD was once again found to be enhanced in Fmr1 
LEH KO rats (Fig 3.5) and PPLFS-LTD was independent of new protein synthesis 
(Fig 3.15). Whilst the protein synthesis independency of DHPG-LTD in WT animals 
from this colony provide a confounding factor, the finding of protein synthesis 
dependent DHPG-LTD in WT LEH rats from a separate supplier suggests that genetic 
backcrossing may be a potential solution. This would allow us to then test the effect 




In summary, the data presented in this chapter provide good evidence of shared cellular 
pathophysiology associated with the loss of FMRP in CA1 hippocampus of mice and 
rats. The core phenotypes identified in Fmr1 KO mice that have informed the ‘mGluR 
theory of FXS’ (1) exaggerate mGluR-LTD, (2) protein synthesis independent mGluR-
LTD and (3) enhanced basal protein synthesis, have all been displayed. I have also 
shown that a pharmacological strategy targeting mGluR5 is able to normalise the 
enhanced DHPG-LTD adding to the findings in Fmr1 KO mice that therapeutics 
targeting group 1 mGluRs can ameliorate some of the phenotypes associated with the 
loss of FMRP. This work provides the first cross-mammalian evidence for mGluR-
dependent cellular phenotypes in models of FXS and can act as a foundation for future 
investigations into hippocampal function in rat models of FXS that would otherwise 
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Although intellectual disability is often seen as the defining feature of FXS it is often 
co-occuring with a range of emotional features, which are the most debilitating aspects 
for many families. These features include anxiety, gaze avoidance and elevated stress 
(Hessl et al. 2004). These behaviours are consistent with amygdala dysfunction, a key 
component of the brains fear circuitry involved in both the acquisition, expression and 
storage of fear memories (Davis 2006). Consistent with this, amygdala abnormalities 
have been identified in FXS patients using functional and structural MRI studies 
(Watson et al. 2008; Gothelf et al. 2008; Kates et al. 1997; Hazlett et al. 2009). 
Behavioural studies using Fmr1 KO mice have also identified abnormalities in social 
behaviour, anxiety and fear conditioning (McNaughton et al. 2008; Paradee et al. 1999; 
Spencer et al. 2008) highlighting the importance of FMRP in amygdala function. 
 
The neurocircuitry of fear responses has classically been studied in rodents using fear 
conditioning paradigms. Many species including humans, primates and rodents are 
able to acquire conditioned fear reactions following the association of a neutral 
stimulus with a noxious event (LeDoux 2003). As these fear responses closely 
resemble the behavioural and physiological symptoms of human fear responses, they 
are thought to have clinical relevance to the understanding of the underlying 
neurobiology of fear pathology in human conditions such as FXS.  
 
Several studies have identified the basolateral amygdala (BLA); which is composed of 
the basal (BA) and lateral amygdala (LA) nuclei; as a key component in fear learning 
across species (LeDoux et al. 1990). The LA receives direct sensory input from both 
the thalamus and cortex (Pitkänen et al. 1997). Studies showing that long-term 
potentiation (LTP) at these inputs is occluded by fear learning has led to the hypothesis 
that this may represent the cellular correlate of the acquisition of fear memories (Blair 
et al. 2001; Tsvetkov et al. 2002). These forms of plasticity have particular relevance 
to FXS as group 1 mGluR-dependent forms of LTP have been identified at both of 
these inputs (Rodrigues et al. 2002; Cho et al. 2011). In line with the mGluR signalling 
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dysfunction in FXS, studies in Fmr1 mice have identified deficits in mGluR-LTP at 
thalamic inputs to the LA (Suvrathan et al. 2010; Zhao et al. 2005). This is 
accompanied by deficits in fear learning in Fmr1 KO mice (Paradee et al. 1999). 
Another well characterised component fear and anxiety related circuit is the BA which 
serves in the storage and expression of fear memories (Gale et al. 2004; Anglada-
Figueroa 2005). Several studies in Fmr1 mice have revealed significant defects in 
inhibitory signalling within the BA that could also contribute to the described deficits 
in amygdala mediated behaviours (Olmos-Serrano et al. 2010; Olmos-Serrano et al. 
2011; Kratovac & Corbin 2013; Martin et al. 2014; Vislay et al. 2013). 
 
Recent work in our lab has revealed that Fmr1 KO rats show deficits in cued fear 
conditioning (Dr Sally Till, University of Edinburgh, personal communication) 
suggesting an underlying pathology in amygdala function of Fmr1 KO rats. LTP at 
both cortical and thalamic inputs to the LA underlies this form of learning in rats and 
is regulated by group 1 mGluR signalling (Rodrigues et al. 2002; Cho et al. 2011). As 
I have shown in my work in the CA1 hippocampus (Chapter 3), group 1 mGluR 
signalling is affected in Fmr1 KO rats.  Therefore, I wanted to test the fidelity of 
mGluR-LTP at the two major inputs to the LA in Fmr1 KO rats using previously 
established protocols. The loss of FMRP is also associated with cellular 
hyperexcitability in the BA as a result of deficits in inhibitory signalling. This circuit 
excitability affects amygdala output which can lead to changes in amygdala dependent 
behaviours. Therefore, I next examined the intrinsic excitability of principal neurons 










4.2.1 mGluR-dependent LTP at thalamic inputs is impaired in the lateral 
amygdala of Fmr1 KO rats 
 
Long-term potentiation at auditory thalamic inputs of the lateral amygdala is believed 
to represent the cellular correlate of auditory fear learning. Tetanic stimulation of 
axons in the internal capsule, where the inputs from the auditory thalamus are believed 
to enter the lateral amygdala, results in a form of LTP that is dependent on both 
NMDA-receptors and mGlu5-receptor activation (Rodrigues et al. 2002; Bauer et al. 
2002). Here, I investigated if this mGluR-dependent form of synaptic plasticity is 
intact in our rat model of Fragile X syndrome. Tetanic stimulation of thalamic inputs 
to the lateral amygdala at 30Hz resulted in a form of LTP in WT animals that was 
significantly impaired in Fmr1 KO rats (Fig 4.1 B; WT: 132.41 ± 4.57%; n=7; KO: 
110.77 ± 5.36%; n=6; p=0.01). Some forms of LTP have been shown to be absent in 
animal models of Fragile X syndrome due to changes in the threshold for induction 
(Meredith et al. 2007). Thus I repeated these experiments with an increased tetanic 
stimulation frequency of 100Hz (Humeau et al. 2007). Even with this more robust form 
of induction, LTP was still significantly impaired in Fmr1 KO rats (Fig 4.1 D; WT: 
156.94 ± 9.80%; n=8; KO: 119.17 ± 3.63%; n=8; p=0.003). Therefore, in line with 
studies from Fmr1 KO mice, mGluR-dependent plasticity is impaired at thalamic 
inputs to the lateral amygdala. 
 
4.2.2 mGluR-dependent LTP at cortical inputs to the LA is absent in Fmr1 KO 
rats 
 
As well as thalamic inputs, the LA also receives synaptic inputs arising from various 
cortical regions. As these inputs can undergo plasticity independently, it is likely that 
synaptic potentiation at either input is sufficient for fear learning (Tsvetkov et al. 2004; 
Romanski & LeDoux 1992). In vivo studies have suggested that associative interaction 
of these two inputs in the LA could facilitate the formation of fear memories (Doyere 
et al. 2003). In vitro studies have shown that paired stimulation of 
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thalamic and cortical inputs to the LA, using temporal delays that have been observed 
in vivo (Quirk et al. 1997), result in LTP at cortico-amygdala synapses (Cho et al. 
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2011). This form of LTP was also found to be dependent on group 1 mGluR signalling 
(Cho et al. 2011). As I have shown deficits in other mGluR-dependent synaptic 
plasticity mechanisms in Fmr1 KO rats, here I investigated if this form of plasticity 




Initially, I tested if I could independently activate thalamic and cortical inputs. I 
activated cortical and thalamic inputs to principal neurons of the LA to elicit EPSCs 
using stimulating electrodes placed in the external capsule and internal capsule 
respectively (Fig 4.2). Comparison of the arithmetic sum of EPSCs elicited by separate 
activation of cortical or thalamic inputs was found to strongly correlate with responses 
when both inputs were simultaneously stimulated (Fig 4.2 B; r=0.942). Furthermore, 
no paired pulse facilitation was observed between inputs with a 50ms inter-pulse 
interval (Fig 4.2 D). These findings confirm that using this strategy is able to 


























Figure 4.3 mGluR-dependent LTP at cortical inputs to the LA is reduced 
in Fmr1 KO rats (A) Schematic of experimental design. Stimulating 
electrodes placed in external and internal capsule to stimulate cortical 
and thalamic inputs respectively. LTP was induced with 90 pairs of 
thalamic and cortical stimuli with 15ms interval at 1Hz. (B) Example EPSC 
traces from WT and Fmr1 KO recordings showing baseline (black) and 
30mins post-stimulation (red). Scale 50pA, 10ms. (C) Timecourse showing 
LTP induced at cortical inputs in WT and Fmr1 KO rats. (D) This protocol 
induced significant LTP in WT rats (WT: 128.83 ± 5.84%; n=9 slices/9 
animals; p=0.001, Student paired t-test) but was no LTP in Fmr1 KO rats 
(104.97 ± 5.27%; n=7 slices/7 animals; p>0.05, Student paired t-test). 
*** 




Next, I induced LTP using paired stimulation of thalamic and cortical inputs for 90 
seconds at 1Hz frequency. Thalamic inputs were stimulated 15ms prior to cortical 
inputs to mimic the suggested timing of inputs to the lateral amygdala recorded in vivo 
(Quirk et al. 1997). Using this protocol, significant potentiation of EPSC amplitude 
was seen in WT cortico-amygdala pathway (Fig 4.3 D; WT: 128.83 ± 5.84%; n=9; 
p=0.001). The induction of LTP in WT cortical inputs required paired thalamic 
stimulation as stimulation of cortical inputs alone for 90 seconds at 1Hz showed no 
potentiation (Fig 4.4; WT cortical: 99.28 ± 5.71%; n=3; p>0.05). However when this 
protocol was performed in Fmr1 KO slices, no LTP was found in cortico-amygdala 
pathway (Fig 4.3 D; KO: 104.97 ± 5.27%; n=7; p>0.05). This data shows that as well 
as a loss of mGluR-dependent LTP at thalamic synapses to the LA, cortico-amygdala 




Figure 4.4 LTP at cortical input in WT animals requires paired thalamic 
stimulation (A) Timecourse of LTP induction with 90 stimulations, 1Hz at 
cortical inputs only. No significant LTP was induced in WT rats with only 
cortical stimulation (WT cortical: 99.28 ± 5.71%; n=3 slices/3 animals; 







4.2.3 Intrinsic properties were unchanged in principal neurons off the lateral 
amygdala in Fmr1 KO rats 
 
Next, I examined if the observed deficits in LTP could be the result of abnormal 
intrinsic physiology of the postsynaptic LA neuron. No changes were observed in any 
passive membrane intrinsic properties (Table 4.1). Furthermore, active properties 
measured using a family of current steps did not differ between genotypes (Fig 4.6; 
F(1,35)=0.007; p=0.93). The amount of current required to elicit an action potential 
was also comparable between genotypes (Fig 4.6 B; WT: 115.00 ± 8.96pA; n=21; KO: 
103.13 ± 5.53pA; n=16; p>0.05). These results suggest that changes in postsynaptic 
excitability are not responsible for the observed deficits in LTP induction in the LA. 
 
4.2.4 mEPSC frequency is increased, but amplitude unchanged, in the absence of 
FMRP 
 
As well as mGluR-dependent deficits in synaptic plasticity in the lateral amygdala of 
Fmr1 KO animals, there have also been suggestions of changes in presynaptic release 
probability at excitatory synapses on to LA principal neurons (Suvrathan et al. 2010). 
Therefore, I compared the frequency and amplitude of mEPSCs in lateral amygdala 
neurons between our genotypes. Whole cell recordings were performed of LA 
principal neurons at -70mV in the presence of 300nM tetrodoxin and 75µM picrotoxin 
to block GABAA mediated transmission. Here I found a significant decrease in the 
frequency of mEPSCs in Fmr1 KO animals (Fig 4.6 C; WT: 2.68 ± 
Table 4.1 Summary of subthreshold properties of WT and Fmr1 KO LA principal 
neurons. Statistics were performed using Student unpaired t-test. 
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0.25Hz; n=5; KO: 1.65 ± 0.16Hz; p=0.009) however mEPSC amplitude was 
unchanged (Fig 4.6 A; WT: -20.68 ± 0.47pA; n=5; KO: -21.36 ± 0.67pA; n=5; 
p>0.05). No changes were observed in mEPSC kinetics (Fig 4.6 E; WT rise time: 1.08 
± 0.05ms; n=5; KO rise time: 1.02 ± 0.08ms; n=5; p>0.05; Fig 4.6 F; WT decay time: 
4.76 ± 0.24ms; n=5; KO decay time: 4.70 ± 0.11ms; n=5; p>0.05). These results 
suggest that presynaptic release probability onto lateral amygdala principal neurons is 
decreased in Fmr1 KO rats whilst postsynaptic conduction is unchanged. 
 
To further test the possibility that presynaptic release is reduced in Fmr1 KO rats, I 
measured paired pulse ratios (PPR) at both thalamic and cortical inputs to the LA. At 
thalamic synapses, I found PPRs of evoked EPSCs to be significantly larger in KO rats 
compared to WT rats across multiple inter-pulse intervals, indicating a reduction in 
release probability in the absence of FMRP (Fig 4.7 A; F(1,9)=15.27; p=0.004). 






















Figure 4.5 Neuronal excitability in Fmr1 KO LA principal neurons is unaffected 
(A) Current-firing responses showed no differences in the number of action 
potentials fired in response to various current injections in Fmr1 KO neurons 
(F(1,35)=0.007; p=0.93, Two way RM-ANOVA). (B) Rheobase current was 
comparable between genotypes (WT: 115.00 ± 8.96pA; n=21 cells/7 animals; KO: 







to WT controls (Fig 4.7 B; F(1,7)=22.04; p=0.002). The observed reduction in mEPSC 
frequency and changes in PPR at both inputs to the LA provide strong evidence that 
presynaptic release is reduced in Fmr1 KO rats. 
 
4.2.5 Inhibitory synapses on to principal neurons of the LA are unaffected in 
Fmr1 KO rats 
 
FMRP expression has been shown in GABAergic interneurons throughout the brain 
(Feng et al. 1997; Olmos-Serrano et al. 2010) suggesting an involvement in 
interneuron function. Given the observed alterations in the lateral amygdala excitatory 
circuitry of Fmr1 KO rats, I next investigated if inhibitory transmission is similarly 
affected in lateral amygdala principal neurons. Here, recordings of LA principal 
neurons were performed at -70mV using modified Cl- internal (see methods) in the 
presence of 300nM TTX and 10µM CNQX to block AMPAR mediated transmission. 
I observed no significant alterations in mIPSC amplitude (Fig 4.8 A; WT: -41.32 ± 
8.23pA; n=5; KO: -43.63 ± 2.26pA; n=5; p>0.05), frequency (Fig 4.8 C; WT: 8.13 ± 
0.72Hz; n=5; KO: 7.37 ± 0.94Hz; n=5; p>0.05), rise time (Fig 4.8 E; WT: 1.88 ± 










Figure 4.7 Release probability in reduced at both thalamic and cortical inputs on 
to LA principal neurons (A) Paired pulse facilitation at thalamic inputs to Fmr1 KO 
LA principal neurons was increased at a range of inter-pulse intervals 
(F(1,9)=15.27; p=0.004, Two way RM-ANOVA). (B) Paired pulse facilitation at 
cortical inputs to Fmr1 KO LA principal neurons was increased at a range of inter-
pulse intervals (F(1,7)=22.04; p=0.002, Two way RM-ANOVA).  
A B Thalamic synapses Cortical synapses 
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± 0.44ms; KO: 12.16 ± 0.54ms; n=5; p>0.05). This analysis revealed no changes in 
mIPSC frequency or kinetics suggesting that inhibitory neurotransmission is 
unaffected in the LA of Fmr1 KO rats. 
 
4.2.6 Basal amygdala excitatory and inhibitory circuitry are unaffected in Fmr1 
KO rats 
 
As well as the LA, the basal amygdala (BA) has been shown to play a role in fear and 
anxiety behaviours, serving as a storage for fear memories (Ehrlich et al. 2009; 
Anglada-Figueroa 2005; Gale et al. 2004). FXS has been increasingly linked with 
excitatory/inhibitory imbalances associated with dysfunction of inhibitory 
transmission in several brain regions (Gibson et al. 2008; Selby et al. 2007). Previous 
studies in Fmr1 KO mice have revealed significant deficits in inhibitory synapse 
formation and function resulting in hyperexcitability of BA principal neurons (Olmos-
Serrano et al. 2010; Vislay et al. 2013). Here, I investigated both mEPSC and mIPSCs 
on to BA principal neurons as indicators of excitatory and inhibitory 
neurotransmission. Contrary to findings in the LA, I observed no significant 
differences in mEPSC frequency in Fmr1 KO BA principal neurons (Fig 4.9 C; WT: 
7.60 ± 0.84Hz; n=6; KO: 7.64 ± 1.04Hz; n=5; p>0.05). Similarly, mEPSC amplitude 
(Fig 4.9 A; WT: -18.61 ± 1.55pA; n=6; KO: -19.69 ± 1.33pA; n=5; p>0.05), rise time 
(Fig 4.9 E; WT: 1.14 ± 0.03ms; n=6; KO: 1.25 ± 0.07ms; n=5; p>0.05) and decay time 
(Fig 4.9F; WT: 3.57 ± 0.06ms; n=6; KO: 3.54 ± 0.02ms; n=5; p>0.05) were 
comparable between genotypes. In contrast to reports in Fmr1 KO mice (Olmos-
Serrano et al. 2010; Martin et al. 2014), no significant differences were observed in 
mIPSC amplitude (Fig 4.10 A; WT: -30.89 ± 2.79pA; n=4; KO: -32.35 ± 2.44pA; n=4; 
p>0.05) or frequency (Fig 4.10 C; WT: 8.85 ± 0.86Hz; n=4; KO: 7.33 ± 1.23pA; n=4; 
p>0.05). mIPSC kinetics were also unaltered in Fmr1 KO neurons (Fig 4.10 E; WT 
rise time: 2.23 ± 0.07ms; n=4; KO rise time: 2.19 ± 0.17ms; n=4; p>0.05; Fig 4.10 F; 
WT decay time: 12.45 ± 0.56ms; n=4; KO decay time: 12.21 ± 0.51ms; n=4; p>0.05). 
This data indicates that GABAergic synaptic transmission is intact in the BA of Fmr1 






4.2.7 Fmr1 KO BA principal neurons are hyperexcitable compared to WT 
controls 
 
Excitatory/inhibitory balances can also manifest as a result of changes in the intrinsic 
properties of neurons as well as synaptic abnormalities. Here, I tested the intrinsic 
properties of BA principal neurons in Fmr1 KO rats. I found that input resistance was 
significantly greater in Fmr1 KO BA neurons compared to WT controls but all other 
measured parameters were comparable (Table 4.2). In line with this, Fmr1 KO neurons 
fired more action potentials in response to a family of current steps compared to WT 
controls (Fig 4.11 A; p=0.02). This was associated with a decrease in rheobase in the 
absence of FMRP (Fig 4.11 B; WT: 248.61 ± 7.69pA; n=18; KO: 222.22 ± 9.67pA; 
n=18; p=0.04). This data suggests that despite excitatory and inhibitory circuits being 
intact in Fmr1 KO BA nuclei, principal neurons are intrinsically hyperexcitable in the 




4.3.1 mGluR-dependent phenotypes in the lateral amygdala 
 
As well as intellectual disability, FXS is also associated with a range of emotional 
features including anxiety, gaze avoidance and elevated stress (Hessl et al. 2004). 
These behaviours are consistent with amygdala dysfunction, a key component of brain 
circuitry responsible for fear learning. Studies using Fmr1 KO mice have highlighted 
abnormalities in the acquisition of amygdala-dependent behaviours such as fear 
learning (Paradee et al. 1999). A large body of evidence has shown the LA to be the 
neural centre for fear conditioning (Shin & Liberzon 2010).  
 
During auditory fear conditioning, the integration of a conditioned (CS) and 








memories (LeDoux 2003). This process has been shown to be impaired in transgenic 
mice lacking mGluR5 as well as by local application of the mGluR5 antagonist MPEP 
in vivo (Schulz et al. 2001; Rodrigues et al. 2002). In vitro work has also shown that 
LTP at thalamic inputs to the LA, believed to represent a cellular correlate of fear 
learning, is dependent on mGluR5 signalling (Rodrigues et al. 2002). Based on the 
observation that group 1 mGluR signalling is altered in the absence of FMRP, previous 
studies in Fmr1 KO mice have identified deficits in mGluR-LTP at these synapses 
consistent with the observed deficits in fear learning (Zhao et al. 2005; Suvrathan et 
al. 2010; Paradee et al. 1999). Here I observed a similar deficit in mGluR-dependent 
plasticity at thalamic inputs to the LA of Fmr1 KO rats. No differences were observed 
in the intrinsic excitability of principal neurons in the LA suggesting this did not 
contribute to the deficit in LTP. This is in agreement with the finding that fear 
acquisition is affected in these animals (Dr Sally Till, personal communication) and 
provides further evidence of the translation of group 1 mGluR-dependent phenotypes 
from mouse to rat FXS models. 
 
In this chapter, I also investigated LTP at cortical inputs to the LA, a pathway that has 
not previously been investigated in Fmr1 KO mice. Using low-frequency paired 
activation of thalamic and cortical inputs to the LA, LTP was induced at cortico-
amygdala synapses that has been shown to be dependent on group 1 mGluR signalling 
(Cho et al. 2011). This induction protocol is designed to mimic the temporal pattern of 
synaptic activation that occurs in the LA in vivo during fear conditioning paradigms, 
leading to LTP of the cortical input which carries CS driven signals.  Consistent with 
the notion that this form of plasticity is crucial for fear 
Table 4.2 Summary of subthreshold properties of WT and Fmr1 KO BA principal 
neurons. Statistics were performed using Student unpaired t-test. 
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learning, it has also been shown to be occluded in slices from fear conditioned rats 
(Cho et al. 2011). Here, I found this form of mGluR-LTP was also absent in the LA of 
Fmr1 KO rats. Together with results from the thalamic pathway, this suggests that 
alterations in group 1 mGluR signalling in the absence of FMRP are preventing the 
expression of LTP in pathways that are crucial for fear memory formation. 
 
Although one may hypothesise that alterations in mGluR-dependent LTP would exist 
in Fmr1 KO animals in light of the ‘mGluR theory of FXS’, the contrasting roles of 
mGluRs in synaptic plasticity in the hippocampus and amygdala highlight the 
complications of translating this theory across brain regions. Work from the 
hippocampus showing that mGluR5 signalling is enhanced in Fmr1 KO animals would 
suggest that mGluR-LTP in the LA of Fmr1 KO rats may be exaggerated, as was 
observed with hippocampal mGluR-LTD. Yet both here and in studies of Fmr1 KO 
mice (Suvrathan et al., 2010; Zhao et al., 2005) we find it to be absent. This is in 

























Figure 4.11 Fmr1 KO BA principal neurons are hyperexcitable (A) Fmr1 KO 
neurons fire significantly more action potentials in response to various current 
injections (F(1,34)=5.922; p=0.02, Two way RM-ANOVA). (B) Rheobase current 
was significantly reduced in Fmr1 KO neurons (WT: 248.61 ± 7.69pA; n=18 cells/6 





potential explanation for this effect could be through mGluR5s interaction with 
NMDARs. mGluR5 in the LA has been shown to be predominantly expressed on the 
postsynaptic terminal where they interact with other glutamate receptors, in particular 
NMDARs (Naisbitt et al., 1999). In agreement with this, mGluR agonists have been 
shown to potentiate NMDAR currents (Fitzjohn et al., 1996; Pisani et al., 2001) 
through a mechanism that is inhibited by mGluR5 deletion or pharmacological 
inhibition (Mannaioni et al., 2001; Pisani et al., 2001). Thus mGluR5 is in a critical 
position to modulate synaptic plasticity through modulation of NMDARs. mGluR5 and 
NMDARs interact physically through scaffolding proteins. One known interaction is 
via Homer proteins which have been shown to bind with Shank, a protein that exists 
as part of the NMDAR associated PSD-95 complex (Naisbitt et al., 1999; Hayashi et 
al., 2009). As mGluR5-Homer interactions are thought to be disrupted in Fmr1 KO 
mice (Giuffrida et al., 2005; Ronesi & Huber, 2008), the ability of mGluRs to modulate 
NMDAR signalling may be lost in the absence of FMRP. As LTP at thalamic inputs 
is also dependent on NMDAR signalling (Rodrigues et al., 2002), one could 
hypothesise that it is this mechanism that underlies the absence of mGluR-dependent 
LTP at thalamic inputs in the LA of Fmr1 KO rats. Future experiments investigating 
the ability of mGluR activation to modulate NMDAR currents in Fmr1 KO neurons 
would complement this. Also, this hypothesis could be further tested through addition 
of a peptide that mimics the C-terminal tail of mGluR5 to the intracellular solution 
used during whole cell recordings of WT neurons. This strategy has previously been 
used to disrupt mGluR5-Homer interactions (Ronesi & Huber, 2008) which would 
reveal if this interaction was necessary for LTP induction in this pathway. 
 
Whilst the described hypothesis may be applicable to the observed LTP deficit at 
thalamic inputs to the LA, it is unlikely that this could explain the plasticity deficit at 
cortical inputs as this form of plasticity is not dependent on NMDAR signalling (Cho 
et al., 2013). This deficit is most likely due to an insufficient rise in intracellular Ca2+ 
concentration to reach a threshold for LTP induction in Fmr1 KO neurons. Previous 
studies in Fmr1 KO mPFC pyramidal neurons has revealed deficits in spike time 
dependent plasticity related to reduced Ca2+ signalling (Meredith et al., 2007). 
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However these studies suggested a role of L-type voltage gated Ca2+ channels (VGCC) 
which do not contribute to the form of plasticity studied here (Cho et al., 2012). As 
insufficient postsynaptic depolarisation takes place during the induction of mGluR-
dependent cortical LTP to activate NMDAR or VGCC, intracellular Ca2+ increases 
may arise from mGluR driven release of internal stores via IP3 signalling. Consistent 
with this, Xestospongin-C, a compound which inhibits release from IP3-sensitive Ca2+ 
stores, blocks plasticity of this pathway (Cho et al., 2012).  
 
It is unknown how IP3 signalling is affected in animal models of FXS however 
evidence from human fibroblast studies has shown that Ca2+ release is depressed 
through IP3-receptors (IP3R) in the absence of FMRP (Schmunk et al., 2015). IP3Rs 
are enriched in the spine apparatus (SA), a specialised region of the endoplasmic 
reticulum which extends into dendritic spines where it acts as a local intracellular Ca2+ 
store (Fifkova et al., 1983). Long isoforms of Homer, containing a C-terminal domain 
coiled-coil structure, cross-link group 1 mGluRs in the postsynaptic membrane to 
IP3Rs in the SA which results in rapid, spatially localised Ca2+ in response to mGluR 
activation (Tu et al., 1998). Homer 1a, which does not contain the coiled-coil domain, 
is unable to crosslink these two receptors. Consistent with this, upregulation of Homer 
1a in cerebellar purkinje neurons reduces and delays mGluR-triggered release of 
intracellular Ca2+ (Tu et al., 1998). Given that mGluR5 is more associated with Homer 
1a in the absence of FMRP and shows reduced association with long Homer isoform 
(Ronesi et al., 2012), this could result in reduced Ca2+ release from intracellular stores 
following mGluR activation in Fmr1 KO neurons. Alternatively, changes in calcium 
buffering or extrusion could also contribute to changes in postsynaptic calcium 
concentration however these effects have not previously been reported in any neurons 
lacking FMRP. Comparison of Ca2+ signals using two photon imaging of dendritic 
spines during plasticity induction may reveal if deficits in Ca2+ signalling play a role 




4.3.2 Nucleus specific changes in excitability of amygdala 
 
Inhibitory circuits of the amygdala are the major determinant of activity within the LA 
and BA nuclei (Olmos-Serrano & Corbin, 2011). Interneurons comprise 
approximately 20% of neurons within these nuclei and play roles in gating plasticity 
as well as modulating principal neuron output (Kemppainen & Pitkänen, 2000; Quirk 
& Gehlert, 2003). FXS has been increasingly linked with E/I imbalances associated 
with dysfunction of inhibitory transmission in several brain regions (Gibson et al., 
2008; Selby et al., 2007). FMRP is expressed in the majority of interneurons in the BA 
(Olmos-Serrano et al., 2010) and its absence results in multiple deficits in GABAergic 
signalling. Work in Fmr1 KO mice, has identified deficits in synaptic transmission at 
inhibitory synapses on to BA principal neurons including reduced mIPSC frequency 
and amplitude (Olmos-Serrano et al., 2010; Vislay et al., 2013). This effect was 
developmentally regulated with deficits appearing at P10, showing no effect at P14-
16, but then reappearing in the third postnatal week. However here I found that 
mIPSCs were unaffected in both LA and BA nuclei of 4-6 week old Fmr1 KO rats 
suggesting that GABAergic synaptic transmission is unaffected. As studies in Fmr1 
KO mice identified deficits at earlier ages, it is possible that these effects have 
normalised by this time point. Therefore, future experiments investigating the 
development of inhibitory neurotransmission in both the LA and BA may reveal 
significant effects in Fmr1 KO rats. 
 
As well as deficits in phasic inhibition, there have been several reports of reduced tonic 
GABA activity in Fmr1 KO BA principal neurons (Olmos-Serrano et al., 2010; Martin 
et al., 2015). Tonic GABA activation results in shunting inhibition on excitatory 
neurons thereby constraining neuronal excitability (Semyanov et al., 2004). Therefore 
reduced tonic GABA activation results in hyperexcitability of principal neurons in the 
BA of Fmr1 KO mice (Olmos-Serrano et al., 2010). Here, I observed a similar 
hyperexcitability of BA principal neurons in Fmr1 KO rats suggesting a reduction in 
tonic GABA conductances may be also be present. Deficient inhibitory tone in the 
amygdala could lead to overexpression of fear responses producing pathological stated 
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of anxiety as shown by FXS individuals (Quirk & Gehlert, 2003). However this is only 
one potential explanation for this effect therefore future experiments investigating the 





In summary, the loss of FMRP results in deficient LTP at both of the major inputs to 
the LA associated with the formation of fear memories. Excitatory inputs to the LA 
also show a reduced release probability in Fmr1 KO rats. In the BA, no deficits were 
observed in excitatory or inhibitory neurotransmission in Fmr1 KO rats. However, BA 
principal neurons were hyperexcitable in the absence of FMRP which has previously 
been associated with reduced tonic inhibition. Interestingly, these effects are 
constrained to the BA as no changes in neuronal excitability were observed in the LA 
of Fmr1 KO rats. This data provides further evidence of the distinct effects FMRP loss 
can have on circuit function even in closely associated brain regions highlighting the 
complications in designing a therapeutic strategy to target the wide range of 











Age-dependent LTP deficits and 
neuronal hypoexcitability in the 















The prefrontal cortex (PFC) is a cortical region that plays a key role in higher order 
cognitive functions such as attention, working memory and cognitive flexibility 
(Miller 2000). Many of these functions associated with the PFC are affected in 
neurodevelopmental disorders such as FXS. Studies using Fmr1 KO mice have 
revealed changes in several PFC mediated behaviours (Moon et al. 2006; Krueger et 
al. 2011; Sidorov et al. 2014; Kramvis et al. 2013; Dansie et al. 2013) as well as 
significant biochemical and physiological phenotypes in this cortical region (Liu et al. 
2011; Paul et al. 2013; Testa-Silva et al. 2012). Changes in translaminar long term 
plasticity (LTP) have been observed in several of PFC subregions in Fmr1 KO mice 
as well as changes in local connectivity (Larson et al. 2005; Meredith et al. 2007; Wang 
et al. 2008; Koga et al. 2015; Martin et al. 2015; Testa-Silva et al. 2012). 
 
As well as local connectivity, the PFC also provides long-range excitatory outputs to 
other brain structures in a subregion dependent manner (Hoover & Vertes 2007). The 
main cortical output layer, layer 5 (L5), contains pyramidal neurons that can be 
distinguished based on their long-range target. These neurons show distinct intrinsic 
physiology as well as different intralaminar connections suggesting they can form 
distinct subnetworks depending on their long-range target (Wang et al. 2006; Brown 
& Hestrin 2009; Dembrow et al. 2010).  
 
The PFC is composed of many functionally and anatomically distinct subregions. One 
PFC subregion of particular interest in the study of FXS is the prelimbic medial PFC 
(PL). The PL primarily innervates limbic sites allowing it to modulate various aspects 
of cognitive behaviour (Vertes 2004). A key projection target is the basolateral 
amygdala (BLA) which shows robust reciprocal connectivity with the PL (Mcdonald 
1998; Little & Carter 2013). This pathway has been implicated in both the acquisition 
and expression of fear learning (Corcoran & Quirk 2007; Laviolette 2005; Vidal-




Interestingly for the study of FXS, activation of group 1 mGluR subtypes has been 
found to modulate the excitability of L5 mPFC pyramidal neurons and enhance mPFC 
output (Kalmbach et al. 2013; Kiritoshi et al. 2013; Fontanez-Nuin et al. 2011; Marek, 
G.J; Zhang 2009). Some of these effects have also been shown to be dependent on the 
long-range projection target of the pyramidal neuron (Kalmbach et al. 2013). 
Therefore, I hypothesised that the constitutive activation of mGluR5 suggested by work 
in Fmr1 KO mice (Giuffrida et al. 2005; Ronesi et al. 2012; Osterweil et al. 2010) 
could lead to significant changes in L5 pyramidal neuron excitability and connectivity. 
As the timing and fidelity of PL activity has been shown to play a role in both the 
acquisition and expression of fear learning (Vidal-Gonzalez et al. 2006; Burgos-
Robles et al. 2009), changes in the intrinsic properties of PL subnetworks that project 
to the BLA could contribute to the deficits in fear learning shown in Fmr1 KO animals. 
 
Here I investigated both local and long-range connectivity of PL L5 pyramidal neurons 
in Fmr1 KO rats. First, I tested LTP at layer 2/3 (L2/3) to L5 synapses in both the PL 
of juvenile and adult Fmr1 rats. Next, I used retrograde labelling to identify specific 
L5 pyramidal neurons with long-range projections to the BLA. I then used whole cell 
electrophysiological recordings to assess the intrinsic physiology as well as excitatory 













5.2.1 Age-dependent LTP deficit in prelimbic mPFC of Fmr1 KO rats 
 
Several studies have identified LTP deficits in various subregions of the mPFC in 
Fmr1 KO mice (Meredith et al. 2007; Zhao et al. 2005; Martin et al. 2015). Some of 
these phenotypes also show age-dependency, with LTP intact in juvenile animals but 
deficits appearing during adulthood (Larson et al. 2005; Martin et al. 2015). Here I 
studied layer 2/3 to layer 5 synapses of the prelimbic (PL) of the mPFC. Firstly, we 
wanted to test if LTP was intact in 4-6 week old Fmr1 KO rats. No significant 
difference was observed in the magnitude of LTP at this age (Fig 5.1 D; WT: 118.06 
± 5.76%; n=6; KO: 116.37 ± 3.95%; n=6; p>0.05). However when I tested the same 
paradigm in 10-12 week old rats I observed a clear LTP deficit in Fmr1 KO rats 
compared to WT controls (Fig 5.1 F; WT: 119.43 ± 5.28%; n=7; KO: 98.43 ± 3.99%; 
n=7; p=0.008). These data show that whilst LTP is supported across these ages in WT 
animals, the ability to express LTP is impaired with age in Fmr1 KO rats. 
 
5.2.2 Age-dependent LTP deficit is also observed in Fmr1 Sprague Dawley rat 
model 
 
Next I tested if the age-dependent LTP deficit I observe in our Long Evans Fmr1 KO 
rats is present in the Sprague Dawley (SD) Fmr1 KO rat model. As found previously, 
no significant difference was observed in the magnitude of LTP between genotypes at 
4-6 weeks (Fig 5.2 B; WT: 118.04 ± 4.07%; n=5; KO: 119.78 ± 6.31%; n=5; p>0.05) 
but LTP was absent in 10-12 week old SD Fmr1 KO rats (Fig 5.2 D; WT: 129.66 ± 
5.99%; n=7; KO: 100.57 ± 6.46%; n=6; p=0.007). These findings are in agreement 
with data from the Fmr1 KO LEH rats indicating that in the absence of FMRP, LTP 








5.2.3 Basal synaptic strength is unaffected at L2 excitatory inputs onto L5 
neurons in Fmr1 KO rats 
 
A recent study in Fmr1 KO mice similarly found age-dependent deficits in mPFC LTP 
which they linked to an increase in AMPA/NMDA ratio resulting from a decrease in 























Figure 5.2 Age-dependent deficit of LTP in SD Fmr1 KO rat prelimbic mPFC (A) 
Timecourse showing LTP induction in 4-6 week old WT and Fmr1 KO SD rats. (D) 
No significant difference was observed in magnitude of LTP between genotypes 
(WT: 118.04 ± 4.07%; n=5 slices/5 animals; KO: 119.78 ± 6.31%; n=5 slices/5 
animals; p>0.05, Student unpaired t-test). (D) Timecourse showing LTP 
induction in 10-12 week old WT and Fmr1 KO rats. (E) LTP was significantly 
reduced in Fmr1 KO rats compared to WT controls at 10-12 weeks (WT: 129.66 
± 5.99%; n=7 slices/7 animals; KO: 100.57 ± 6.46%; n=6 slices/6 animals; 




















synapses on to L5 pyramidal neurons. AMPAR and NMDAR mediated responses were 
evoked at -70mV and +40mV respectively. I found no significant difference in 
AMPA/NMDA ratio at these synapses in Fmr1 KO rats (Fig 5.3 B; WT: 3.02 ± 0.45; 
n=7; KO: 3.10 ± 0.47; n=6; p>0.05). Power analysis of this data revealed that 2770 
cells/genotype would need to be analysed in order to observe a significant effect. This 
data suggests that basal synaptic function is unaffected at L2 inputs to L5 pyramidal 
neurons in adult Fmr1 KO rats. In contrast to studies of Fmr1 KO mice, it also suggests 
that a change in AMPA/NMDA ratio does not contribute to the loss of LTP in Fmr1 
KO PL mPFC. 
 
5.3 Intrinsic cell physiology and synaptic connectivity in mPFC neurons that 
project to the basolateral amygdala of Fmr1 rats 
 
5.3.1 Investigation of prelimbic layer V circuits that project to the basolateral 
amygdala in Fmr1 KO rats 
 
As well as its local translaminar connectivity, the mPFC is in a position to provide top-
down control to several other cortical and subcortical regions by influencing their 
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activity through long range projections. It does this through a variety of pyramidal 
neurons with different long-range targets that form the main output layer of the mPFC. 
Importantly, the intrinsic physiology and local connectivity of pyramidal neurons in 
layer 5 mPFC is greatly influenced by their long range connectivity. Therefore, when 
assessing neuronal excitability or synaptic connectivity in these circuits, it is important 
to distinguish neurons based on their projection targets. 
 
One key projection target is the basolateral amygdala (BLA), which shows strong 
reciprocal connectivity with the PL mPFC (Little & Carter 2012; Little & Carter 2013). 
This pathway has been implicated in both the acquisition and expression of fear 
learning, behaviours which have been found to be affected in Fmr1 KO rats. Therefore, 
I adopted a strategy that would allow us to restrict our electrophysiological analysis to 
the specific subset of neurons that provide input to the BLA. Here I stereotaxically 
injected retrobead tracers into the BLA of 3-4 month old Fmr1 rats (Fig 5.3 A). 
Following animal recovery for a minimum of 1 week, acute slices containing prelimbic 
mPFC were taken and cell somas containing retrobeads identified using confocal 
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microscopy. Labelled projection neurons were distributed throughout both L2-3 and 
L5 in both the prelimbic and infralimbic mPFC as found in previous studies (Gabbott 
et al. 2005) however for this study recordings were limited to prelimbic L5 neurons. 
This confirmed the presence of a subset of L5 pyramidal neurons that project to the 
BLA (PL-BLA projection neurons). 
 
5.3.2 Layer 5 contains two classes of PL-BLA projections neurons 
 
Whole cell electrophysiological recordings were performed from retrobead containing 
L5 PL neurons visualised using fluorescence microscopy (Fig 5.3). Neuronal 
excitability was investigated using a series of ascending depolarising current steps. At 
rheobase, the current injection required to generate a single action potential, neurons 
could be classified as either regular spiking neurons (RS) or burst spiking neurons (BS) 
(Van Aerde & Feldmeyer 2015). RS neurons were defined as neurons able to generate 
a single action potential in response to a suprathreshold current. BS neurons were 
defined as neurons that fired a burst of two or more action potentials in an all or none 
manner in response to suprathreshold current. These two subsets of neurons were 
observed in both WT and Fmr1 KO animals at similar ratios. However due to the low 
number of BS neurons in both genotypes, experiments were restricted to RS neurons 
where possible i.e. could not be done in experiments where action potential firing was 
blocked due to external/internal solution composition. 
 
5.3.3 Regular spiking PL-BLA projection neurons are hypoexcitable in Fmr1 KO 
rats 
 
The intrinsic properties of L5 pyramidal neurons can be modulated by mGluR5 
activation (Kiritoshi et al. 2013). As mGluR5 is suggested to be constitutively active 
in animal models of FXS, I tested the intrinsic excitability of L5 PL-BLA in Fmr1 KO 
rats. I found that Fmr1 KO neurons were hypoexcitable compared to WT controls. PL-
BLA projection neurons fired significantly fewer action potentials in response to a 
series of depolarising current steps from 25-400pA (Fig 5.4 B; F(1,56)=23.3; 
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p=0.0001). Rheobase was also significantly larger in Fmr1 KO animals (Fig 5.4 C; 
WT: 100.00 ± 5.00pA; n=26; KO: 124.22 ± 5.78pA; n=32; p=0.003). This data 
indicates that PL-BLA projection neurons have reduced intrinsic excitability in the 
absence of FMRP. 
 
5.3.4 Hypoexcitability in PL-BLA projection neurons is not due to alterations in 
subthreshold intrinsic properties 
 
Some studies that have found changes in neuronal intrinsic excitability in Fmr1 KO 
animals have linked this phenotype to a change in membrane input resistance (Gibson 
et al. 2008; Olmos-Serrano et al. 2010). To explore the underlying mechanism of the 
reduction in intrinsic neuronal excitability, intrinsic membrane properties of PL-BLA 
projection neurons were compared between genotypes. Surprisingly, input resistance 
was comparable between the two genotypes (Fig 5.5 A; WT: 134.94 ± 7.47MΩ; n=26; 
KO: 123.66 ± 5.12MΩ; n=32; p>0.05). Power analysis of this data revealed that 148 
cells/genotype would be required to see a significant decrease in Fmr1 KO PL-BLA 
projection neuron input resistance. Additionally no significant differences were 
observed in any intrinsic membrane properties (Fig 5.5 B; WT time constant: 28.01 ± 
1.17ms; n=26; KO time constant: 30.70 ± 1.57ms; n=32; p>0.05; Fig 5.5 C; WT 
capacitance: 222.63 ± 13.87pF; n=26; KO capacitance: 255.62 ± 12.40pF; n=32; 
p>0.05; Fig 5.5 D; WT Sag: 8.74 ± 0.77%; n=26; KO Sag: 10.97 ± 0.83%; n=32; 
p>0.05) however Fmr1 KO neurons were slightly but significantly depolarised at rest 













Figure 5.5 PL-BLA projection neurons are hypoexcitable in Fmr1 KO rats 
(A) Example traces of WT and Fmr1 KO neurons voltage responses to -
100pA, rheobase (WT: 100pA, KO: 125pA) and 2x rheobase current steps. 
Scale 100ms, 20mV. (B) PL-BLA projection neurons fire significantly fewer 
action potentials in response to a series of depolarising current steps 
from 25-400pA (F(1,56)=23.3; p=0.0001, Two way RM-ANOVA). (C) 
Rheobase was significantly larger in Fmr1 KO neurons compared to WT 
controls (WT: 100.00 ± 5.00pA; n=26 cells/11 animals; KO: 124.22 ± 





















5.3.5 Post action potential currents are not affected by loss of FMRP  
 
Trains of action potentials are followed by an afterhyperpolarisation (AHP) which is 
an important regulator of cell excitability (McKay et al. 2009). Post-burst AHPs 
consist of two components which can be distinguished based on their timing. The 
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Figure 5.6 Hypoexcitability in PL-BLA projection neurons is not due to 
alterations in subthreshold intrinsic properties (A) Input resistance not 
significantly different between genotypes (WT: 134.94 ± 7.47MΩ; n=26 cells/11 
animals; KO: 123.66 ± 5.12MΩ; n=32 cells/16 animals; p>0.05). (B) Membrane 
time constant is unaffected in Fmr1 KO PL-BLA projection neurons (WT: 28.01 ± 
1.17ms; n=26 cells/11 animals; KO: 30.70 ± 1.57ms; n=32 cells/16 animals; 
p>0.05). (C) Membrane capacitance was not significantly different between 
genotypes (WT: 222.63 ± 13.87pF; n=26 cells/11 animals; KO: 255.62 ± 12.40pF; 
n=32 cells/16 animals; p>0.05). (D) Sag, a measure of Ih current, was 
comparable between genotypes (WT: 8.74 ± 0.77%; n=26 cells/11 animals; KO: 
10.97 ± 0.83%; n=32 cells/16 animals; p>0.05). (E) Fmr1 KO PL-BLA projection 
neurons are significantly depolarised at rest compared to WT controls (WT: -
71.70 ± 0.49mV; n=26 cells/11 animals; KO: -69.68 ± 0.59mV; n=32 cells/16 
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has a decay time of <200ms. mAHP amplitude is affected by both the number of action 
potentials in a train as well as their frequency (Abel et al. 2004). In order to control for 
this effect, I evoked mAHP using a train of 5 action potentials at fixed frequencies 
ranging from 20-100Hz. I found that the absence of FMRP had no significant effect 
on mAHP amplitude at this range of frequencies (Fig 5.6 A; (F(1,26)=2.836; 
p=0.1042). The slow AHP (sAHP) reaches its peak after the mAHP has decayed and 
has a timecourse of several seconds (Sah & Faber 2002). sAHP was evoked using 15 
action potentials at 50Hz (McKay et al. 2009) and measured 1 second after the end of 
the train. Here I also saw no significant difference between WT and Fmr1 KO neurons 
(Fig 5.6 B; WT: -1.31 ± 0.18mV; n=12; KO: 1.34 ± 0.14mV; n=16; p>0.05). The 
afterdepolarisation (ADP) that follows a single action potential was also compared 
between genotypes. No significant change in ADP amplitude was observed in Fmr1 
KO neurons (Fig 5.6 C; WT: 21.04 ± 0.99mV; n=12; KO: 20.84 ± 0.89mV; n=17; 
p>0.05). This suggests that post action potential currents do not play a role in the 
observed hypoexcitability of Fmr1 KO PL-BLA neurons. 
 
5.3.6 Loss of FMRP results in changes in action potential kinetics 
 
As well as changes in intrinsic membrane properties, changes in active cation 
conductances that underlie the firing of an action potential can also influence neuronal 
excitability. Previous studies have revealed both a direct and indirect role of FMRP in 
regulating some of these ion channels (Brown et al. 2010; Deng et al. 2013). Therefore, 
I investigated action potential waveform and kinetics in our WT and Fmr1 KO PL-
BLA projection neurons to see if these factors could contribute to the observed change 
in intrinsic excitability. In line with the hypoexcitability of Fmr1 KO neurons, action 
potential threshold was significantly depolarised in the absence of FMRP (Fig 5.7 C; 
WT: -40.31 ± 0.66mV; n=26; KO: -38.18 ± 0.48; n=32; p=0.01). Threshold voltage 
was significantly correlated with the maximum number of action potentials fired 
(p=0.04). Further analysis of action potential waveform revealed no significant 







Figure 5.7 Post burst AHP are not affected by loss of FMRP (A) Example trace 
of mAHP, the maximum hyperpolarisation following a train of action 
potentials, evoked by a train of 5 action potentials at various frequencies (20-
100Hz). Scale 50ms, 5mV. No significant difference in mAHP was found 
between genotypes (F(1,26)=2.836; p=0.1042, Two way RM-ANOVA). (B) 
Example trace of sAHP, measured as hyperpolarisation 1s after train of 15 
action potentials at 50Hz. Scale 100ms, 5mV. No significant difference in sAHP 
magnitude was observed between genotypes (WT: -1.31 ± 0.18mV; n=12 
cells/6 animals; KO: -1.34 ± 0.14mV; n=17 cells/10 animals; p>0.05, Student 
unpaired t-test). (C) Example traces of ADP following a single action potential 
Scale 10ms, 20mV. No significant difference in ADP magnitude was observed 
between genotypes (WT: 21.04 ± 0.99mV; n=12 cells/6 animals; KO: 20.84 ± 
0.89mV; n=17 cells/10 animals; p>0.05, Student unpaired t-test). 
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WT: 83.57 ± 0.96mV; n=26; KO: 81.64 ± 0.96; n=32; p>0.05) or width (Fig 5.7 E; 
WT: 1.02 ± 0.02; n=26; KO: 1.07 ± 0.03; n=32; p>0.05). Phase plot analysis revealed 
significant differences in action potential kinetics between genotypes (Fig 5.7 F). Fmr1 
KO action potentials had a slower maximum depolarisation speed (Fig 5.7 G; WT: 
317.06 ± 8.50mV/ms; n=26; KO: 289.47 ± 9.22mV/ms; n=32; p=0.035) as well as a 
slower maximum repolarisation speed (Fig 5.7 H; WT: -75.92 ± 2.08mV/ms; n=26; 
KO: -69.63 ± 1.66mV/ms; n=32; p=0.02). This data suggests that whilst passive 
currents at rest are not affected in Fmr1 KO neurons, ionic conductances that underlie 
action potential firing are altered. 
 
5.3.7 Axon initial segments are significantly shorter in Fmr1 KO PL-BLA 
projection neurons 
 
Changes in action potential threshold and maximum dv/dt indicate changes in the 
underlying Na+ conductances in Fmr1 KO neurons. Action potentials are initiated by 
the axon initial segment (AIS). This highly specialised structure contains a high 
density of Na+ channels which are recruited and stabilised in the membrane by the 
structural protein Ankyrin-G (Zhuo et al., 1998). AIS length and distance from soma 
have been shown to regulate action potential threshold as well as action potential 
waveform (Kole & Stuart 2008; Kole et al. 2008). As Ankyrin G is highly enriched in 
the AIS, I used immunocytochemistry to examine the morphology of the AIS in PL-
BLA projection neurons in Fmr1 rats. I observed a significant decrease in AIS length 
in Fmr1 KO rats compared to WT controls (Fig 5.8 B; WT: 30.90 ± 1.31µm; n=4; KO: 
24.60 ± 0.72µm; n=4; p=0.03). No significant difference in AIS distance from soma 
was found between genotypes (Fig 5.8 C; WT: 2.79 ± 0.20µm; n=4; KO: 2.82 ± 
0.45µm; n=4; p>0.05). As AIS length is known to regulate action potential threshold 
and neuronal excitability (Kole & Stuart 2008) this morphological change results in 






























Figure 5.8 Loss of FMRP affects action potential waveform in Fmr1 KO PL-BLA 
projection neurons (A) Schematic showing measurements of action potential 
waveform. (B) Example traces of action potential from WT and Fmr1 KO neuron. 
Scale 20mV, 1ms. (C) Action potential threshold was significantly depolarised in 
Fmr1 KO neurons (WT: -40.31 ± 0.66mV; n=26 cells/ 11 animals; KO: -38.18 ± 
0.48; n=32 cells/16 animals; p=0.01). (D) Action potential height was not 
significantly different between genotypes (WT: 83.57 ± 0.96mV; n=26 cells/ 11 
animals; KO: 81.64 ± 0.96; n=32 cells/16 animals; p>0.05). (E) Action potential 
half-width was not significantly different between genotypes (WT: 1.02 ± 0.02; 
n=26 cells/ 11 animals; KO: 1.07 ± 0.03; n=32 cells/16 animals; p>0.05). (F) 
Phase plot of action potential in WT and Fmr1 KO neuron. (G) Max dvdt was 
significantly reduced in Fmr1 KO neurons compared to WT controls (WT: 317.06 
± 8.50mV/ms; n=26 cells/ 11 animals; KO: 289.47 ± 9.22mV/ms; n=32 cells/16 
animals; p=0.035). (H) Min dvdt was significantly increased in Fmr1 KO neurons 
compared to WT controls (WT: -75.92 ± 2.08mV/ms; n=26 cells/ 11 animals; KO: 
-69.63 ± 1.66mV/ms; n=32 cells/16 animals; p=0.02). Statistical tests performed 
with Student unpaired t-test. 
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5.3.8 K+ conductances are unaffected in Fmr1 KO neurons 
 
Layer 5 mPFC pyramidal neurons contain several classes of voltage gated K+ channels 
(VGKC) (Dong & White 2003).  K+ channels also influence many aspects of neuronal 
excitability including action potential threshold, resting membrane potential and 
shaping action potentials (Kang et al. 2000). These properties suggest that alterations 
in K+ conductances could also contribute to the hypoexcitability of Fmr1 KO neurons. 
Previous studies have identified at least three classes of K+ current in rat layer 5 mPFC 
pyramidal neurons that can be isolated based on their biophysical properties using 
different protocols (Dong & White, 2003, Kalmbach et al. 2015). Sustained K+ 
currents such as non-inactivating K current (IK-Sustained) and the slow-inactivating K 
current (IK-SLOW) play roles in action potential duration whereas the rapidly 
inactivating ‘A-type’ K+ current (IK-FAST) have effects on firing frequency, action 
potential repolarisation and fAHP (Kang et al. 2000). 
Total whole-cell VGKC currents (IK-WC) were evoked using 4s pre-pulse to -100mV 
to deinactivate any inactivated K+ channels followed by a depolarising step to +50mV. 
No significant differences were observed in total VGKC currents between genotypes 
(Fig 5.9 A; WT: 50.69 ± 4.73pA/pF; n=8; KO: 52.04 ± 5.66pA/pF; n=6; p>0.05). A 
second protocol was used to isolate the IK-Sustained component of this current. A 
prolonged 30s depolarising prepulse to +20mV was used initially to inactivate any 
current components that showed inactivation kinetics. This was followed by a test step 
to +50mV which elicited a small non-inactivating current (IK-Sustained). Again no 
significant differences were observed in this current component between genotypes 
(Fig 5.9 B; WT: 10.75 ± 0.82pA/pF; n=8; KO: 10.77 ± 1.60pA/pF; n=6; p>0.05). To 
isolate the IK-FAST current component, a brief prepulse to +20mV was used to inactivate 
this fast inactivating current without significantly altering the slow-inactivating or 
sustained components. Digital subtraction of this current from the total VGKC current 
revealed a rapidly inactivating current termed IK-Fast. A-type K+ currents were not 
significantly different in Fmr1 KO neurons compared to WT controls (Fig 5.9 D; WT: 
12.95 ± 1.78pA/pF; n=8; KO: 15.84 ± 3.03pA/pF; n=6; p>0.05). Finally, the slow-
inactivating current (IK-SLOW) was calculated by digital subtraction of IK from the total 
VGKC current. No significant differences were observed in this component PL-BLA 
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projection neuron K+ current (Fig 5.9 C; WT: 26.80 ± 3.68pA/pF; n=8; KO: 25.20 ± 
4.54pA/pF; n=6; p>0.05). As expected from this data, no significant differences were 
observed in the relative contribution of the three K+ current components between 
genotypes (Fig 5.9 E; F(1,12)=0.161; p=0.695). Together, these data show that no 
differences in any component of the whole cell VGKC current of PL-BLA projection 
neurons exist between WT and Fmr1 KO rats suggesting that changes in whole-cell 
K+ currents do not play a role in the altered intrinsic excitability of Fmr1 KO neurons. 
 
5.3.9 Kv4 component of A-type K+ current was comparable between genotypes 
 
Macroscopic currents are composed of distinct channels with comparable kinetics 
(Korngreen & Sakmann 2000). Kv1 or Kv4 subunits can contribute to A-type K+ 
currents. These two conductances can be separated by their kinetics of recovery from 
inactivation (Coetzee et al. 1999). Kv4 subunits show full recovery following 
inactivation within 100ms however Kv1 subunits are an order of magnitude slower 
(Routh et al. 2013). As changes in Kv4.2 conductances has been implicated in various 
cell types in Fmr1 KO mice (Routh et al. 2013; Gross et al. 2011; Kalmbach et al. 
2015) I tested the relative contribution of these two components of the A-type K+ 
current. Using an interstimulus interval ranging from 10-100ms to recover K+ channels 
from inactivation, two 200ms test steps from -100mV to +50mV were used to isolate 
the A-type K+ current as previously described. Using this method, I found the time 
course of recovery of A-type K+ current was comparable between genotypes (Fig 
5.10). With a 100ms recovery time, A-type K+ currents had recovered equally in both 
WT and Fmr1 KO neurons (Fig 5.10 B; WT: 87.38 ± 2.73%; n=7; KO: 88.24 ± 1.99%; 
n=8; p>0.05). Based on their kinetics of recovery from inactivation, this second current 
should be mediated by Kv4 channels only, therefore, this data suggests that Kv1 and 


































































































WT Fmr1 KO 
Figure 5.9 Axon initial segment is significantly shorter in Fmr1 KO PL-
BLA projection neurons (A) Confocal image of bead labelled soma 
showing immunocytochemistry for axon initial segment (AIS) specific 
Ankyrin-G (green) and NeuN (blue). (B) AIS length is significantly 
increased in Fmr1 KO rats (WT: 30.90 ± 1.30µm; n=4 animals; KO: 24.60 ± 
0.72µm; n=4 animals; p=0.03, Student unpaired t-test) (C) Cumulative 
distribution of AIS length data. (D) No difference between genotypes was 
observed in AIS distance from soma (WT: 2.79 ± 0.20µm; n=4 animals; 
KO: 2.82 ± 0.45µm; n=4 animals; p=0.95, Student unpaired t-test). (E) 
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Figure 5.10 No changes in any component of whole-cell K
+
 current in Fmr1 KO 
PL-BLA neurons (A) No significant difference in whole-cell K
+
 current in Fmr1 KO 
neurons (WT: 50.69 ± 4.73pA/pF; n=8 cells/4 animals; KO: 52.04 ± 5.66pA/pF; 
n=6 cells/3 animals; p>0.05, Student unpaired t-test). (B) No significant 
difference in sustained K
+
 current in Fmr1 KO neurons (WT: 10.75 ± 0.82pA/pF; 
n=8 cells/4 animals; KO: 10.77 ± 1.60pA/pF; n=6 cells/3 animals; p>0.05, 
Student unpaired t-test). (C) No significant difference in slow-inactivating K
+
 
current in Fmr1 KO neurons (WT: 26.80 ± 3.68pA/pF; n=8 cells/4 animals; KO: 
25.20 ± 4.54pA/pF; n=6 cells/3 animals; p>0.05, Student unpaired t-test). (D) 
No significant difference in fast-inactivating K
+
 current in Fmr1 KO neurons (WT: 
12.95 ± 1.78pA/pF; n=8 cells/4 animals; KO: 15.84 ± 3.03pA/pF; n=6 cells/3 
animals; p>0.05, Student unpaired t-test). (E) No significant difference in 
relative contribution of different current components to whole cell K
+
 current in 




5.4 Synaptic currents in Fmr1 PL-BLA projection neurons 
 
5.4.1 Loss of FMRP does not affect spontaneous but does reduce miniature 
excitatory postsynaptic current frequency in PL-BLA projection neurons 
 
As well as receiving long range inputs from several different brain regions, layer 5 
mPFC pyramidal neurons are interconnected forming a local microcircuit. The local 
excitatory connectivity of these neurons is also highly correlated with their long range 
targets (Brown & Hestrin 2009; Morishima et al. 2011). I next investigated if the loss 
of FMRP leads to any changes in excitatory synaptic transmission in PL-BLA 
projection neurons. Spontaneous excitatory postsynaptic currents (sEPSC) were 
recorded at -70mV in the presence of 75µM picrotoxin to block fast inhibitory 
currents. No significant differences were observed in sEPSC amplitude (Fig 5.11 B; 
WT: -28.45 ± 2.29pA; n=5; KO: -25.71 ± 3.15pA; n=6; p>0.05) or frequency (Fig 5.11 
D; WT: 7.56 ± 0.83Hz; n=5; KO: 7.05 ± 0.98Hz; n=6; p>0.05). sEPSC kinetics were 
also unaffected in Fmr1 KO neurons (Fig 5.11 F; WT rise time: 1.73 ± 0.06ms; n=5; 
KO rise time: 1.78 ± 0.08ms; n=6; p>0.05; Fig 5.11 G; WT decay time: 7.56 ±0.83ms; 
















Figure 5.11 Putative Kv4.2 component of A-type K
+
 current is comparable 
between genotypes (A) Peak A-type recovery from inactivation was comparable 
between genotypes. (B) Current recovery at 100ms was not significantly different 
in Fmr1 KO neurons (WT: 87.38 ± 2.73%; n=7 cells/3 animals; KO: 88.24 ± 1.99%; 




The addition of TTX (300nM) to the external solution allows the isolation of miniature 
excitatory postsynaptic potentials (mEPSC). As mEPSCs are independent of action 
potentials, their frequency is thought to reflect both the number of synaptic 
connections as well as their presynaptic release probability whilst the amplitude is an 
indicator of postsynaptic strength. Comparison of mEPSC in PL-BLA projection 
neurons revealed no significant difference in amplitude (Fig 5.12 B; WT: -21.25 ± 
1.78pA; n=5; KO: -22.65 ± 2.01pA; n=6; p>0.05) suggesting postsynaptic function is 
unchanged in Fmr1 KO neurons. Howeverm mEPSC frequency was significantly 
greater in Fmr1 KO neurons compared to WT controls (Fig 5.12 D; WT: 5.23 ± 
0.50Hz; n=5; KO: 7.55 ± 0.42Hz; n=6; p=0.001). Similar to sEPSC, no significant 
differences in mEPSC kinetics were observed (Fig 5.12 F; WT rise time: 1.94 ± 
0.06ms; n=5; KO rise time: 1.76 ± 0.07ms; n=6; p>0.05; Fig 5.12 G; WT decay time: 
5.45 ± 0.13ms; n=5; KO decay time: 5.51 ± 0.20ms; n=6; p>0.05). This data suggests 
that despite a reduction in the intrinsic excitability of PL-BLA projection neurons, this 
does not lead to changes in local network driven synaptic events in Fmr1 KO neurons. 
However, the loss of FMRP does result in a reduction in the number of excitatory 
synaptic inputs or release probability on to PL-BLA projection neurons.  
 
5.4.2 Inhibtory transmission onto Fmr1 KO PL-BLA projection neurons is 
unaffected 
 
Network excitability can also be affected by inhibitory transmission in cortical circuits. 
Previous studies in cortical regions including layer 5 mPFC have revealed that local 
interneurons can selectively innervate pyramidal neurons depending on their long 
range targets (Krook-Magnuson et al. 2012; Varga et al. 2009; Lee et al. 2014). 
Therefore, I investigated inhibitory postsynaptic currents (IPSC) in PL-BLA 
projection neurons to identify if changes in inhibitory neurotransmission could affect 
the excitability of cortical microcircuits that project specifically to the BLA. 




























































Figure 5.12 sEPSC in L5 PL-BLA were comparable between genotypes (A) 
Example traces displaying sEPSCs recorded at -70V in the presence of 75µM PTX 
in both WT and Fmr1 KO neurons. Scale 200ms, 10pA (B) sEPSC amplitude was 
unaffected between genotypes (WT: -28.45 ± 2.29pA; n=5 animals/14 cells; KO: -
25.71 ± 3.15pA; n=6 animals/11 cells; p>0.05). (C) Cumulative frequency of 
sEPSC amplitudes in WT and Fmr1 KO neurons. (D) sEPSC frequency was 
comparable between genotypes (WT: 7.56 ± 0.83Hz; n=5 animals/14 cells; KO: 
7.05 ± 0.98Hz; n=6 animals/11 cells; p>0.05). (E) Cumulative frequency of sEPSC 
inter-event intervals in WT and Fmr1 KO neurons. (F) No differences were 
observed in sEPSC rise time (WT: 1.73 ± 0.06ms; n=5 animals/14 cells; KO: 1.78 ± 
0.08ms; n=6 animals/11 cells; p>0.05) or (G) decay time (WT: 7.56 ±0.83ms; n=5 
animals/14 cells; KO: 7.05 ± 0.98ms; n=6 animals/11 cells; p>0.05). Statistical 
tests performed with Student unpaired t-test. 
























































Figure 5.13 mEPSC frequency is increased in Fmr1 KO PL-BLA projection 
neurons (A) Example traces displaying mEPSCs recorded at -70V in the presence 
of 75µM PTX and 300nM TTX in both WT and Fmr1 KO neurons. Scale 200ms, 
5pA (B) mEPSC amplitude was unaffected between genotypes (WT: -21.25 ± 
1.78pA; n=5 animals/16 cells; KO: -22.65 ± 2.01pA; n=6 animals/13 cells; 
p>0.05). (C) Cumulative frequency of mEPSC amplitudes in WT and Fmr1 KO 
neurons. (D) mEPSC frequency was significantly increased in Fmr1 KO neurons 
(WT: 5.23 ± 0.50Hz; n=5 animals/16 cells; KO: 7.55 ± 0.42Hz; n=6 animals/13 
cells; p=0.001). (E) Cumulative frequency of mEPSC inter-event intervals in WT 
and Fmr1 KO neurons. (F) No differences were observed in mEPSC rise time 
(WT: 1.94 ± 0.06ms; n=5 animals/16 cells; KO: 1.76 ± 0.07ms; n=6 animals/13 
cells; p>0.05) or (G) decay time (WT: 5.45 ± 0.13ms; n=5 animals/16 cells; KO: 
5.51 ± 0.20ms; n=6 animals/13 cells; p>0.05). Statistical tests performed with 











B; WT: -41.63 ± 2.35pA; n=6; KO: -52.03 ± 6.86pA; n=5; p>0.05) or frequency (Fig 
5.13 D; WT: 5.49 ± 0.76Hz; n=6; KO: 6.56 ± 0.54Hz; n=5; p>0.05) between WT and 
Fmr1 KO rats. sIPSC rise time (Fig 5.13 F; WT: 2.11 ± 0.10ms; n=6; KO: 1.83 ± 
0.14ms; n=5; p>0.05) and decay time (Fig 5.13 G; WT: 14.45 ± 0.53ms; n=6; KO: 
14.69 ± 0.79ms; n=5; p>0.05) were unaffected by the loss of FMRP. Similarly, no 
significant differences were observed in miniature IPSC properties in Fmr1 PL-BLA 
projection neurons. mIPSC amplitude (Fig 5.14 B; WT: -44.17 ± 3.11pA; n=5; KO: -
47.29 ± 4.65pA; n=6; p>0.05), mIPSC frequency (Fig 5.14 D; WT: 3.95 ± 0.74Hz; 
n=5; KO: 4.31 ± 0.53Hz; p>0.05), mIPSC rise time (Fig 5.14 F; WT: 1.63 ± 0.04ms; 
n=5; KO: 1.67 ± 0.08; n=6; p>0.05) and mIPSC decay time (Fig 5.14 G; WT: 14.54 ± 
0.32ms; n=5; KO: 13.97 ± 0.21ms; n=6; p>0.05) were all comparable between 
genotypes. This data suggests that both inhibitory connectivity onto PL-BLA 
projection neurons as well as network driven inhibitory activity are unaffected in Fmr1 




5.5.1 Age-dependent plasticity deficits 
 
The mPFC is a cortical region that plays a key role in higher order cognitive functions 
such as attention, working memory and cognitive flexibility which are affected in FXS. 
Reports from Fmr1 KO mice have revealed both biochemical and functional 
phenotypes in several subregions of the PFC (Zhao et al. 2005; Meredith et al. 2007, 
Wang et al. 2008). Interestingly, some studies have revealed age-dependent deficits 
associated with the loss of FMRP in PFC circuits. LTP in the piriform cortex was 
found to be intact in Fmr1 mice however showed a progressive   deficit as animals 
aged (Larson et al. 2005). Here I report a similar deficit in the PL cortex, a subregion 
of the mPFC. LTP was found to be intact in juvenile Fmr1 KO rats but showed deficits 
in young adult rats. These findings have also recently been reported in Fmr1 KO mice 
mPFC (Martin et al. 2015) suggesting a conserved mechanism associated with the loss 































































Figure 5.14 sIPSCs are unaffected in Fmr1 KO PL-BLA projection neurons (A) 
Example traces displaying sIPSCs recorded at -70V in the presence of 20µM CNQX 
in both WT and Fmr1 KO neurons. Scale 20pA, 100ms (B) sIPSC amplitude was 
unaffected between genotypes (WT: -41.63 ± 2.35pA; n=6 animals/8 cells; KO: -
52.03 ± 6.86pA; n=5 animals/9 cells; p>0.05). (C) Cumulative frequency of sIPSC 
amplitudes in WT and Fmr1 KO neurons. (D) sIPSC frequency was unaffected in 
Fmr1 KO neurons (WT: 5.49 ± 0.76Hz; n=6 animals/8 cells; KO: 6.56 ± 0.54Hz; n=5 
animals/9 cells; p>0.05). (E) Cumulative frequency of sIPSC inter-event intervals 
in WT and Fmr1 KO neurons. (F) No differences were observed in sIPSC rise time 
(WT: 2.11 ± 0.10ms; n=6 animals/8 cells; KO: 1.83 ± 0.14ms; n=5 animals/9 cells; 
p>0.05) or (G) decay time (WT: 14.45 ± 0.53ms; n=6 animals/8 cells; KO: 14.69 ± 
0.79ms; n=5 animals/9 cells; p>0.05). Statistical tests performed with Student 
unpaired t-test. 

























































Figure 5.15 mIPSCs are unaffected in Fmr1 KO PL-BLA projection neurons (A) 
Example traces displaying mIPSCs recorded at -70V in the presence of 20µM 
CNQX and 300nM TTX in both WT and Fmr1 KO neurons. (B) mIPSC amplitude 
was unaffected between genotypes (WT: -44.17 ± 3.11pA; n=5 animals/9 cells; 
KO: -47.29 ± 4.65pA; n=6 animals/8 cells; p>0.05). (C) Cumulative frequency of 
mIPSC amplitudes in WT and Fmr1 KO neurons. (D) mIPSC frequency was 
unaffected in Fmr1 KO neurons (WT: 3.95 ± 0.74Hz; n=5 animals/9 cells; KO: 
4.31 ± 0.53Hz; n=6 animals/8 cells; p>0.05). (E) Cumulative frequency of mIPSC 
inter-event intervals in WT and Fmr1 KO neurons. (F) No differences were 
observed in mIPSC rise time (WT: 1.63 ± 0.04ms; n=5 animals/9 cells; KO: 1.67 ± 
0.08; n=6 animals/8 cells; p>0.05) or (G) decay time (WT: 14.54 ± 0.32ms; n=5 
animals/9 cells; KO: 13.97 ± 0.21ms; n=6 animals/8 cells; p>0.05). Statistical 
tests performed with Student unpaired t-test. 
WT Fmr1 KO 
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was due to an age dependent decrease in NMDAR signalling, resulting in an increased 
AMPA/NMDA current ratio. However, this was not observed in our recordings 
suggesting a reduction in NMDA currents does not contribute to the loss of LTP in 
Fmr1 KO rats. This has also not been reported in any other PFC LTP deficit in Fmr1 
KO mice (Larson et al. 2005; Zhao et al. 2005) suggesting other mechanisms may 
explain the loss of LTP observed here. Preincubation with the mGluR5 antagonist 
MPEP has been shown to restore adult LTP in mPFC circuits (Martin et al. 2015) 
suggesting exaggerated mGluR signalling associated with the loss of FMRP plays a 
role in this LTP deficit (Ronesi & Huber 2008). Given the ability of mGluR5 to 
enhance NMDAR currents, it is unclear how acute pharmacological inhibition is able 
to enhance NMDAR currents and restore LTP as reported by Martin et al (2015). 
However, the ability of mGluR5 activation to potentiate NMDAR currents has not been 
explored in models of FXS therefore a different mechanism could be taking place in 
the absence of FMRP that affects this relationship. 
 
Another potential mechanism for LTP loss could be through changes in dopamine 
(DA) signalling in the absence of FMRP. DA signalling modulates PFC neuronal 
activity and affects several PFC functions such as working memory and attention 
(Zahrt et al. 1997; Granon et al. 2000). DA receptor 1 (D1R) signalling has also been 
shown to be required for the expression of LTP in rat PL mPFC circuits (Huang et al. 
2004). D1R activation increases synaptic strength through insertion and 
phosphorylation of the AMPAR-subtype GluR1 as well as phosphorylation of 
NMDARs, however both of these effects are diminished in the absence of FMRP (Xu 
et al. 2012). These effects are associated with a hyperphosphorylation of D1R which 
prevents activation of downstream pathways in Fmr1 KO neurons (Xu et al. 2012). 
Other groups have also reported a reduction in D1R protein levels in PFC neurons 
suggesting that DA signalling is dampened in Fmr1 KO PFC (Paul et al. 2013). These 
findings have been associated with deficits in PFC synaptic plasticity including DA-
mediated facilitation of LTP in anterior cingulate cortex (ACC) (Wang et al. 2008) as 
well as DA-mediated enhancement of inhibitory synaptic activity (Paul et al. 2013). 
Therefore, one could hypothesise that reduced D1R signalling during LTP induction 
in Fmr1 KO rats underlies the loss of LTP. Interestingly, low level group 1 mGluR 
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antagonists have been shown to restore D1R phosphorylation in Fmr1 KO neurons to 
WT levels, restoring DA-mediated facilitation of LTP in the ACC (Xu et al. 2012). 
This suggests exaggerated mGluR signalling in the absence of FMRP results in 
diminished DA signalling however the mechanism for this is unclear. Nonetheless, 
this presents a potential therapeutic strategy to restore LTP in Fmr1 KO PL circuits 
and could explain previous observations in mice (Martin et al. 2015). As FXS patients 
present increasing ID with age (Utari et al. 2010) it is tempting to link this to our 
finding, however the role that LTP in PL mPFC plays in cognitive function is 
unknown. Despite this, it is clear that the loss of FMRP results in profound changes in 
mPFC translaminar communication.  
 
5.5.2 Hypoexcitability of neurons 
 
The mPFC receives and integrates information from a wide range of diverse brain 
regions as well as providing reciprocal connectivity allowing it to play a role in a 
variety of cognitive functions. Layer 5 acts as the major output layer of the cortical 
column, with glutamatergic pyramidal neurons providing long range projections to 
distinct cortical and subcortical areas. A large body of work has highlighted how these 
L5 neurons form a heterogeneous population with distinct local circuit organisation, 
intrinsic properties and neuromodulation depending on their long range target (Wang 
et al. 2006; Brown & Hestrin 2009; Dembrow et al. 2010; Morishima et al. 2011). This 
suggests that distinct subcircuits exist within the L5 pyramidal neuron population 
which regulate specific behaviours through their unique synaptic inputs as well as 
projection targets. 
 
Here I used retrograde tracing to identify a L5 subpopulation of pyramidal neurons 
that provide long-range projections to the basolateral amygdala. This projection 
pathway is known to be important for the expression of fear memories, a behaviour 
which is known to be affected in Fmr1 KO animals (Paradee et al. 1999). As mGluR5 
activation has been shown to modulate both excitatory and inhibitory transmission in 
L5 mPFC pyramidal neurons, I predicted several elements of intrinsic and synaptic 
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physiology would be perturbed in Fmr1 KO circuits as mGluR5 is thought to be 
constitutively active in the absence of FMRP (Ronesi & Huber 2008). However, I 
found none of the physiological phenotypes associated with enhanced mGluR5 
signalling in Fmr1 KO rats. PL-BLA neurons were found to be intrinsically 
hypoexcitable in the absence of FMRP, firing fewer action potentials in response to 
current injection than WT control neurons. This is contrary to studies which have 
shown significant increases in intrinsic excitability in mPFC neurons in the presence 
of mGluR5 positive allosteric modulators (PAM) (Kiritoshi et al. 2013; Sun & 
Neugebauer 2011). Similarly, sEPSC amplitude was also unchanged in our recordings 
but has previously been shown to be increased by mGluR5 PAMs (Kiritoshi et al. 
2013). These results suggest that exaggerated mGluR5 signalling does not affect the 
intrinsic excitability of L5 pyramidal neurons in Fmr1 KO PL mPFC. However, one 
must be cautious comparing results using acute pharmacology to a circuit that has 
possibly undergone development with enhanced mGluR5 signalling as compensatory 
mechanisms in these animals may mask these effects. 
 
5.5.3 Mechanism underlying hypoexcitability 
 
Despite these results, a clear hypoexcitability was observed in PL-BLA pyramidal 
neurons in Fmr1 KO rats. This result is contrary to what is commonly hypothesised in 
Fmr1 KO studies which is typically associated with circuit hyperexcitability stemming 
from increased input resistance (Contractor et al. 2015). Hypoexcitability of PL-BLA 
neuron in Fmr1 KO was not associated with changes in intrinsic membrane properties 
suggesting that subthreshold conductances were unaffected in these neurons. The loss 
of FMRP has been associated with the dysregulation and dysfunction of several diverse 
voltage-gated ion channels which have been shown to impact neuronal function in 
various ways including intrinsic excitability. Ih currents, mediated by HCN-channels, 
can modulate neuronal excitability through regulation of membrane resistance, 
synaptic integration and resting membrane potential (Shah, 2014). Studies have 
revealed opposing changes in dendritic expression of HCN-channels in pyramidal 
neurons of hippocampus versus cortex of Fmr1 KO mice emphasising the variability 
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with which FMRP loss can affect cellular excitability in different brain regions (Brager 
et al. 2012; Zhang et al. 2014; Kalmbach et al. 2015). Ih currents in PL-BLA neurons 
appeared to be subtly enhanced in Fmr1 KO rats however this effect was not 
significant (Fig 5.5) so it is unclear if this could have an effect on intrinsic excitability. 
Ih has also been shown to contribute to the generation of mAHP following a burst of 
action potentials (Oswald et al. 2009). As this was also comparable between genotypes 
in this study (Fig 5.6), this suggests that Ih changes do not contribute to the observed 
hypoexcitability of Fmr1 KO PL-BLA neurons. However, previous studies that have 
identified changes in Ih currents in Fmr1 KO neurons have shown that the effect is 
restricted to the dendritic compartment, with no observable changes in the soma. 
Therefore, as I recorded currents exclusively in the somatic compartment, I cannot rule 
out changes in dendritic processes that may contribute to changes in neuronal 
excitability. 
Another channel that can affect neuronal excitability and has been shown to be affected 
by the loss of FMRP is the A-type K+ channel Kv4.2. Kv4.2 is known to regulate 
current threshold as well as action potential repolarisation in cortical pyramidal 
neurons (Carrasquillo et al. 2012) both of which are affected in Fmr1 KO PL-BLA 
neurons. FMRP has also been shown to regulate Kv4.2 expression (Gross et al. 2011; 
Lee et al. 2011) leading to functional changes in Fmr1 KO neurons (Routh et al. 2013) 
making this a good candidate to underlie the phenotypes observed here. However, I 
observed no changes in Kv4.2 currents in our cells, or in any other tested K+ 
conductance (Fig 5.9). Once again our recordings were limited to soma, as Kv4.2 
shows dendritic gradient I cannot rule out changes in this compartment as identified in 
the Fmr1 KO CA1 pyramidal neurons are not present (Routh et al. 2013). 
 
FMRP can also directly activate some ion channels via protein-protein interactions. 
This includes the Slack channel (sequence like a Ca2+-activated K+ channel) (Brown 
et al. 2010) and BK channels (large-conductance Ca2+-activated K+ channel) (Deng et 
al. 2013). Whilst I did not directly measure either of these conductances, both are 
known to play a role in the AHP that follows a burst of action potentials. As I observed 
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no changes in AHP at any frequency, this suggests that changes in these conductances 
did not contribute to PL-BLA neuron hypoexcitability. 
 
Despite membrane resistance being unchanged in Fmr1 KO PL-BLA neurons, I 
observed that rheobase, the minimum current required to trigger an action potential, 
was significantly larger (Fig 5.4). This was accompanied by an increase in action 
potential threshold in the absence of FMRP (Fig 5.7) which suggests the availability 
of voltage-gated Na+ channels, which influence action potential voltage threshold 
(Royeck et al. 2008), is affected in Fmr1 KO neurons. In agreement with this action 
potential max dv/dt, a measure which reflects underlying Na+ conductances, was also 
significantly reduced (Fig 5.7). Action potential threshold is believed to be dependent 
on the axon initial segment (AIS), a specialised structure with a high density of Na+ 
channels approximately 50 times greater than proximal dendrites (Kole & Stuart 2008: 
Kole et al. 2008). As well as the density of Na+ channels, the location and length of the 
AIS are both thought to influence a neurons action potential threshold. Results here 
suggest a shortening of AIS length in Fmr1 KO PL-BLA neurons (Fig 5.8). This result 
is in good agreement with the observed changes in action potential waveform. Further 
experiments investigating Na+ currents in PL-BLA neurons could provide support for 
this mechanism as a shorter AIS length should result in a reduction in Na+ current 
density. 
Whilst the AIS was classically thought of as a static structure, it is now known that it 
is able to modulate both its length and distance from soma in response to neuronal 
activity (Grubb & Burrone 2010). This structural plasticity allows the neuron to fine-
tune its excitability according to the level of its synaptic activity thereby 
homeostatically regulating its input-output relationship. As mEPSC frequency is 
increased in Fmr1 KO PL-BLA neurons (Fig 5.12), indicating that the number of 
inputs or release probability is increased, the decrease in AIS length could represent a 
compensatory response of KO neurons to normalise their output in response to 
increased synaptic input. This is supported by the observation that no changes were 
observed in action potential driven EPSCs (Fig 5.11) suggesting that despite an 
increase in the frequency of inputs, circuit excitability is maintained possibly through 
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cell intrinsic properties. However, from these results it is not possible to decipher 
which of these phenotypes is associated with the loss of FMRP and which is 
compensatory.  
 
5.5.4 Are changes in neuronal excitability across all mPFC L5 pyramidal neurons 
or subtype specific?  
 
Whilst L5 pyramidal neurons do show intrinsic differences depending on their long-
range targets, it is possible that the results observed here represent a phenotype that is 
general to all mPFC L5 pyramidal neurons of Fmr1 KO rats. Previous studies that have 
investigated neuronal excitability in undefined mPFC L5 pyramidal neurons have 
found no changes in adult Fmr1 KO mice (Martin et al. 2015). However others have 
reported reduced c-fos staining across the Fmr1 KO mPFC, suggesting neuronal 
activity is reduced in these circuits (Krueger et al. 2011). If all subtypes are similarly 
affected, these findings would be counter to the commonly held view that neuronal 
circuits are hyperexcitable in Fmr1 KO animals (Contractor et al. 2015). However, 
these studies are typically confined to early developmental time points with some 
phenotypes only appearing transiently (Gibson et al. 2008; Zhang et al. 2014; Routh 
et al. 2013; Brager et al. 2012). As discussed earlier, the intrinsic neuronal 
hypoexcitability here could represent a compensatory change in response to general 
circuit hyperexcitability which only becomes apparent at later stages of development. 
Future work assessing the effect of FMRP loss on other mPFC subcircuits would be 
of interest in elucidating whether these effects are general to all mPFC L5 pyramidal 
neurons. 
 
Equally, the phenotypes identified in this chapter could be restricted to be PL-BLA 
mPFC neurons. Recent work in Fmr1 KO mice has shown that the loss of FMRP 
differentially affects two subpopulations of mPFC L5 pyramidal neurons (Kalmbach 
et al. 2015). This reflects the capability for specific phenotypes in Fmr1 KO neurons 
to develop depending on cell extrinsic effects (e.g. synaptic inputs). Previous work has 
suggested layer 5 pyramidal neurons receive only ~20% of their synaptic inputs from 
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other local L5 neurons, with the majority of inputs coming from other prefrontal 
regions, CA1 hippocampus and the BLA (DeNardo et al. 2015). PL-BLA neurons have 
been shown to receive enhanced input from ascending BLA projections creating a 
strong reciprocal circuit (Little & Carter 2013; Cheriyan et al. 2016). Therefore in 
Fmr1 KO animals where BLA circuits are thought to be hyperexcitable (Olmos-
Serrano et al. 2010; Vislay et al. 2013) synaptic inputs onto PL-BLA neurons could be 
significantly enhanced relative to neighbouring L5 pyramidal neurons. The disparity 
in synaptic activity between different populations of neurons could result in cell-
specific compensatory mechanisms to fine tune neuronal activity as suggested by the 
results described here. 
 
5.5.5 What could these results mean for behaviour? 
 
The prelimbic mPFC is an important structure in the processing of fear memories. PL-
BLA neurons have been shown to be preferentially recruited during fear expression as 
well as retrieval (Orsini et al. 2011; Knapska et al. 2012). Therefore, hypoexcitability 
of PL-BLA neurons in Fmr1 KO rats could contribute to deficits in fear learning as 
the relevant mPFC circuits are harder to recruit. Similarly, the acquisition of fear 
memories has been shown to be dependent on intrinsic plasticity of prelimbic circuits. 
Fear conditioning results in a reduction in intrinsic excitability of PL-BLA neurons 
similar to that described in Fmr1 KO neurons. Whilst one study linked this with a 
decreased input resistance (Song et al. 2015), another found that action potential 
threshold was depolarised and max dv/dt reduced in PL-BLA neurons following fear 
conditioning, mirroring the effects of FMRP loss (Szlapczynska, 2014). Interestingly 
these effects were not present in neighbouring neurons that project to the contralateral 
mPFC suggesting they may be restricted to PL-BLA neurons. As fear conditioning is 
known to activate ascending BLA projections to the PL (Senn et al. 2014) this could 
trigger plasticity of L5 PL-BLA neurons intrinsic excitability as previously 
hypothesised. Therefore, it is possible that the hypoexcitability of PL-BLA neurons in 
Fmr1 KO rats could reflect a circuit that has already adapted to a state of high fear 
resulting from BLA hyperexcitability. This could occlude any further learning-related 
146 
 
changes in these pathways, contributing to the deficits in fear learning associated with 
Fmr1 KO animals (Paradee et al. 1999). Future work focussing on other elements of 
these pathways and how they are affected by fear learning may reveal changes in the 
underlying physiology associated with fear memory formation, which are yet to be 














































6.1 mGluR pathophysiology in the Fmr1 rat 
 
Since its original inception, the mGluR theory of FXS has informed the design and 
predicted outcomes of many studies attempting to ameliorate phenotypes in models of 
FXS. It has been corroborated by a wide range of experiments from laboratories around 
the world at several levels of experimental interrogation and has significantly 
enhanced our understanding of the underlying pathophysiology of FXS. This data has 
formed a strong preclinical data set that has resulted in clinical trials targeting mGluR5 
signalling in FXS patients. The development of genetically modified rats represent a 
valuable new tool for the study of NDDs such as FXS. As well as presenting several 
advantages over mice as preclinical models (discussed earlier), the generation of Fmr1 
KO rats has allowed us directly test the conservation of mGluR-dependent phenotypes 
across mammalian species. 
 
In this thesis we have been able to recapitulate many of the mGluR dependent 
phenotypes originally identified in the Fmr1 KO mouse in both CA1 hippocampus and 
lateral amygdala. We also report preliminary results showing that pharmaceutical 
interventions targeting mGluR5, using the negative allosteric modulator CTEP, are 
able to reverse some of these phenotypes as has commonly been reported in Fmr1 KO 
mice literature. This data provides additional support that dysfunction of mGluR5 
signalling contributes to pathophysiology of FXS. It also provides validation of the 
therapeutic strategy of targeting mGluR5 which has been carried forward into clinical 
trials for treating the human condition. These trials have recently been discontinued as 
no significant benefit of drug treatment. Here I will discuss these trials and their 
implications for future work treating mGluR5 as a target in FXS. 
 
6.1.2 mGluR5 as a target in FXS 
 
Mavoglurant (AFQ056), a non-competitive mGluR5 inhibitor, has shown rescue of 
molecular, dendritic spine and behaviour phenotypes in Fmr1 KO mice (Levenga et 
al. 2011; Gantois et al. 2013; Pop et al. 2014). A small scale exploratory cross-over 
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trial showed no beneficial effect of mavoglurant, however post hoc analysis showed a 
significant positive outcome in patients with completely methylated FMR1 promoter 
(Jacquemont et al. 2011). This resulted in a large-scale double blind, placebo 
controlled, 3 month trial evaluating the effectiveness of mavoglurant at multiple doses 
in both adult and adolescent FXS patients stratified by their methylation status of 
FMR1. This trial found no significant benefit of drug treatment in any of the assessed 
outcome measures. A concurrent phase 2 trial at Roche using the mGluR5 negative 
allosteric modulator RG7090 also found no significant efficacy in the primary and 
secondary endpoints assessed in FXS patients. These results suggest that, contrary to 
over a decade of work in FXS animal models, there is no significant therapeutic action 
of reduced mGluR5 signalling in FXS. 
 
One possible explanation for this negative result could be that the phenotypes observed 
in rodent models of FXS are not translatable to humans. Beyond the obvious criticism 
that rodent and human physiology are not directly comparable, problems in the study 
of FXS could also stem from the construct validity of the animal models used. The 
available animal models, including the Fmr1 KO rats discussed in this thesis, are 
generated by genetic modification of DNA to resulting in complete transcriptional 
silencing of the FMR1 gene. This strategy is in contrast to human FXS which is the 
result of hypermethylation of the FMR1 promoter sequence, with only rare instances 
of FXS resulting from point mutations. Whilst one could argue that the complete 
disruption of FMR1 provides good construct validity for the full mutation, this does 
not reflect the considerable genetic heterogeneity that underlies human FXS. Although 
clinical severity of FXS typically correlates with CGG repeat number, the methylation 
status and transcriptional silencing of FMR1 is not exactly correlated with repeat 
length (Loesch et al., 2004). Similarly, clinical severity can vary greatly in full 
mutation carriers and some individuals still show detectable levels of FMRP (Pretto et 
al. 2014). Individual patients also show multiple repeat lengths in their genomic DNA 
across different tissues due to somatic mosaicism which again contributes to the 
genetic heterogeneity (Lokanga et al., 2013). The full KO model also fails to 
recapitulate the developmental silencing of FMRP in human tissue. FMRP expression 
is at normal levels until approximately 10 weeks gestation in full mutation males, with 
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complete silencing occurring by 12.5 weeks (Willemsem et al., 2002). The loss of this 
complexity represents mechanistic differences between the rodent models and human 
genotype which may contribute to the difficulty in translating preclinical phenotypes 
into human trials. 
 
These findings could also result from flaws in trial design which must be addressed in 
future trials for the treatment of FXS. Firstly, the age of patients used in the trial may 
have been sub-optimal for therapeutic intervention. Despite the use of adolescents in 
the mavoglurant trial, the youngest patients were still likely equivalent to a young adult 
age in mouse studies (Berry-Kravis et al. 2016). Whilst mouse studies have shown 
rescue of anatomical, biochemical and behavioural phenotypes in young adults with 
mGluR5 antagonism (Michalon et al. 2012) some groups have reported greater 
treatment effects at early ages relative to later development (Su et al. 2011). As 
neuronal plasticity is generally declines with age, therapeutic intervention may be 
more effective the earlier it is begun. Therefore, in future clinical trials it would be 
desirable to begin at the earliest possible time point to fully test the age-dependence of 
mGluR5 inhibition treatment. Secondly, the duration of treatments may not be 
adequate to see beneficial effects in human FXS trials. Given the obvious expense of 
clinical trials, durations are limited. As the longest study duration in the mGluR5 trials 
was 12 weeks it may be informative to use a longer treatment period or extended 
clinical follow-up window to assess the efficacy of drug targets. Thirdly, the outcome 
measures used in these studies are typically vulnerable to a strong placebo effect due 
to the role of parents and caregivers in rating schemes (Berry-Kravis et al., 2015). This 
is a well-documented issue in trials addressing IDs (Sandler, 2005). Therefore, the use 
of more objective outcome measures is required to counteract this effect. Finally, the 
outcome measures used in these studies do not cover all of the symptomatic domains 
of FXS and are mainly focused on the behavioural symptoms associated with the 
condition. These features may not show improvement with drug treatment whereas 
cognitive measures may show more significant improvement to treatments aimed at 
restoring normal synaptic plasticity. Behaviours that can act as markers of central 
response, such as pre-pulse inhibition or event related potentials, may also be useful 
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as non-biased measures of drug treatment. These analyses can also be performed in 
preclinical models allowing better translation and prediction of effects in human trials. 
 
6.2 Fear and emotionality in FXS 
 
As well as intellectual disability, FXS is associated with a number of emotional 
symptoms including anxiety, high stress levels and fearfulness. Given the established 
role of the amygdala in emotional processing as well as the acquisition and storage of 
fear memories, it has become an area of interest in the study of FXS. Observations that 
the acquisition of fear memories is reduced in both Fmr1 KO mice and rats, suggests 
that the synaptic plasticity underlying this form of memory is affected in the absence 
of FMRP. It has previously been reported that mGluR-dependent LTP at thalamic 
inputs to the lateral amygdala is absent in Fmr1 KO mice. The lateral amygdala 
receives major cortical and thalamic inputs that are able to undergo synaptic plasticity 
during fear learning. As these inputs can undergo plasticity independently, it is likely 
that synaptic potentiation at either input is sufficient for fear learning (Tsvetkov et al., 
2004; Romanski & LeDoux, 1992). In this thesis, we report deficits in mGluR-
dependent LTP at both the cortical and thalamic inputs to the lateral amygdala in Fmr1 
KO rats. This supports the hypothesis that deficits in plasticity within the lateral 
amygdala contributes to fear acquisition deficits in Fmr1 KO rats. 
 
As well as synaptic plasticity and local signalling in the amygdala, the mPFC can also 
influence fear learning and emotional processing through its long range connectivity 
with the basolateral amygdala. Whilst the mPFC and amygdala have been studied in 
isolation in Fmr1 KO mice, no studies have addressed their reciprocal connectivity 
and how this can influence FXS behaviours. In this thesis we have taken a first step in 
investigating how top-down control of the amygdala is affected in the mPFC. We 
found prelimbic mPFC neurons that send long-range projections to the amygdala are 
intrinsically hypoexcitable in Fmr1 KO rats. This appears to be the result of structural 
changes in the axon initial segment (AIS), resulting in an increased action potential 
152 
 
threshold and dynamics in Fmr1 KO neurons. These changes are likely the result of 
homeostatic changes, possibly in response to increased synaptic input in Fmr1 KO 
neurons. Future work addressing the correlation of AIS length with intrinsic 
physiology is required to assess whether this structural change is sufficient to explain 
the observed neuronal hypoexcitability.  
Future work using optogenetics techniques to investigate the synaptic properties of the 
long range connections to the basolateral amygdala in Fmr1 KO rats would also be 
interesting assessing the fidelity of neurotransmission between these two areas. As fear 
learning has been shown to involve plasticity of both the intrinsic properties of neurons 
in the mPFC and their synaptic connectivity with the basolateral amygdala, it would 
be interesting to assess these properties before and after fear learning in Fmr1 KO rats. 
As fear circuitry can also be imaged in awake rats using fMRI (Harris et al., 2015), 
these in vitro techniques could be used in complement with in vivo imaging to assess 
how the mPFC and basolateral amygdala interact during acquisition of fear memories 
and how this is affected in FXS. 
 
6.3 Future modelling of FXS 
 
Appropriate preclinical models are a requirement for the meaningful study of human 
diseases. Whilst animal models have no doubt contributed greatly to our understanding 
of FXS, the potential for human derived cell lines as a tool for the study of FXS is also 
an exciting prospect. Human embryonic stem cells (ESCs) from FXS affected embryos 
allow the investigation of aspects of FXS that were previously unattainable in other 
model systems such as CGG region expansion and the developmental timing of FMR1 
silencing (Castren et al. 2005; Eiges et al. 2007). Whilst this makes human ESCs a 
useful model, the ethical concerns and the difficulty in adequately representing the 
genetic and clinical variability of FXS in this system presents limitations. Advances in 
induced pluripotent stem cell (iPSC) technology have allowed the generation of FXS-
iPSC lines derived from human FXS patients. Unlike FXS-ESCs, the FMR1 gene 
maintains its hypemethylation status following reprogramming meaning it is not a 
suitable model for studying the silencing mechanisms of FXS (Urbach et al. 2010). 
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Despite this, FXS-iPSC lines present a unique system for studying subpopulations of 
FXS individuals with differing genetic and clinical profiles. 
 
The addition of these human cell line technologies to the preclinical animal models of 
FXS and non-invasive techniques used in FXS patients provides researchers with a 
powerful toolbox for the study of FXS. However as each of these systems presents its 
own advantages and limitations, an orchestrated research effort addressing the same 
question across multiple levels of analysis would be most beneficial. An interesting 
example of this strategy has been adopted by the Fragile X syndrome research centre, 
a multi-centre collaborative effort using an integrated approach to test the mechanisms 
of auditory processing sensitivity. These groups have also attempted to develop 
complementary tests of auditory processing using auditory event-related potentials that 
will allow direct comparison between human and animal studies. The ability to 
perform non-invasive imaging in rats also represents a unique feature of the Fmr1 KO 
rat that could be capitalised upon in a similar way. Using a framework like this where 
phenotypes are followed from multiple levels of analysis and using analogous methods 
in both preclinical models and human studies will be key to the successful translation 
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